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Abstract
African American (AA) women are disproportionately affected by HIV/AIDS. The
infection rate for AA women continues to increase, and literature lacks information
specifically on education for AA women regarding viral suppression at diagnosis. The
purpose of the study was to understand the lived experiences of AA women living with
HIV in the District of Columbia, particularly how they acquired knowledge of viral
suppression. To understand their experiences with antiretroviral medications, viral
suppression, discrimination, and stigma, this qualitative study applied a hermeneutic
phenomenological approach. The theories of resilience and empowerment were applied.
Ten HIV positive AA women living in the District of Columbia were selected through
purposeful sampling. Primary data were collected through semistructured open-ended
interviews. Clinical data from DC Health/HAHSTA HIV Surveillance system were used
to triangulate responses. Participants’ self-report showed 80% achieved viral suppression.
Study findings indicate that education on the importance of viral suppression was not
consistently provided to women at time of HIV diagnosis. Unprotected sex, men
returning from prison, and lack of HIV education were named as factors spreading the
infection. The consistent factor in HIV survivability for the sample were unfettered
access to HIV treatment, availability of antiretroviral medication, self-efficacy,
spirituality, and support group. This study promoted social change by identifying precise
areas of HIV education for AA women to be incorporated in HIV prevention and
treatment interventions.
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Chapter 1: Introduction to the Study
Introduction
Human immunodeficiency virus (HIV) affects millions of people globally. HIV is
defined as a retrovirus which attacks the T-lymphocytes cells in the body, destroying the
body’s defense mechanism against infections (CDC, 2019). The infected person becomes
immune compromised, with potential to degenerate into acquired immune deficiency
syndrome (AIDS). At this point, the person becomes symptomatic to the HIV infection,
with symptoms including, diarrhea, rashes, weakness, and unexplained weight loss. The
immune compromised body is then frequently attacked by opportunistic infections such
as Pneumocystis Carinii Pneumonia (PCP), fungal infections, syphilis, Hepatitis B,
Hepatitis C and Mycobacterium avium complex (MAC), among others (Panel on
Opportunistic Infections in HIV-Infected Adults and Adolescents, 2018). HIV virus is
transmitted through unprotected sexual intercourse with an infected person, sharing
needles and syringes during injection drug use, from mother to child, and transfusing
HIV contaminated blood (WHO, 2018b)
In 2017, there were 36.9 million people living with HIV around the world and
35.1 million of them were adults, while 1.8 million were children under the age of 15
(United Nations on AIDS, 2018). According to United Nations, about 940,000 people
died of the disease in 2017 and 35.4 million since the disease epidemic began (2018). In
the United States, an estimated 1.1 million people have been infected with HIV (Center
for Disease Control and Prevention [CDC], 2019a). The CDC also estimates that 38,700
new infections occur yearly (2019a). HIV was first reported in 1981 among men who
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have sex with men (MSM) in Los Angeles (CDC, 1981). However, in the last 3 decades,
the trend in the prevalence of diagnosed HIV infection has changed affecting every
demographic: race, ethnicity, age group, males and females (CDC, 2019a). Overall, in
2017, more than 7,000 women were diagnosed with HIV in the United States (CDC,
2019a). Women made up 19% (7,401) of the total 38,739 new HIV diagnoses in 2017
(CDC, 2019b). The CDC further noted that African Americans females make up 13% of
the United States female population. However, 59% of all the women infected with HIV
in the United States are African American (AA) females (CDC, 2019b). In contrast,
Hispanic females make up 17.4% of the female population, but 16% of the disease
burden (CDC, 2019b). White females are 61.2% of the female population but have
prevalence rate of 20% (CDC, 2019b). There is an overall downward trend for new
infections across the United States. This downward trend is not true for all groups,
however. The CDC (2016a) reported an increase of HIV infections among 25 to 34 yearolds African American women for the 3 consecutive years of 2012, 2013 and 2014.
In 2014, the number of HIV infections was high among African American
females in the United States, at 4,208, compared to Hispanic/Latino females at 1,111 HIV
infections and White females at 988 infections during the same year (CDC, 2017). A
similar pattern emerged in 2015, with the number of HIV infections for AA females at
4,075, Hispanic/Latino females at 1,052, and White females at 962 infections (CDC,
2017). In 2016, new HIV diagnosis trends based on race and gender remained consistent
with AA women engaged in heterosexual contact disproportionately affected at 4,189
HIV infections. White women infected through heterosexual contact were at 1,032 and

3
Hispanic/Latina women infected through heterosexual contact were at 1,025 infections
(CDC, 2017). Skarbinski, et al. (2015), in their analysis, confirmed reduction of HIV
transmission rates along the care continuum. However, even in an analysis of reduction
rates, their analysis showed increases in new infections among AA women. The steady
increase in HIV infection among AA females remains a concern.
New infection in the District of Columbia is consistent with national rate, with
AA women being disproportionately affected by HIV/AIDs. In 2011, the HIV prevalence
rate in the District of Columbia was above epidemic level at 2.5% and the prevalence rate
among AA females was at 2.6% (District of Columbia/Department of Health//HIV/AIDS,
Hepatitis, STD and TB Administration [DC/DOH/HAHSTA] Annual report, 2012). In
2018, the overall HIV prevalence rate fell to 1.8% (DC/DOH/HAHSTA, 2017) while
prevalence rate among AA women was 1.6%. This exceeded the prevalence rates for
Latino and White women which were 0.3% and 0.01% respectively (Figure 1). Put
another way, the general population of African American (AA) female in the District is
48.5% but this demographic accounted for 94.3% of new HIV infections in 2018
(DC/DOH/HAHSTA, 2019).
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Figure 1. HIV prevalence by race/ethnicity and gender identity, District of Columbia,
2018. From “Annual epidemiology& surveillance report: data through December 2018”,
DC/DOH/HAHSTA (2019).
HIV has no cure. As a chronic disease, HIV is treatable with effective active
medications. The hallmark clinical benefits of HIV treatment and engaging in HIV care is
achieving viral suppression (AIDSinfo, 2019). In this status, the virus is undetectable in
the blood and leads to improved health outcomes (Panel on Antiretroviral Guidelines for
Adults and Adolescents [DHHS Guideline], 2018). However, adherence to lifelong
medications remains a challenge (National Institute of Allergy and Infectious Diseases,
2013). Holstad, Dilorio, & McCarthy (2011) found that low adherence to HIV medication
was linked to detectable viral loads, low CD4 count and high risk behaviors for HIV
acquisition.
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In the 2016 District of Columbia HIV annual report, summarized in Figure 2
below, among AA women living with the disease, 97.5% were linked to care at some
point. Amongst which 77.7% are retained in care, 57.7% had more than one medical
visit. In the same report, 75.8% were ever virally suppressed while 61.7% were
suppressed at last known viral status in the year (DC/DOH/HAHSTA, 2017).

Figure 2. 2016 Care dynamics among women living in DC, by selected characteristics.
From “Annual epidemiology & surveillance report: data through December2016”
DC/DOH/HAHSTA (2017).
There is little data in the existing body of HIV/AIDS research that focuses on
African American women in order to understand their perspectives on viral suppression.
This data is critical to create informed interventions that will be effective in reducing the
infection rate in this subpopulation and support healthy living with HIV/AIDS. Available
literature shows a gap in understanding of viral suppression and its effect on the lived
experiences of AA women. It is imperative that women who are HIV positive learn the
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importance and meaning of viral suppression. The social change in this study is the
potential to increase knowledge to prevent HIV transmission and also increase the quality
of life for AA women who have the disease.
Available literature shows women of reproductive age (15-49 years) are mostly
impacted with HIV (CDC, 2019c, CDC 2018a, DC/DOH/HAHSTA, 2017, World Health
Organization, 2006). In 2017, 13% of new HIV diagnoses were among young women
ages 13-24 (CDC, 2019c). Eighty six percent of these young women were infected
through heterosexual contact. The social implication of HIV among young African
American women includes transmission to newborn, known as vertical transmission. This
can happen either in the uterus, during birth or while breast feeding (AIDSinfo, 2019b).
In addition, HIV infected people suffer stigma, and various forms of discrimination. At
the same time, some African American women have been infected at young age and
living well with the disease for many years. This study expects to understand the
resiliency in African American women infected with HIV that may have contributed to
their experiences living and surviving the infection. This study will also attempt to
understand the role of empowerment to surviving the infection.
Another potential for social change is using key findings in this study to develop
interventions geared towards viral suppression among the African American community.
The interventions may be implemented in various clinics to help other HIV positive AA
women thrive and live well with the disease. The new knowledge will impact the
development and planning of the Mayor’s “Ending the HIV Epidemic Campaign.
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Chapter 1 is a synopsis of the epidemiology of HIV and the implication of the
disproportionate rate of infection among women, particularly African American women.
Specifically, viral load suppression will be discussed as a point of reference among this
disproportionately affected population. In this chapter, I include the background of the
study, problem statement, purpose of the study, and research questions. Other topics
summarized in this chapter included the theoretical framework applied to the study,
nature of the study, significance of the study, assumptions, scope and delimitations, and
limitations of the study. Some technical terms such as CD4 count, viral load suppression,
vertical transmission, phenomenology, and resiliency are defined to ensure
comprehension.
Background of the Study
The United States witnesses approximately 40,000 HIV infections every year
(CDC, 2019d). Meanwhile, HIV prevention focuses mainly on MSM in general, and
young Black MSM in particular. However, the infection rate among African American
females is at 1.9 % of new infections in the District of Columbia (DOH/DC/HAHSTA,
2017) and accounted for 4,189 new infections in 2016 in the United States (CDC, 2017).
This has led Haverkos, Chung and Perez (2003) to inquire if there is an HIV epidemic
among heterosexuals in the United States, found insidious and underestimated HIV
epidemics among AA heterosexual community and recommended immediate mitigation
strategies.
Many studies have examined HIV/AIDS surveillance data. Hall, Espinoza,
Benbow and Hu (2010) statistically analyzed 2007 data in 12 metropolitan areas and
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found that 0.3% to 1% of the populations in each area lived with HIV. Researchers report
that over the course of the epidemic, the composition of infected population has changed
to include more infections among persons of color. This change in the HIV epidemic
from white males who have sex with men to AA females is one of the reasons for my
research focus. HIV diagnoses for African American females was 4,931 in 2011, 4,666
in 2012, 4,307 in 2013, 4208 in 2014, 4,075 in 2015, and 4,189 in 2016 (CDC, 2017).
According to the same report, these number are significantly above the diagnoses of
heterosexual African American men. For heterosexual AA men, 2,449 were newly
diagnosed in 2011, 2,257 in 2012, 2,059 in 2013, 1,997 in 2014, 2,048 in 2015, and 1,926
in 2016. Diagnoses among Hispanic females were 1,189 in 2011, 1,054 in 2012, 1, 050 in
2013, 1,111 in 2014, 1,052 in 2015 and 1,025 in 2016 (CDC, 2017). Diagnoses among
White females in the same years were 1,014 in 2011, 970 in 2012, 913 in 2013, 988 in
2014, 962 in 2015, and 1,032 in 2016. (CDC, 2017).
Hall et al. (2013) found that 857,276 persons with HIV in the United States had
not achieved viral suppression, which is the key outcome of HIV treatment and
subsequent reduction in transmission. Lanier et al. (2013) used surveillance data on HIV
positive AA women in the District of Columbia to explore sociocultural correlates for
HIV progression to AIDS. Among 3,050 women with complete data in this study, 59.4%
had progressed to AIDS and, at their most recent medical visit, 36.4% had a CD4 count
<200 cells; 18.8% of the participants progressed to AIDS within 12 months of diagnosis.
The researchers found no relationship for progressing to AIDS with poverty, educational
level, or census tract. In this analysis, 25% of women did not have the typical risk factors
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for acquisition of HIV except that 50% reported heterosexual sex. While African
American women made up 48.5% of the estimated population of the District of Columbia
in 2015, they accounted for 94.1% of all female HIV cases living in the District in 2016
(DC/DOH/HAHSTA, 2017).
Lending credence to the high need for this study is the analysis by Nwangwu-Ike,
Hermandez, An, Huang, and Hall (2015) that shows HIV diagnosis is decreasing among
females, but the highest rate remains for African American females. For African
American women, acquiring higher education did not result in a decrease in AIDS cases
(Horton, 2013). Epidemiological patterns showed African American females ages 15-35
years were still vulnerable to AIDS death but at a reduced rate. Most importantly,
disparities exist in viral suppression for African Americans and younger females (Hall et
al, 2013; Nwangwu-Ike et al., 2015; Gray, et al., 2013). Virally suppressed HIV infected
persons are less likely to transmit HIV (Skarbinski, et al., 2015). Viral suppression
reflects the result of a viral load test (i.e., the level of HIV in a person’s body is very low
[<200 copies/ml] or undetectable). Suppressed viral load improves the health of the
person living with HIV, increases survival, and reduces risk of transmitting HIV
(AIDSinfo, 2019).
Researchers have examined problems of nondisclosure of HIV status among low
literacy populations to ascertain if there are potential risks or protective factors for HIV
prevention and sexual behaviors. Polansky, Teti, Chengappa, and Aaron (2015) noted
that 79% of women in a monogamous committed relationship disclosed to partners,
compared to only 43% of women with multiple partners. In this study, none of the
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women with multiple nonprimary partners disclosed HIV status. Self-disclosure of HIV
status was positively associated with closeness and commitment among low-income
urban African American women.
When disclosure of HIV status increases, transmission decreases, and stigma also
reduces (Heggeness, Brandt, Paulus, Lemaire & Zvolensky, 2017). Stigma is regarded as
a major barrier that prohibits HIV positive persons from seeking care and receiving the
benefits of HIV treatment. According to Buseh and Stevens (2007), African American
women experience stigma socially, internally, and externally. Stigma also has deep roots
in gender, race, ethnicity, class, sexuality, and culture, and continues to be seen as a great
impediment to reducing HIV transmission (Valdiserri, 2002). Reducing stigma should be
incorporated in many educational programs. A study by Coleman, Tate, Gaddist and
White (2016) in a faith-based community noted lower HIV related stigma among
females, people who had a higher education, people who knew someone with HIV/AIDS,
and people who knew a gay person. Black churches have embarked on numerous health
related outreach programs among the black community but stigma in black churches
continues to affect the conduct of HIV related health activities (Pryor, Gaddist, &
Johnson-Arnold, 2015).
Another significant predictor of HIV infection is acquisition of sexually
transmitted diseases. High rates of sexually transmitted diseases offer some explanation
for increased incidences of HIV (Reif, Geonnotti & Whetten, 2006; Kanekar & Sharma,
2009), as STD compromises the integrity of the sexual tract for easier acquisition of the
virus during nonprotective sex. In 2016 in the District of Columbia, 8,569 people were

11
diagnosed with Chlamydia, 3,797 gonorrhea diagnoses and 181 Syphilis were recorded
(DC/DOH/HAHSTA, 2017).
As HIV continues to affect communities, especially the African American
community, treatment of HIV is assessed using the continuum of care. The care
continuum is a system currently used to assess and measure the efficacy of HIV treatment
from the early initiation of diagnosis through a continuum of five steps. The steps of care
include the number of people diagnosed, linked to care, engaged in care, prescribed
antiretroviral medication, and virally suppressed (CDC, 2017). In the District of
Columbia, the continuum of care begins with the number of HIV cases diagnosed and
living in the District, time person was linked to care, retained in any care, and virally
suppressed. Reduction in infection is one of the benefits of adhering to antiretroviral
medication. An observational study conducted by Rodger et. al (2016) supported the
importance of HIV treatment. The study included 1238 HIV discordant MSM and
heterosexual couples to observe HIV transmission during condomless sex. The HIV
positive partner was virally suppressed and on antiretroviral medication. Although, the
study reported 10 HIV transmissions among the MSM couples and one in a heterosexual
couple, none of the transmission was phylogenetically linked, therefore, the couple
transmission was zero for the study. In other words, the discordant couple did not
acquired HIV through their partners. Furthermore, the research findings of this study
corroborate the results of the randomized control trial known as HIV Prevention Trials
Network (HPTN052) in which HIV infection was reduced by 96% if an HIV positive
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partner is taking and adhering to antiretroviral medication (Cohen, McCarley, & Gamble,
2011).
HIV treatment therefore works as prevention of HIV transmission. This supports
the fact that when infected people engage early in treatment, they receive the full benefit
of treatment through use of antiretroviral medication. Anyone who tests positive must be
treated immediately as poor engagement might decrease the benefit of highly effective
antiretroviral medication (Cohen et al., 2012; Gardner, McLees, Stenier, Rio, & Burman,
2011). Antiretroviral medications have been very effective in the treatment of HIV and
are also highly effective in HIV prevention.
HIV is transmitted by an infected person. Therefore, initiatives to target
uninfected persons with antiretrovirals to prevent acquisition of HIV from infected
person is critical to reducing infection. Uninfected individuals at risk for HIV can take
pre-exposure prophylaxis (PrEP) to reduce risk of infection (CDC, 2019e). Efficacy in
prevention of HIV by taking a daily antiretroviral medication called Truvada has shown
promise. Baeten et al. (2014) demonstrated that a single antiretroviral medication,
Tenofovir or Truvada (Emtricitabine plus Tenofovir), both provided high protection
against acquisition of HIV-1 in heterosexual men and women as a pre-exposure
prophylaxis. Radzio, et al. (2012) modeled the benefit of 2 weekly doses of Truvada for
repeated exposures in Rhesus Macaques monkeys. The six animals that received Truvada
remained SHIV negative demonstrating that vaginal and systemic levels of Truvada was
protective against infection. The model showed effectiveness in prevention of vaginal
transmission which might be a possibility for a simplified regimen for HIV prevention for
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women. In a meta-analysis of seven randomized controlled trials involving 14,804
individuals, Jiang et al. (2014) showed that PrEP was effective in reducing new HIV
infection among populations at a high risk of infection. According to CDC (2019e),
taking one PrEP pill a day reduced infection through sex by 90% and through injection
drug use by 70%. The use of additional preventive measures with PrEP adds more
preventive value.
PrEP is a successful method for reducing HIV infection risks in men and women.
When prescribed, PrEP is entirely within a woman’s control to use for prevention of HIV
in comparison to a condom. However, Truvada as a PrEP medication is underutilized
among women at risk for HIV infection (Aaron et al., 2018). Some of the systemic
barriers to PrEP access are that medical providers do not offer it without insurance, lack
of awareness among young men who have sex with men, and individual barriers
(Bauermeister, Meanley, Pingel, Soler, & Harper, 2013; Ojikutu, et al., 2018). Although
the referenced study was conducted among young men who have sex with men, it holds
same for AA women. Due to the efficacy of PrEP as a prevention tool, PrEP needs to be
discussed and encouraged among AA women as an important intervention and to reduce
disparities.
Adherence to HIV antiretroviral medications is critical to their effectiveness as
they must be taken as prescribed. In a systematic review and meta-analysis,
nonadherence was associated with forgetfulness, travel, change of routine, desire to avoid
side effects, pill burden, secrecy due to stigma, alcohol use, and lack of food (Shubber et
al., 2016). In another study, a sample of AA women living with HIV were asked to
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identify roles that their providers played in enhancing their adherence to PrEP use. They
identified good provider-patient relationship, holistic patient care, good patient education,
effort to model adherence, and motivation as very important to adherence (Okoro &
Odedina, 2016). Peer education was also mentioned as a medication adherence enhancer
(Okoro & Odedina, 2016).
To ensure that women adhere to a treatment regimen, many medical providers
agree women should be assessed for readiness for antiretroviral medication before
writing a prescription to avoid development of resistance to medication. Smith et al.
(2013) assessed 288 HIV positive patients for readiness skills in relation to antiretroviral
therapy (ART). Their study used a structured survey that covered self-reported
information, motivation, and behavioral skills specific to retention in pre-ART HIV care.
Eligible participants were 18 years and older, newly entering into care, and ineligible for
ART (CD4 > 200cell/mm3). Seventy five percent of patients in the sample were women.
The findings identified eight information deficits, eight motivation deficits, and eight
behavioral deficits. The researchers argued that HIV positive patients could benefit from
facilitated social support, further education about the immune system, additional social
motivation to build positive attitudes, and increased positive interactions with medical
staff. The study also found that self-efficacy might be related to viral suppression and
subsequent positive health outcomes.
Unfortunately, high functioning or self-declared commitment does not necessarily
translate into medication adherence for better health outcomes. In a randomized
intervention program for women being released from prison, high confidence and
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expectations of ability to manage disease prior to their release for prison did not
materialize postrelease (Haley et al., 2014). Some of the reasons identified included
substance use, relapse, stressful life experiences, and stigma.
There are no studies that focus on women’s lived experiences with HIV infection
and their understanding of viral suppression. In addition, there is no research on young
black women’s perspectives on living with HIV, barriers and challenges to medication
adherence, and their views on HIV within the black community. No research has applied
self-efficacy as a construct of empowerment theory and resilience to understand viral
suppression and adherence to antiretroviral medication among AA women in the District
of Columbia. Yet, it is paramount to understand the vulnerability of this population to
HIV infection and their own understandings of the epidemic. Study findings can be
applied to interventions across the spectrum of age and ethnicity both in the affected and
infected to stem the tide of HIV infection in the study population.
Problem Statement
African American females account for 94.3% of new HIV infections among
women in the District of Columbia (DC/DOH/HAHSTA, 2017). African American nonHispanic women are nine times more likely to be infected with HIV/AIDS than any other
race or ethnicity (Sionean et al., 2014). Thus, understanding the vulnerability of this
population to HIV infection is essential to public health. Efforts to study this
phenomenon have taken different directions. In the realm of social determinants, Hatcher
et al. (2012) observed that women with high and moderate negotiating power with their
sexual partners were less likely to engage in risky behavior than those with low
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negotiating power. Others have studied the effects of low levels of education on HIV
infection (Melton, 2014), the shortage of available partners for college educated AA
women (Newsome, Airhihenbuwa & Snipes, 2014), and the role of multiple sexual
partners and prior sexually transmitted diseases (Norwood, 2011). Buseh and Stevens
(2007) made an effort to understand how HIV positive women respond to stigma as a
barrier to care and how women engage family or peer support and become advocates to
fight stigma. Pollini, Blanco, Crump and Zuniga (2011) confirmed that isolation and
stigma are important barriers to engaging in HIV medical care among persons of color.
The possibility of a connection between adherence, sexual risk, viral load, and HIV
infected women prescribed ART has also been investigated (Holstad, Dilorio, &
McCarthy, 2011). With about 30 antiretroviral medications now available, being HIV
positive has been transformed from a death sentence to manageable infection (Chen et al.,
2013). However, while the overall infection rate has been decreasing in the U.S., that has
not been the case for AA women.
There remains a lack of information on AA women’s knowledge and
understanding of viral suppression. Consequently, resulting survival rates, reduction of
risk of transmission, and improved health outcomes at diagnosis is lacking for this
population. Taking antiretroviral medication is known to reduce the viral load in the
blood, leading to a competent immune system when viral suppression is achieved
(Cohen, McCauley & Gamble, 2012). Achieving viral suppression is key to reducing
HIV infection as it ensures a reduction of the community level viral load. According to
Brawner (2014), community viral load is a population marker of infectivity of people
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living in a geosocial area. Decreased community viral load and increased HIV testing are
associated with reduction in new HIV infections (Das et al., 2010). Viral suppression
reflects the result of a viral load test in which the level of HIV in a person’s body is very
low (<200 copies/ml) or undetectable (Cohen, McCauley & Gamble, 2012; Pollini et al.,
2011). Unfortunately, a younger age is associated with late initiation of care after
diagnosis and a longer time to achieve viral suppression (Pollini et al., 2011; Eshleman,
et al., 2017). There is a gap in an understanding of viral suppression and its effect on the
lived experiences of AA women. This study added to the literature by describing HIV+
AA women’s understanding of viral suppression and how it affects their lives and
relationships.
Purpose of the Study
The purpose of this study was to increase understanding of HIV infection and
viral suppression from the perspectives of young AA women living with HIV. The study
used a phenomenological approach to uncover the lived experiences of HIV positive AA
women and viral suppression, including how HIV positive individuals are discriminated
against in the community and experience strong stigma from family and friends, as
reported by Buseh and Stevens (2007). Another aspect of this study was to use a feminist
lens to understand black women’s unequal position in relation to HIV infection. In
pursuance to understand the lived experience, it is important to understand increases of
HIV infection among this group through the lens of empowerment theory.
Under empowerment theory, women are asked to identify the source of
disenfranchisement internally and take charge of their life decisions. As articulated,
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empowerment theory posits that entering into the world of the abused or oppressed helps
to empathize and understand their needs. Empowerment is the process utilized to enhance
the personal, interpersonal, and political power of an individual to ensure better life
outcomes (Turner & Maschi, 2015). In this theory, the participants know better. My study
findings support gender as the basic framework that conditions women to an increased
risk of HIV infection. In an analysis of HIV/AIDS disease burden among AA women,
Brawner (2014) proposed a gender responsive model as an initial step to dialogue and
examination of HIV/AIDS as a social issue. Issues of gender roles and socialization may
have to be explored more to understand the HIV vulnerability among African American
women. One in 32 AA women may be diagnosed with HIV in her lifetime (CDC, 2014),
making geo-behavior critical. Geo-behavior basically refers to where one lives, what one
does and with whom, which all link to vulnerability to HIV infection (Brawner, 2014). In
addition, my study findings contributed knowledge and understanding of power
relationships, social constructs and social positions concerning HIV infection.
Furthermore, understanding experiences of women as it pertains to their clinical
status, especially achieving viral suppression, is vital to ending HIV infection among
women. Ensuring viral suppression through antiretroviral medication is a prelude to the
end of HIV/AIDS (United Nations AIDS, 2014). Examining the lives of this group of
women provided an opportunity to learn how they experience the disease, what
prevention methods may be most effective, and how their experiences link to achieving
viral suppression.
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Research Questions
Three main questions drove the direction of the study.
Research Question 1: What is the lived experience of AA women with HIV/AIDS
in DC?
Subquestion 1a: What are their daily routines of medication adherence?
Subquestion 1b: What challenges constitute stigma and discrimination that they
face in daily living?
Research Question 2: How do HIV positive women describe/explain viral
suppression?
Research Question 3: How do HIV positive women explain/describe the high rate
of HIV infection among AA in the District?
Theoretical Foundation
For this study, I used two theories as foundational. The first theory was resilience
theory. I used this theory to understand platform of positive- strength, protective factors
and adaptive abilities that people with adversity develop instead of a focus on the deficits.
The second theory was empowerment theory, applied to better understand how
empowerment can aid to overcome trauma and adversity. In this section, I briefly
describe each theory and why I used them for this study.
Resilience Theory
According to Luthar, Cicchetti, and Becker (2000), resilience is a “construct
connoting the maintenance of positive adaptation by individuals despite experiences of
significant adversity” (p 543). In an argument on the most applicable definition of
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resilience, Panter-Brick asserted that resilience is not a one-time achievement but
sustained over time as it harnesses resources along the continuum of care (Southwick et
al., 2014).
Resilience has no agreed upon definition but emerged from the field of
psychology and Freud’s assumptions that early negative experiences in life produces an
adult with psychopathology. Garmezy, a clinical psychologist, looked at resilience in two
disciplines, psychoanalysis and development. The researcher looked at the underlying
reasons for the differences in outcomes of these two groups of schizophrenic patients.
One group is competent, as demonstrated in the lives of the stable patients who are
married, have children, and keep jobs (Rolf, 1999). They still experience schizophrenic
episodes, but they recover with shorter stays in hospitals and were integrated into their
community. The other group had longer stays, up to 13 years or more in institutions. The
differences in outcomes of these two groups formed the premise and need to study the
underlying difference in these patients, with a focus on areas such as cognitive skills,
motivation, and protective factors (Harlow, 2009).
Empowerment Theory
A second theory applied in this study is empowerment theory. In this theory,
women living under a patriarchal social system are subservient to men, lacking privileges
that their male counterparts enjoy (Maier, 2016). Empowerment theory posits that
entering the world of the abused or oppressed helps in empathizing and understanding
their needs if the researcher themselves is not in the abused or oppressed group.
Empowerment is the process utilized to enhance the personal, interpersonal, and political
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power of an individual to ensure better life outcomes (Turner & Maschi, 2015). In this
theory, the impacted population knows better. Empowerment theory turns inwards for
women to identify the source of disenfranchisement internally and take charge of their
life decisions.
In this study, resiliency theory was studied with respect to empowerment theory.
As AA women, vulnerability to HIV is not determined entirely by engaging in risky
behavior but can also include geo-behavior. Thus, it is important to better understand
how empowerment can aid to overcome trauma and adversity, as well as initially
connecting with and moving along the continuum of HIV care.
Conceptual Framework
My study employed the resilience construct from developmental and social
variables. This was more of how nurture shapes nature. There were questions of home
disciplines and family culture to learn when adaptive capacity or behaviors were acquired
or developed. My study tried to understand resilience on the platform of positivestrength, protective factors and adaptive abilities instead of a focus on the deficits.
Although Rutter (2013) states that findings from studies that incorporated resilience may
not translate into clear prevention and treatment ideas because of the dynamic views of
different individuals to adversities, it can provide some positive leads to research.
What are the factors that may contribute to this resilience? An additional method
used in the study included the creation of a time life trajectory. A sample of AA women
was chosen to create their time life trajectories. From qualitative interviews, I collected
data and created timeline beginning from when HIV infection was first diagnosed to
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indicating experiences along the continuum of HIV care. According to Yates and Masten
(2014), a resilience concept guided study allows the researcher to emphasize competence
and successful adaptation to overcoming negative challenges.
Research designed with a combination of resiliency and empowerment theories
will provide information, motivation, behavioral skills, self-efficacy, social interaction
that is useful in exploring the lived experiences of African American women. Semi
structured interview questions were constructed using resilience and empowerment, selfefficacy, and social variables to ascertain or construct the meaning of HIV infection as
unique to each individual participant. The focus was on strength (either innate or built
from family interactions), overcoming adversity, staying on medication, and achieving
positive health outcomes.
Nature of the Study
This qualitative study applied a phenomenological approach. Open-ended
questions were used to conduct in-depth interviews of 10 women. The interviews were
recorded, and audio materials transcribed. This approach has philosophical implications
and tends to reduce individual experiences to a description of the meaning of the
phenomenon: “what” the people experienced and “how” they experienced it (Creswell,
2013).
This study also used triangulation to validate and verify information obtained
from the women interviewed by drawing on clinical outcome information of viral
suppression from the DC Health HIV database. Triangulation according to Rudestam and
Newton (2015) is getting information from different sources as a way to corroborate
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evidence. HIV clinical indicators, CD4 count and viral load were extracted from District
of Columbia Health (DC Health) HIV Surveillance System. CD4 count and viral load of
sample of AA women who tested HIV positive across some years, 2000, 2010, 2015 and
2018 were extracted and used as data and information triangulation.
This led to a deeper understanding of the phenomena. This qualitative approach
allowed HIV positive AA women to describe their own lived experience with HIV/AIDS,
discuss these clinical outcomes, and share with others. Edmund Husserl and Martin
Heidegger are the two main authors of phenomenology as a qualitative approach. This
methodology hinges on the assumption that reality consists of phenomena, as understood
in the conscious. The uniqueness of individuals and how different individuals attribute
meaning to similar life experiences and how a phenomenon is understood is also referred
to as interpretive phenomenology (Burkholder, Cox, & Crawford, [Eds.], 2016;
Rudestam & Newton, 2015; Kelly, n.d.). A phenomenological study identified
participants from among individuals who have the relevant lived experiences in order to
understand the experiences to make meaning to others. The results or findings can further
be developed to influence policies and practices.
In this phenomenological study, the experiences of the participants were
interpreted using the hermeneutic loop. The hermeneutic loop originated from the Greek
god Hermes, known to be a messenger. It is used in the discipline of philosophy to
explore and interrogate experiences. As a cyclical loop, the hermeneutic loop lends
credence that to understand the whole, it can only be understood by understanding the
influences of the different parts (Harris, 2015). This also means that any misinterpretation
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of a part will distort the meaning of the whole. Each person’s experience was different
and has meaning only to that person. As such, in analysis of the data, each experience
was understood as all the parts are joined together to bring out the meaning of the whole
experience. To understand the meaning of the HIV experience of a participant, the cycle
starts with a question about the event (HIV infection), and sorts through actions or speech
that surrounded the event. The next part of the process led to what the participants did
with the phenomenon (HIV infection), which corresponds to engagement with the part in
the hermeneutic loop and reflects the challenges that trigger actions and feedback. The
next part was to understand or reinterpret the challenges which lead to understanding the
whole - living with HIV disease. The loop showed interrelationships within the parts and
influences the parts to understanding the whole.
Having a philosophical basis, phenomenological inquiry discusses a phenomenon
as a search for wisdom. Judgments about reality are suspended and there is an angle of
intentionality of consciousness, as reality is perceived within the individual and the
meaning of the experience, phenomenology also allows for the inner essence, internal
subjective experiences, to be explored. In this method of inquiry, information of
individual’s cognitive processing structure, which is a conscious experience, is involved
(Percy, Kostere & Kostere, 2015). Therefore, making meaning of living with HIV
infection, and understanding what the structure of participants cognitive processing of the
experience was key to phenomenological study. Hence phenomenology investigates the
pre reflective conscious experiencing of an event (Percy, Kostere & Kostere, 2015, p.77)
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All qualitative data were analyzed manually. First there was a manual
transcription of all interviews recorded by Microsoft word voice recorder. There was a
careful reading of the transcribed interviews line by line and sentence by sentence, rereading of all transcripts creating themes and memos.
Definitions
The following are operational definitions of technical terms used in this study.
Human Immunodeficiency Virus (HIV): This is a virus that attacks T-lymphocytes
cells in the body, destroying the body's defense against infections. Once the T-cells are
attacked by HIV, the immune system becomes deficient and does not work properly
(CDC, 2019, HIV.gov, 2019).
CD4 cell count (T-cell): This is a type of white blood cell for which the HIV virus
has great affinity. HIV reduces the number of CD4 cells (T cells) in the body. A normal,
healthy range for CD4 cells is about 500-1,500 (CDC, 2018e).
Viral load: This is a test to measure the amount (copies) of HIV genetic materials
in one milliliter (ml) of blood. The central treatment goal of HIV medication is to reduce
the amount of virus in the blood to the lowest measurable or detectable by the technology
used. HIV RNA can be detectable up to < 20 copies/ml of blood. (NAM Publication,
2018, CDC, 2017e, 2018e)).
Acquired Immunodeficiency Syndrome (AIDS): When the CD4 count drops below
200 as result of advanced HIV disease, a person is diagnosed with AIDS. This damage to
the immune system makes it increasingly difficult for the body to fight off infections and
some other diseases (CDC, 2018b).
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Opportunistic Infections (OIs): These are infections that occur more frequently
and are more severe in individuals with weakened immune systems, including people
with HIV. Opportunistic infections take advantage of a very weak immune system to
cause infections in the immunocompromised person. Opportunistic infections include
Pneumocystis carinii Pneumonia (PCP), Candidiasis (fungal infections), Mycobacterium
avium complex (MAC), toxoplasmosis, cytomegalovirus (CMV) infection, varicellazoster virus (VZV) infection, cryptococcal infection, histoplasmosis, Hepatitis B,
Hepatitis C, bacterial respiratory diseases, bacterial enteric diseases, syphilis, Human
papillomavirus, and others (Panel on Opportunistic Infections in HIV-Infected Adults and
Adolescents, 2018).
Antiretroviral Therapy (ART): This therapy is characterized by the use of HIV
medication to treat HIV infection. There are six classes of highly effective antiretroviral
drugs, namely: nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside
reverse transcriptase inhibitors (NNRTIs), protease inhibitors (PI), integrase inhibitors
(INSTIs), fusion inhibitors (FIs) and chemokine receptor antagonists (CCR5 antagonists)
(AIDSinfo, 2019a). The general recommendation for HIV treatment is a combination of
at least three antiretroviral medications from at least two classes of drugs.
Viral Suppression: Viral suppression reflects the result of a viral load test, i.e.,
when the level of HIV in a person’s body is very low (<200 copies/ml) or undetectable.
Suppressed viral load improves the health of the person living with HIV, increases
survival and reduces the risk of transmitting HIV (DHHS Guideline, 2018). The key goal
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of ART is to achieve and maintain durable viral suppression. Thus, the most important
use of viral load testing is to monitor the effectiveness of therapy after initiation of ART.
HIV Treatment: This involves adhering to treatment regimen/guidelines including
using antiretroviral medications that slow disease progression. Treatment adherence
increases the likelihood that the infected person will live out a normal life free from
disease complications.
Treatment Guidelines: This is guidance from the U.S. Department of Health and
Human Services that recommends how an HIV positive person should be treated with
ART, when to start treatment, what to use, and how to monitor and ensure positive health
outcomes are achieved (AIDSinfo, 2019).
Treatment Adherence: This includes initiating care with an HIV provider (linkage
to care), regularly attending appointments (retention in care), and adherence to
antiretroviral therapy (ART). The concept of a “continuum of care” has been used to
describe the process of HIV testing, linkage to HIV care, initiation of ART, adherence to
treatment, retention in care, and virologic suppression (CDC, 2018b).
HIV Testing: An HIV test detects if there is HIV genetic material present in a
person. Three types of testing are available: antibody tests, combination tests
(antibody/antigen tests), and nucleic acid tests (NATs). Antibody tests detect HIV
antibodies in blood and the mouth’s mucosal membrane. HIV antibodies develop 3 to 12
weeks in readiness to fight the virus once the body is infected. Combination tests
(antibody/antigen tests) detect both HIV antibodies and HIV antigens in blood. This type
of testing detects infection before antibodies form as it takes about 2 to 6weeks to detect
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antigens. NATs detect HIV in the blood 7 to 28 days after infection (AIDSinfo, 2018).
The Centers for Disease Control and Prevention (CDC) recommends universal testing for
people aged 13 to 64 years old and more often for people who engage in high HIV risk
activity. High-risk behaviors include unprotected sex (sex without a condom) with
someone who is HIV positive or whose HIV status you don’t know; having sex with
many partners; and injecting drugs and sharing needles, syringes, or other drug
equipment with others. CDC also recommends that all pregnant women be tested for HIV
early in pregnancy (AIDSinfo, 2018).
HIV prevalence: This refers to the number of persons living with HIV at a given
time and is used in epidemiology to estimate the probability that a person selected at
random from a population will have the disease. CDC reports prevalence as the number
of persons living with HIV infection in a given population at a given time where a
prevalence rate is calculated per 100,000 people (CDC, 2016, CDC, 2017).
HIV incidence: This is defined as the number of newly HIV infected persons in a
specific time period. An HIV incidence rate is in turn generated by dividing the estimated
number of newly infected people at a specific period by the number of people at risk
(CDC, 2016).
Pre-exposure prophylaxis (or PrEP): This refers to any medication taken by a
person who does not have HIV to lower the risk of infection. The person must be
adherent to the medication and take as directed (CDC, 2019g). Baeten, et al. (2014)
demonstrated that Tenofovir alone and a combination of Emtricitabine plus tenofovir for
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pre-exposure prophylaxis both provided high protection for acquisition of HIV-1 in
heterosexual men and women.
Stigma: A mark of disgrace related to someone’s circumstances either due to
incarceration, disease, mental health or something else that a society looks down on.
Usually the negative belief is unfair and affects the health of the person who stigmatized.
HIV stigma affects testing, engagement, and staying in HIV care, leading to more
infections (Berger, Ferrans & Lashley, 2001; Valdiserri, 2002).
Health disparity: The greater occurrence of a disease in a particular population is
known as health disparity, which might be observed according to gender, race, education
or even geographical location (CDC, 2014). Health disparity is also defined as a
particular health difference between groups that could be socially, economically or
environmentally engineered (HealthyPeople.gov, 2019).
Non-disclosure: The failure to reveal information about one’s health. Many HIV
infected individuals prefer not to inform their sexual partners or intimate friends about
their HIV status due to fear of stigmatization and other social reasons. The prevalence of
non-disclosure is three times higher among black African heterosexual men who have sex
with men (MSM; Daskalopoulou, et al., 2017).
Vertical transmission: This refers to HIV transmission from an HIV-infected
mother to her child during pregnancy, labor and delivery, or breastfeeding (through breast
milk) (AIDSinfo, 2018b)
Heterosexual transmission: Heterosexual transmission of HIV is considered to
have occurred when someone infected with HIV denies any other risk factors except

30
sexual contact with the opposite sex who is infected with HIV (Haverkos, Chung &
Perez, 2003).
Phenomenology: Derived from philosophy, it is a method of inquiry that studies
appearances instead of reality. It is the study of experiences, how they are experienced,
structures of the experiences as subject to the person’s point of view. Experiences that
can be studied through a phenomenological approach include imagination, thought,
emotion, desire, volition, and action (Mastin, 2009; Percy, Kostere & Kostere, 2015)).
Feminism: The advocacy of equality for women’s rights as part of efforts to
correct the powerlessness, domination and oppression of women by another gender in the
social, political, and economic arenas (Turner & Maschi, 2015).
Empowerment: According to Rahman (2013), empowerment includes the
processes that lead people to perceive themselves as able and entitled to make decisions
and involves undoing negative social construction so that people come to see themselves
as having the capacity and the right to act and influence decisions. Empowerment can be
defined within three dimensions. One is personal—the development of a sense of self,
individual confidence, and capacity, along with undoing the defects of internalized
oppression. Second is the rational dimension, which consists of developing the ability to
negotiate and influence the nature of a relationship and decisions made within it. The
third dimension is collective, which includes involvement in political structures, but
might also cover collective action based on cooperation rather than competition (Rahman,
2013). Empowerment enables women to take control of their lives to achieve a set of
goals and demands to actualize a change in social structures detrimental to their lives.
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Self-Efficacy: This is a belief in an individual’s ability to succeed in specific
situations or accomplish a task. An individual’s sense of self-efficacy can play a major
role in how they approach goals, tasks, and challenges, and in their capability to attain
designated types of performance (Artino, 2012).
Collective efficacy: This refers to the ability of members of a community to
control the behavior of individuals and groups in the community. It describes what group
members are willing to do to improve their lives. Collective efficacy is the willingness to
intervene and the capacity for informal social control as members collectively agree on
what is acceptable behavior and reinforce it among themselves (Higgins & Hunt, 2016).
Assumptions
One assumption associated with this study is that participants are eager to share
their stories and truthfully recant events in their lives. However, accurately sharing life
stories might be difficult as time has elapsed and sometimes recall of information might
be hard. To mitigate against this assumption, participants were asked the same question
in different ways, to try to elicit information to answer the research questions. Another
assumption is thinking that women of the age criteria were willing to open up about their
sexual activities and because the researcher is AA, that participants were comfortable and
willing to share their stories. That participants who previously consented to participate
will follow through to complete the session is another assumption. No one was forced to
participate. To address this last assumption, all interviews were conducted in a relaxed
environment. I reinforced to participant that the study was done in good faith and was
respectful if a participant refused to answer a question or felt uncomfortable in any way.
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Scope and Delimitations
Positive health outcomes during HIV antiretroviral therapy are characterized by
progressive reduction of the HIV virus in the blood (Eshleman et al., 2017). The
undetectable level and sustained viral load suppression denotes positive outcomes. This
means at this stage of disease, comorbidities are reduced (Granich et al., 2015) and
symptoms of the disease are almost nonexistent as an HIV positive individual lives a
normal life span as any other non-HIV positive person (CDC, 2016b, CDC, 2019a). It is
important that this information be shared with HIV positive women at the time of entry
into care. Education on the benefits of viral suppression is key as it may become the
motivation for retention, engagement, and adherence to care and treatment. Miedema,
Maxwell, and Aggleton (2011) emphasized that education is needed and might be central
to increasing young people’s awareness and reducing vulnerability to HIV acquisition. A
search of the literature did not result in any articles where such education was the
foundation of the information provided to HIV positive African American women. In a
study of urban AA in the South, Klein, Sterk and Elifson (2016) found Athat only 43% of
the participants had knowledge of HIV infection and transmission, and the authors
recommended establishing HIV educational and intervention programs for AA adults at
risk for infection. Some young HIV-positive parents (born with HIV) largely agreed that
being a role model for their children was a motivation to pursue education and
employment, while fear of discrimination hindered disclosure of status (Fair, Allen,
Trexler, & D’Angelo, 2017; Valdiserri, 2002).
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The specific focus of this study is HIV+ AA women’s understanding of viral load,
viral suppression, and transmission at diagnosis and along the continuum of care. It is
important to document AA women’s perceptions about HIV knowledge and their
experiences at diagnosis and in HIV care. It is also pertinent to know when women knew
about all the benefits of viral load suppression and how such knowledge may or may not
have influenced adherence to care. The findings result in an understanding of how to
improve women’s experiences upon diagnosis and engagement in care. This study
focused on heterosexual AA women living with HIV. The research study was conducted
in the District of Columbia where there was access to the population. The results of the
research is limited and not representative of all HIV positive women living in the District
of Columbia. Excluded from the HIV positive AA in this study are those who are not
heterosexual. Other excluded groups are women who are outside of the age being studied
or had never been on antiretroviral medication.
Limitations
One limitation of this study is the validation of information from participants.
Describing one’s lived experience necessitates a good strategy to ensure accurate
information is obtained. Patton (2015) discussed four types of triangulation of data that
could help reduce this issue, namely triangulation of qualitative sources, mixed
triangulation, analytical triangulation, and theory/perspective triangulation. Substantial
information can be obtained through triangulation of the different sources of information
and crosschecking against theories and multiple sources of data. According to Carter,
Byrant-Lukosius, DiCenso, Blythe and Neville (2014), data source triangulation ensures
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that information collected from multiple sources are used for validation of information
collected to have a different perspective of the data. Triangulation helps to make sense of
any inconsistent or conflicting data (Patton, 2015). The data was triangulated by
including interviews against documents, data from the DC Department of Health, and
viral load and CD4 count tests were triangulated against interview documents. Other
methods for assessing the quality of the data include conducting peer review, for
example, passing the information through peers who acted as fact checkers against other
external sources or through peer debriefing (Creswell, 2013).
The findings in this study are not generalizable outside of my study sample and
the District of Columbia area. It is typical for a phenomenological study to not
necessarily be generalizable, though they nonetheless offer in-depth exploration of a
topic. Another major limitation in this qualitative inquiry is my bias as researcher.
Validation of this research plan started from ensuring that researcher bias and prejudice
about people with HIV who are not engaged in care (Aziz & Smith, 2011) and other
prejudices was discussed to allow for objectivity of data. Creswell (2013) called it
clarifying researcher bias, where the researcher makes known experiences and prejudices
that may affect the credibility of the results ahead of time.
Another limitation included my potential for asking leading questions which may
suggest answers to participants. Further, there is the limitation of the power relationship
between the researcher and the participants. One caution in any phenomenological
research approach was to ensure that the interviewer did not influence the contents of a
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participant’s description. My knowledge of HIV/AIDS must not affect participants’
actual experience by making sure that questions were crafted objectively.
Significance of the Study
Guidelines from the National HIV/AIDS Strategy, United States Department of
Health and Human Services (DHHS), and other national policies for HIV treatment have
provided benchmarks and made milestones in the treatment of the disease. There are very
effective antiretroviral medications now available that are nontoxic in contrast to the first
generation medications, all working towards good quality treatment for HIV (DHHS
Guideline, 2018). However, conspicuously missing in research are women’s lived
experiences with HIV and how such experiences may facilitate infection when viral
suppression is not achieved. At the same time, the United States alone sees at least 40,000
new infections yearly and high prevalence among women of childbearing age (CDC,
2018c). For 3 consecutive years (2012, 2013 and 2014) when new infections showed a
downward trend, there continued to be spikes in infections in the 25 to 34 age group
(CDC, 2019f). One study that targeted young HIV positive parents (who perinatally
acquired HIV) noted that the parents’ motivation to be role models to their children led to
pursuit of education and employment (Fair, Allen, Trexler, & D’Angelo, 2017). This was
done with the hope to protect their children from discrimination and stigma. Yet, the
same parents were found to be afraid to disclose HIV status to their children for fear of
stigma. The infection rate continues to decline in the United States, and although motherto-child infection has drastically fallen, in 2016, 73 infants were born with the disease
(CDC, 2018).
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This study has significant impact in addressing health disparities in the study
population. According to Meyer, Yoon, and Kaufmann (2013), health disparities exist
when differences in health outcomes are seen among different populations. The
importance of health disparities in public health discourse includes burden of diseases
among particular populations compared to others, lack of access to care and specialty
care, and low socioeconomic status (Meyer, et al., 2013). Provision of quality care varies
depending on the population and part of the country, and differences in cost of care also
exist. In their analysis, Johnson et al. (2013) discussed the characteristics of people with
HIV diseases in an effort to portray the disparities that exist in the lives of those with this
infection and in their use of antiretroviral medication for treatment. The expert panel on
the treatment guidelines noted that one of the goals of HIV treatment is achievement of
viral suppression at least 8 to 24 weeks on antiretroviral therapy and having improved
CD4 count (DHHS Guideline, 2018).
Another positive social change was in the advancement of HIV/AIDS research,
treatment, and prevention. Moreover, this study provided information that align with the
90-90-90 initiative newly adopted by many nations to end AIDS by 2020 (United Nations
AIDS, 2014). The 90-90-90 initiative is intended to spur more focused efforts in
countries’ progress in helping people living with HIV access treatment, get diagnosed,
and achieve viral suppression and positive health outcomes (International Association of
Providers in AIDS Care [IAPAC], 2015). The end of HIV/AIDS is contingent upon
diagnosing all infected persons and providing access to antiretroviral medication to
ensure viral suppression. HIV treatment is very important in ending the HIV epidemic,
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normalizing survival, preventing HIV-related illnesses, averting AIDS related deaths,
preventing new infections, and saving money (United Nations AIDS, 2014). The 90-9090 initiative aims to have 90% of all people living with HIV know their HIV status, have
90% of all people so diagnosed receive sustained antiretroviral therapy, and have 90%
receiving such therapy achieve viral suppression (United Nations AIDS, 2014).
Summary
I discussed the epidemiological synopsis of the HIV/AIDS infection in the
District of Columbia, the United States, and the world as a whole in chapter 1. The
background information and the disproportionate infection among AA women. This
chapter also included knowledge of viral load suppression among AA women as a
reference to improved health outcome. Other topics summarized in this chapter included
the study’s theoretical framework, nature, assumptions, scope, delimitations, limitations,
and significance.
Chapter 2 provides information on the literature review conducted for this study
to establish relevance of the problem. Chapter 3 restates the research questions and the
central concepts used to design the study and the reason for their selection. Chapter 4
presents information on the demographics of the participants, the setting, data collection,
analysis, and evidence of trustworthiness. The last chapter, Chapter 5, will provide an
interpretation of the findings, a discussion on limitations, recommendations, an
exploration of implication, and conclusions of the study.
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Chapter 2: Literature Review
Introduction
The HIV epidemic in AA communities, especially AA women, continues to
attract attention. The public health implications of the epidemic and the recognition of
continued health disparities have led to some targeted interventions. Unfortunately, the
CDC (2019f) continues to record high rates of HIV infection, with the most recent annual
estimate being 40,000 new HIV infections in the United States in 2015. AA are
disproportionately affected. AA non-Hispanic women are 9 times more likely to be
infected with HIV/AIDS than any other race/ethnicity (Sionean et al., 2014).
Several studies have identified possible factors associated with the
disproportionate burden of HIV in AA women. Hatcher, Kumbakumba, Tsai and
Dworkin (2012) noted that the ability to have sexual negotiating power with partners may
reduce the infection rate. Low levels of education have also been shown to be associated
with HIV infection (Melton, 2014) while Newsome, Airhihenbuwa, and Snipes’ (2014)
results indicated that a lack of college-educated partners is a contributing factor to HIV
infection among AA women. The role of stigma as a barrier to care has also been studied
to determine how it fuels infection (Buseh & Stevens, 2008; Pollini, Blanco, Crump and
Zuniga, 2011)
Literature Search Strategy
In an effort to identify relevant sources in order to study this issue in greater
depth, I conducted multiple library searches using different databases. CINAHL Plus
included the full text of many of the articles reviewed. Through ProQuest, the
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Dissertation & Theses @ Walden University database was accessed to search for
additional articles. Other databases searched included PubMed, NCBI, Mendeley Library,
STAT!Ref, Essential Evidence Plus POEMS, Walden University Academic Search
Complete, and SAGE. In addition, high level searches were conducted on the World
Health Organization and CDC websites. Newer articles relevant to research, including
those possibly published after I conducted the initial literature searches, were received via
email through subscriptions to CAB Direct; Research Gate; the New England Journal of
Medicine Journal Watch HIV/AIDS; the Health and Medicine Division of the National
Academies of Science, Engineering, and Medicine; AIDS Patient Care and STDs; and
AIDS Research and Treatment. Some of the identifiers and key words used for the search
included women AND HIV/AIDS; African American AND HIV/AIDS; risky sexual
behaviors; public health education; HIV prevention health promotion; HIV testing; HIV
epidemiology; HIV mortality; HIV AND condom use; poverty AND women; depression
AND HIV/AIDS; District of Columbia AND HIV/AIDS; resilience theory; empowerment
AND women; marginalization AND women; social support AND HIV/AIDS; HIV/AIDS
health literacy; sexually transmitted diseases; HIV stigma; phenomenology;
hermeneutics; AND reproductive health; and barriers to disclosure AND HIV status. In
the search for relevant peer review articles, I also signed up with the National Library of
Medicine (NLM) at the National Institute of Health (NIH) to have relevant articles
emailed directly to the researcher. Although I ended up not using the request system, it
was valuable to have this resource available, if needed.
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Theoretical Foundation
Theory and Origin
Two main theoretical concepts guide this study: resilience theory and
feminist/empowerment theory. Resilience theory is derived from two areas of study—
namely, child psychiatry and developmental psychology (Vernon, 2004). A resilienceguided study allowed me to emphasize competence and the successful adaptation to
overcome negative challenges. And empowerment theory posits that empowered people
take action necessary to create social and personal behavioral change. Proponents of
empowerment theory have developed theory constructs to apply at the individual,
organizational, and community levels. The two theories are expounded below.
Resilience theory.
The school of thought emerged from Freud’s assumptions that early negative
experiences in life produce an adult with psychopathology. Expert researchers such as
Michael Rutter, Norman Garmezy, and Eliot Rodnick applied this assumption in their
study of child psychiatry and development (Harlow, 2009; Rolf, 1999; Vernon, 2004).
Many scholars have defined resiliency theory, a fairly new research theory and approach,
in different ways depending on the approach or issue under investigation. In the United
States, the clinical psychologist Norman Garmezy, who helped develop the theory,
examined resilience in two disciplines: psychoanalysis and development. Garmezy
studied resilience to understand what he and his colleague identified as a distinction
between “process” chronic schizophrenic and a “reactive” stable schizophrenic (Rolf,
1999). The researchers explored the underlying reasons for the differences in outcomes of
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these two groups of patients. They found that one group was competent, as demonstrated
in the lives of the stable patients who were married, had children, and maintained their
jobs. Members of this group still experienced schizophrenic episodes, but they recovered
with shorter stays in hospital and are integrated into their community. The other group
had longer stays in institutions, lasting 13 years or more. The differences in outcomes of
these two groups formed the premise and need to study the underlying differences in
these patients, with a focus on areas such as cognitive skills, motivation, and certain
protective factors (Harlow, 2009).
However, researchers have not yet established a single authoritative definition of
resilience as experts formulate definitions from differing approaches. In a panel
discussion during a conference of the International Society for Traumatic Stress Studies
in 2013, various experts agreed that resilience is a complex construct leading to different
definitions depending on the area of reasoning (Southwick et al., 2014). In a summary of
all definitions generated during this conference, Southwick et al. noted resilience as the
ability to bend but not break, bounce back, and perhaps even grow in adverse life
experiences. Resilience is a “construct connoting the maintenance of positive adaptation
by individuals despite experiences of significant adversity” (Luthar, Cicchetti, & Becker,
2000, p. 543). Other interesting definitions included “stable trajectory of healthy
functioning after an adverse trauma,” “capacity of a dynamic system to adapt
successfully,” and a “process to harness resources to sustain well-being” (Southwick et
al., 2014). In her argument on the most applicable definition, Dr. Catherine Panter-Brick

42
asserted that resilience is not a one-time achievement but sustained over time as it
harnesses resources along the continuum of care (Southwick et al., 2014).
Scholars study resilience theory from different approaches. Determinants of
resilience are viewed through genetic, epigenetic, developmental, demographic, cultural,
economic, and social perspectives (Southwick et al., 2014). Jackson and Miller (2014)
used an ecological approach, where a resiliency-enhancing approach was integrated into
an ecological model to explore AA women’s interactions with the environment,
individuals, the community, and society when describing inequities in education, value of
education and self-efficacy, commitment, mentoring, and faith and spirituality. The
authors further examined resilience in relation to inequities in education, faith and
spirituality, self-efficacy, and the need for mentors.
I applied resiliency theory with respect to empowerment theory in this study. AA
women’s vulnerability to HIV had not been entirely determined by their engagement in
risky behavior; it included geo-behavior, which basically refers to where one lives, what
one does, and with whom—all of which link to vulnerability to HIV infection (Brawner,
2014). Thus, it was important to develop a deeper understanding of how empowerment
aided in overcoming trauma and adversity as well as initially connecting with and
moving along the continuum of HIV care.
Feminist/empowerment theory.
A second theory applied in this study is feminism/empowerment theory.
Feminism is a socio and political construct that tries to observe the interaction of gender
to power relations (Perkins & Zimmerman, 1995). Th empowerment theory posits that
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entering into the world of the abused or oppressed helps empathize and understand their
needs. Empowerment is the process utilized to enhance the personal, interpersonal, and
political power of an individual to ensure better life outcomes (Turner & Maschi (2015).
According to this theory, the impacted population knows better.
Although the debate about whether empowerment is an outcome or a process
rages on (Carr, 2003; Luthar et al., 2000; Perkins & Zimmerman, 1995; Sadan, 2004),
this study followed the process approach, which implied that women in this study
experienced a personal transformation at some point, with a consciounesses powerful
enough to seek and engage in care. Carr (2003) called such an empowering action
conscientization, which is necessary to create social and personal behavioral change.
However, Rahman (2013) advised caution to ensure that empowerment does not manifest
as an exclusionary bias against men—an adversarial orientation and subversive logic that
may threaten harmony in the home—as conscientization that excludes men is dangerous.
Gender empowerment should be inclusive of all and be a matter of a change of values.
This line of thought was explored and considered when empowerment theory was
applied.
Empowerment ensures that thoughts and beliefs about self-changes and the image
of self are enhanced—namely, that an empowered person wields his or her own power
and is motivated to move in the right direction toward a defined positive goal. Moran
(2015) clearly depicted the application of feminist theory as empowerment by exploring
the self through therapy, looking at uncertainty in normal responses to oppression without
a traditional assessment, while exploring upbringing, family life, and religious affiliation.
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Moran (2015) further emphasized that the strength of the client is hyperbolic, which
means reaction to adversity may be exaggerated. The client is an expert on his or her own
life, with exploring a range of possibilities and making informed decisions as to whether
to change a behavior or not remaining the right decision. In this study, the
feminist/empowerment approach functioned as a lens for understanding women’s
unequal position to HIV and resilience in the presence of HIV infection. In particular, it
used a gender lens that involved studying power relationships, social position, and
women’s experiences with HIV infection. According to Turner and Maschi (2015),
working with feminist theories with marginalized and oppressed women led to a better
understanding, assessment, and ultimately intervention strategies to address the gender
powerlessness experienced.
The empowering process and outcomes differ depending on the individual and
population under study. Perkins and Zimmerman (1995) asserted that, when it comes to
individual empowerment, the process could include participation in a community
organization; meanwhile, at the organizational level, empowerment might include
collective decision-making and collective action. Individual or intrapersonal
empowerment can be described as consisting of beliefs, attitudes, competencies, selfdetermination, and efficacy. Other discourses have interpreted intrapersonal
empowerment as the enabling of individuals to achieve personal goals through interaction
with others, thereby making room for both personal motivation and collective action
(Perkins & Zimmerman, 1995).
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Rationale for Application of Resilience and Empowerment Theory
I employed the resilience construct from developmental and social variables in
order to demonstrate how nurture shapes nature. This included questions of home
disciplines and family culture to determine when adaptive capacity or behaviors were
acquired or developed. Gonzales (2003) applied resilience theory in three attributes or
concepts: risk factors, protective factors, and resilient child. My aim was to seek to
understand resilience on a positive platform—namely, strength, protective factors, and
adaptive abilities—instead of a focus on the deficits. Although Rutter (2013) explained
that findings from studies that incorporated resilience may not translate into clear
prevention and treatment ideas because of the dynamic views of different individuals to
adversities, they can provide some positive leads to research.
I also looked at the evolution that transpired from such an adverse event as the
time of HIV diagnosis to favorable adjustment when AA women are engaged in care and
virally suppressed. Some of the infections happened in the 1980s, when the women were
as young as 22 years old and no medication was available, but still exist in 2019. A
metric of resilience for these women are that the virus reached an undetectable level in
their blood. The researcher explored the factors that may contribute to this resilience. In
the framework of epigenetics, resilience could be gene mediated due to phenotypically
expressed skills that could withstand trauma and adverse events (Southwick et al., 2014).
Thus, as children grow up, there might be some interpersonal role modeling by parents or
family members that contributes to the children’s development of resilience (Fritz, de
Graaff, Caisley, van Harmelen, & Wilkinson, 2018; Rosenberg, Baker, Syrjala, Back, &
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Wolfe, 2013). Although discussions of epigenetics are gaining ground in efforts to learn
about resilience, it is beyond the scope of this study.
An additional method used in this study was the creation of a time–life trajectory.
A sample of AA women were chosen to create their time–life trajectory. Using
qualitative interviews, the researcher collected data and created timelines, beginning from
when the HIV infection was first diagnosed, to indicate experiences along the continuum
of HIV care. According to Yates, Tyrell, and Masten (2014), a resilience concept-guided
study allowed the researcher to emphasize competence and successful adaptation in
overcoming negative challenges. Research designed with a combination of resiliency and
empowerment theories provided information useful for exploring the lived experiences of
HIV-positive AA women.
Previous Applications of Theories
Fritz et al.’s (2018) study about childhood adversity and mental health in young
people found a relationship between some resilience factors and increased likelihood of
psychopathology. The researchers categorized resilience factors into three levels:
individual, family, and community levels. Some of the resilience factors studied at the
individual level included distress tolerance, cognitive reappraisal, self-efficacy,
behavioral reward reactivity, emotional reward reactivity, mental flexibility, protective
self-cognition, and socialization. At the family level, Fritz et al. (2018) included positive
parenting, family cohesion, adolescent-and-father communication, adolescent-and-mother
communication, extended family support, positive family climate, immediate family
support, and quality of the parent–child relationship. Community-level resilience factors
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included social support and friend support (Fritz et al., 2018). Although some of the
resilience factors moderated and mediated mental health after childhood adversity, the
authors noted that resilience factors should be studied as a complex system, not in
isolation from one another. A study by Christman and McClellan (2012) asked women in
academia to explain personality traits responsible for or affecting their successful
academic pursuit and resilience in the face of challenges. The authors found a “middle
space” that tends to break gender role assumptions in leadership to chart new boundaries.
In another study, Washington (2008) applied resilience as hope to female
adolescents in an alternate school program who contextualized their negative experiences
into success stories. In their study, they recommended gender-specific programming
efforts to provide a forum and space for impacted females to at least contribute to the
discourse. Findings from the studies discussed thus far have further confirmed that
resilience is not static, but moves along the continuum of different timeframes,
conditions, and capacities to adjust to an adverse event. As patient education continues to
evolve, there is an expectation that patients will actively participate and advocate for
themselves, illustrating and depicting empowered patients. Fumagalli, Radelli, Lettieri,
Bertele, and Masella (2015) described three areas where empowerment theory has been
used. First, as a participative behavior where psychologists defined it as a form of
intrinsic motivation to perform tasks (Huang, Shi, Zhang & Cheung, 2006). Secondly, in
research as an interactive process through which people experience personal and social
change that enabled them to take actions that positively affected their life (Lord &
Hutchison, 1993), and thirdly, as an emergent state of adaptability to difficulty and
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challenges. Bowers, Kreutzer, Cannon-Browers, and Lamb (2017) discussed some
emergent states as the second order of positive emotions, self-efficacy, and positive
affect.
When researchers applied empowerment theory to reproductive experiences over
the life course, they found a strong determinant of the current state of empowerment as
one that emerges immediately after marriage (Lee-Rife, 2010). According to Lee-Rife’s
(2010) study conducted in India, incorporating influences of prior life events, such as
abortions, stillbirths, and miscarriages, shape a woman’s current state of empowerment
and became one factor that lowered violence in marriage.
The concept of empowerment has also been applied in the primary prevention of
HIV/AIDS and has been proven effective in many CDC-funded interventions (Beeker,
Guenther-Grey, & Raj, 1998). In Pinto, Rahman, and Williams’ (2014) study, women in
prison with limited re-entry knowledge participated in 12 one-hour program sessions
embedded with empowering information. At the end of the sessions, the women reported
being empowered on parental rights, housing, and employment. They also had better
advocacy skills that benefited them individually and their community (Pinto et al., 2014).
In another study where women were given the power to use photo or pictures to illustrate
their empowered status, participants showed increased self-esteem, critical thinking
skills, and control over life challenges and HIV; they also had increased access to
resources that improved health choices and behavior (Teti, Pichon, Kabel, Farnan, &
Binson, 2013). In her discussion about empowerment in healthcare settings, Funnell
(2016) described moving away from the traditional patient education to an
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empowerment-based approach. This involves developing educational sessions that
encourage the reflection of one’s life, boost self-management efforts, and improve
problem-solving skills and engagement in clinical care, which helps make behavioral
health changes. Schuler and Nazneen (2018) identified education as an example of an
empowerment-based platform where changes in gender roles resulted in a reduction of
married women experiencing intimate partner violence. Women were able to take new
forms of employment and contribute financially to the household.
Although HIV infection is decreasing in the United States (CDC, 2019a), its
associated stigma does not seem to be dissipating. Discussion on the how such high
infectivity rates affected the lives of AA women living with the disease is imperative.
Rice et al. (2018) found that women mentioned multiple interrelated social determinants
of health that continued to perpetuate stigma, such as gender, race, and income level.
Continued HIV stigma may exacerbate health disparities and engagement in HIV care.
Engaging HIV-positive women in empowering discussions helped build selfesteem, leading to the recognition of inner strength. This might result in acquiring
strategies to survive the disease and perhaps knowledge of what resources to access in
order to improve one’s health. People facing adversities who pursue a purpose can
develop a sense of meaning in life that promotes psychological health with lower levels
of depression (Du, Li, Chi, Zhao, & Zhao, 2017). In addition, I posed questions to HIV
positive women about their life experiences in general. Listening and learning about their
experiences and challenges, along with how these challenges were overcome or are still
being worked through and provided some clarity on the women’s lived experiences.
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According to Yates, Tyrell and Masten (2014), a resilience-guided study allowed the
researcher to emphasize competence and the successful adaptation to overcome negative
challenges. Therefore, the theories of resilience and empowerment are particularly suited
for this study.
Literature Review
HIV is on epidemic level in the United States and disproportionately affects AA
women. The epidemiology of HIV in the District of Columbia continues to see a rise of
new infections among AA women. However, HIV viral suppression leads to positive
health outcomes especially for women on antiretroviral medications. The search for
relevant literature that adequately discussed HIV viral suppression and infection was
thoroughly researched using different relevant key variables.

African American Women and HIV/AIDS Epidemics
When more than 1% of a population has HIV, the CDC defines it as an epidemic
(CDC, 2017b). At the onset of HIV in the 1980s, there was a steady increase in infections
until the advent of effective medications in the 1990s, from nucleoside reverse
transcriptase inhibitors (NRTIs) such as Zidovudine (AZT) and non-nucleotide reverse
transcriptase inhibitors (NNRTIs) to protease inhibitors (PIs). HIV prevention has
primarily focused on gay men, targeting mainly young black men who have sex with
men. However, a marginalized group might be being neglected: young African American
females. Haverkos, Chung, and Perez (2003) confirmed the HIV epidemic among
heterosexuals by showing the greatest percentage increases in this population over time.
In 2016, AA females accounted for 11% of all HIV diagnoses (CDC, 2019h) and 595 of
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all new female HIV diagnoses in 2017 (CDC, 2019b). Skarbinski et al. (2015) found a
reduction in HIV transmission rates along the care continuum, yet between 2012 and
2014, AA women 25–34 years old continued to see spikes in infections (CDC, 2016b).
Among all HIV-infected females living in the District of Columbia, AA females
accounted for 92.5% of new infections in 2015 (District of Columbia Department of
Health, HIV/AIDS, Hepatitis, STD and TB Administration [DC/DOH/HAHSTA], 2016),
a percentage that increased to 94.1% in 2016 (DC/DOH/HAHSTA, 2017). In 2018, of the
12,322 HIV cases living in the DC EMA, black women accounts for 22% of the cases
(DC/DOH/HAHSTA, 2019).
In Washington, DC, non-Hispanic AA females have the highest rate of infection
among all women, having more than 6 times and nearly 50 times greater prevalence rates
compared to women of Hispanic origin and White women, respectively
(DC/DOH/HAHSTA, 2017). HIV infection among heterosexual Black females in 2016
was 1.6% (see Figure 1), exceeding the 1% threshold of a generalized epidemic as
defined by the CDC.
Knowledge of HIV Transmission among African American Women
Transmission of HIV occurs primarily through unprotected sex, infected semen or
vaginal fluid during heterosexual sexual contact, and mother-to-child transmission either
in the womb or during breast feeding (Drayton & Grant, 2017; CDC, 2018a,). HIV can
also be transmitted through the sharing of contaminated drug paraphernalia (Skarbinski et
al., 2015). Skarbinsk et al. (2015) found that most HIV transmission (58%) occurs
through men who have sex with men, particularly among those between 35 and 44 years
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old. Although heterosexually acquired HIV among women was found to be much lower,
at 1.6%, there was no analysis of race and ethnicity in their study.
Klein, Sterk and Elifson (2016) discovered that HIV knowledge was especially
low among older adults in the urban AA South, especially among older adults who have
low educational levels and no personal knowledge of someone with HIV/AIDS.
Henderson et al. (2004) also found that older women, regardless of marital status, had
limited knowledge of HIV transmission through sex. Although various efforts to raise
awareness about HIV continue, Perkins, Stennis, Spriggs, Kwegyir-Afful, and Prather
(2014) questioned whether knowledge of HIV transmission is enough to make a
difference. In another study conducted in urban historically Black colleges and university
(HBCU) settings, AA youths did not perceive themselves as having a high risk of
contracting HIV yet engaged in highly risky behavior for contracting the disease
(Lindong, Edwards, Dennis, & Fajobi, 2017). Klein et al. (2016) studied both HIVnegative and HIV-positive groups and found that this knowledge was not translated into
making less risky choices. Knowledge of HIV also did not deter young girls from
engaging in high risk behavior in detention facilities, despite elevated odds of contracting
HIV for incarcerated AA (Baillargeon et al., 2017; Raiford, Seth, Fasula, & DiClemente,
2017).
HIV transmission among AA is dependent on not only risky behavior, but also
geography. Despite efforts to reduce risk, people located in areas with higher
concentrations of HIV-infected people still face a higher vulnerability of infection. This
is referred to as geo-behavioral vulnerability to HIV (Brawner, 2014). Education and
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knowledge of HIV transmission should form the foundation of every HIV education
session in order to reduce the acquisition of HIV.
Viral suppression also resulted in positive health outcomes for people living with
HIV/AIDS (Cohen, McCarley, & Gamble, 2012), yet there was lack of ample research
that incorporated HIV viral suppression as a component of HIV education nor
emphasized the need for viral suppression as a precursor to reducing HIV infection.
Social Demographics of HIV/AIDS
African Americans in the District of Columbia accounted for 82% and 94% of
new HIV diagnoses among males and females, respectively, from 2004 to 2008 (WestOjo et al., 2010). The district is divided into eight wards, with Wards 7 and 8 having the
highest prevalence of HIV. The majority (89%) of DC residents are 25 years old and
above and have at least a high school diploma, with about 53.4% with graduate degrees
or higher (DC/DOH, 2014). Although the median household income ($48,078) is above
the minimum in other parts of the country, due to the high cost of living and housing in
the district, many people live in poverty. In 2012, 14.19% of DC residents lived below
the federal poverty level, while 26.91% and 20.95% lived at 150% and 200% of the
federal poverty level, respectively (DC/DOH, 2014).
Low income, low education level, and increased poverty tend to be strongly
associated with HIV infection. Wards 2, 5, 7, and 8 show the highest number of HIV
cases, while more new diagnoses are occurring in Wards 5, 6, and 7
(DC/DOH/HAHTSA, 2017). The picture is the same at the national level. In 2017, 86%
of all new infections occurred through heterosexual transmissions—an increase from
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2016 (CDC, 2019b). During the same year, 4,189 Black heterosexual women were newly
diagnosed, which is a much higher number compared to heterosexual Black men (1,926),
White women (1,032), and Hispanic/Latina women (1,025) (CDC, 2017a). A study
conducted in Baltimore, Maryland, found that testing for HIV occurred more often
among women than men, who reported a higher number of sexual partners and/or were
involved in illegal drug trade (Decker et al., 2015), a phenomenon which may cause
overrepresentation in diagnosis statistics. Nonetheless, AA women are the new faces of
HIV infection in Washington, DC, and in the nation, lagging only slightly behind Black
men who have sex with men. The community in which someone lives and socializes
becomes a significant factor in HIV acquisition. The higher the measurable amount of
HIV virus in any community, the higher the rate of infection, which is usually described
as community viral load.
Community Viral Load
The HIV virus is transmitted by people who are HIV positive. This basically
means that only people who are infected can transmit the disease. The prevalence of HIV
is in part dependent on the ongoing transmission risk fueled by high virus among
community members. Miller, Powers, Smith, and Cohen (2013) defined community viral
load (CVL) as the aggregation of individuals with a virus in a community. Herbeck and
Tanser (2016) defined CVL as the mean of the individual viral load in a particular
community. Part of the US National HIV/AIDS Strategy (NHAS) (2015) to end the HIV
epidemic includes expanding HIV testing in the community to identify HIV-positive
individuals and link them to HIV care and treatment. It also includes increasing the
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proportion of HIV-positive individuals with undetectable viral loads (HIV.gov, 2011;
NHAS, 2015).
According to Brawner (2014), CVL is a population marker of the infectivity of
people living in a geosocial area. Decreased community viral load and increased HIV
testing are associated with a reduction in new HIV infections (Das, 2012; Das et al.,
2010). In one study, more than half of the participants had a high viral load associated
with transmission risk (Kranzer, Lawn, Johnson, Bekker, & Wood, 2013). In their study,
among the people living with HIV in a South African township, a small proportion had a
CD4 count less than 200 while more than half had a high viral load that could benefit
from an expansion of antiretroviral therapy (ART) treatment to reduce the virus in the
community.
One study of HIV-positive individuals receiving medical care in Washington, DC,
highlighted the importance of knowing the CVL. Castel et al. (2012) demonstrated that a
reduced CVL is associated with a reduced incidence of HIV. The biomarker of HIV
incidence, high CVL, is observed in communities with high poverty and low high school
graduate rates (Castel et al., 2012). CVL is used as a marker for treatment of HIV,
helping decision-makers target areas of high viral burden and make provisions for
enhanced access to care and treatment for such impacted communities. Das (2012)
advocated for adequate assessment and measurement of CVL, the establishment of a
baseline, modernized surveillance, and the following of CVL trends as a central indicator
for success in prevention and care efforts.
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Treatment of HIV
HIV is treatable and can be classified as a manageable chronic infection. On April
17, 1998, as a result of the efforts of researchers, clinical providers, patients, the
Department of Health and Human Services (HHS), the National Institute for Health
(NIH), the Centers for Disease Control and Prevention (CDC), and the Henry J. Kaiser
Family Foundation, the first guidelines for treating pediatric HIV infection were
published, followed quickly by guidelines for treating adults and adolescents with HIV
infection published on April 24, 1998 (Health Resources and Services Administration,
n.d.).
The guidelines are often updated in light of new research and treatment findings
that might improve the quality of care for people living with HIV (AIDSinfo, 2019a;
AIDSinfo, 2019c). The panel of experts responsible for developing and updating the
guidelines rate certain recommendations as “A” to indicate strongly recommended
practices, “B” for moderately recommended practices, and “C” for optional practices.
The ratings rely on evidence-based clinical trials from randomized controlled trials; nonrandomized, observational cohort studies with long-term clinical outcomes; and expert
opinions. The panel has recently recommended that all individuals with HIV be on ART
regardless of their CD4 count, as ART reduces morbidity and mortality (AIDSinfo,
2019a). ART is also recommended for individuals with HIV to prevent HIV transmission.
ART should only be deferred for clinical/psychosocial reasons, but otherwise initiated as
soon as possible (AIDSinfo, 2019a).
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Guidelines for Treating Adults and Adolescents
The panel’s most recent recommendations for effective treatment of HIV include
taking three active antiretroviral medications from at least two classes. The most
favorable “A” rated recommendation is for one medication from the integrase strand
transfer inhibitor (INSTI) class and two medications from the nucleoside reverse
transcriptase inhibitor (2NRTIs) class. The combinations of medications rated as “A1”
and “A11” are:
•

Dolutegravir/abacavir/lamivudine, which is only for patients who are HLAB*5701-negative (AI), represented as “DTG/ABC/3TCa (AI) if HLA-B*5701negative”

•

Dolutegravir plus tenofovir/emtricitabine (AI), represented as “DTG +
tenofovir/FTC (AI for both TAF/FTC and TDF/FTC”

•

Elvitegravir/cobicistat/tenofovir/emtricitabine (AI), represented as
“EVG/c/tenofovir/FTC (AI for both TAF/FTC and TDF/FTC”

•

Raltegravir plus tenofovir/emtricitabine (AI for tenofovir disoproxil fumarate, AII
for tenofovir alafenamide), represented as “RAL + tenofovir/FTC (AI for
TDF/FTC, AII for TAF/FTC” (AIDSinfo, 2019a; DHHS Guidelines, 2018)

Guidelines for Treating Women: Considerations for ARV in women with HIV
Preconception counseling has been included in the DHHS guidelines to improve
the health of women before conceiving or to ensure that conception is planned. The
importance and benefits of preconception counseling were affirmed by the American
College of Obstetricians and Gynecologists (ACOG) committee in September 2005. The
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goal of such counseling is to reduce the adverse effects suffered by HIV-positive women
of childbearing age. Simone et al. (2018) identified five thematic areas that affect
preconception counseling and barriers to engaging in clinical care. They conducted their
study in seven cities in the United States, with an emphasis on counseling being
consistent across providers. Factors that affect engagement in preconception counseling
and other care include knowledge and attitude, characteristics of the clinical facility, type
of care coordinators, and the ability to access locations when referrals are made to other
places.
Extra steps are taken to prescribe the most appropriate antiretroviral (ARV)
medication for women of childbearing age, especially during pregnancy. The Food and
Drug Administration assigns ARVs and all other drugs to categories that consider
whether and how the drugs should be used by pregnant women and women
contemplating pregnancy. For a drug to be assigned category A, it must be demonstrated
to be safe in pregnancy and pose no risk to a fetus. Unfortunately, no ARV is classified as
category A at this time. Category B drugs are those that failed to demonstrate risk during
testing on animals but have not been subjected to a controlled study on pregnant women.
Category C denotes that animal reproduction studies have been conducted on the drug
and revealed an adverse effect on the fetus; although no adequate and well-controlled
studies on humans have been conducted yet, the potential benefits of pregnant women
using the drug possibly outweigh the potential risks. Some ARVs fall into categories B or
C (Jose, Wallace, Anand, & Barlett, 2014).
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For category D drugs, studies on human subjects have demonstrated a risk of
harm to the fetus, although the drug may still be used during pregnancy if warranted.
Efavirenz is a category D drug (Jose et al., 2014). Women in the first trimester of
pregnancy should especially avoid Efavirenz (AIDSinfo, 2019d). In their clinical trial,
Brogly et al. (2010) found an elevated risk of birth defects in pregnant HIV-positive
women who used Efavirenz during the first trimester of pregnancy. Category X shows
harm to the fetus during animal studies; these drugs should not be used during pregnancy
(Jose et al., 2014).
One medication whose category status is currently challenged is Dolutegravir.
Dolutegravir is a first-line regimen for HIV treatment (AIDSinfo, 2019e). However, it
has been documented to cause neural birth defects (NTDs) in newborns (AIDSinfo,
2019c; U.S. Food and Drug Administration [FDA], 2018). The use of a Dolutegravir–
based regimen for women before 8 weeks of pregnancy is no longer recommended, and if
the female was already on Dolutegravir and virally suppressed, a change before 8 weeks
of pregnancy is recommended. However, if the patient is already on Dolutegravir and the
pregnancy is older than 8 weeks, then no change in medication is recommended
(AIDSinfo, 2019e). In the meantime, the FDA has not yet removed Dolutegravir’s
category B status.
In addition to reducing the risk of transmission, an undetectable viral load during
pregnancy reduces the risk of HIV transmission to the unborn child (in vivo) and the
newborn. Although mother-to-child vertical transmission has drastically fallen in the
United States, efforts should be maintained to ensure that young HIV-positive women
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receive quality care to remain virally suppressed. In this way, children will not be born or
infected with HIV. In providing ARV to women of childbearing age, efforts are also
being made to ensure that many of the pregnancies are planned by using effective
contraceptives. As some ARVs also interact with contraceptives, reducing their efficacy,
ARV medication may need to be changed or extra protection may need to be used
(Matthews et al., 2017).
HIV Medications: Medication adherence
Evidence for the benefits of taking ARVs as well as the resultant effect of
reducing HIV transmission was strengthened by the HPTN 052 randomized clinical trials.
Adherence to medication and viral suppression as a result of good adherence
revolutionized HIV treatment and gave birth to the slogan “Treatment is Prevention.” In
the HPTN 052 clinical trials, HIV infection decreased by 96%, and there was also a
reduction in morbidity and mortality. Participants in the clinical trials exhibited 95%
medication adherence along with a reduction in HIV transmission to others (Cohen et al.,
2012). These findings led researchers to advocate for early diagnosis, the early initiation
of ARV, and consequent viral suppression.
An earlier study by Kitahata et al. (2009) found that patients who started ARV
immediately had better health outcomes than those who deferred medication. Combined
with similar results from population studies, Donnell et al. (2010), Montaner et al. (2010),
and Das et al. (2010) demonstrated that an effective strategy to reduce HIV transmission
is to prescribe appropriate ARVs to everyone infected with HIV.
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Continued medication adherence is especially key to improving health outcomes.
Adhering to medication at least 95% of the time has been advocated as best adherence
practices (CDC, 2013). Factors influencing adherence to medication may involve internal
motivation, circumstances, peers, and provider relationships. For some women,
adherence is especially motivated by a desire to stay alive for their children (Islam,
Minichiello, & Scott, 2018). Okoro and Odedina (2016), studied factors that influence
AA women’s care-seeking behaviors and adherence to HIV/AIDS medications. They
found that the provider–patient relationship is a great resource that promotes adherence
while relationship building influences patients’ understanding of the need to adhere to
ART. Another study by Nokes et al. (2012) found that enhancing self-efficacy was a
predictor of medication adherence. The authors also recommended incorporating selfefficacy into nursing interventions to help adherence. Meanwhile, Bonacci et al. (2016)
found that, although ARV adherence also entails refilling prescriptions, refilling
prescriptions is a poor predictor that someone is engaged and retained in care. The
researchers’ findings indicated that non-adherence is associated with non-retention, as
patients who do not show up for appointments exhibit an increased risk of dropping out
of care. Castel et al. (2016) found that about 83% of people who had ARV adherence in
the preceding 7 days were in care, compared to 69% for people out of care.
Care providers must analyze adherence on a regular or periodic basis to identify
people at risk and have more conversations with patients about the benefits of medication
adherence. An analysis of 12 years of United States Medicaid data showed that 57% of
patients failed to restart ARV after 18 months of stopping, and many of them were
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younger females (Zhang, Shireman, Youn, Lee, & Wilson, 2018). Older adults were more
likely to be adherent to medical visits and phlebotomy visits and experienced greater
levels of viral suppression (Waldrop-Valverde, Guo, Ownby, Rodriguez, & Jones, 2013).
According to Giordano, Jacobson, Mammen, and Moreno-Walton (2017), persons
diagnosed with acute HIV infection (AHI) in the emergency room fare better than
established HIV patients who also visited the emergency room. Their analysis concluded
that persons diagnosed with AHI had better linkage-to-care and greater initiation of ARV,
with 35% of the sample experiencing viral suppression within 6 months after the
emergency room visit. This better strategy needs to be implemented for all HIV-positive
individuals. Nonadherence to medication often leads to low viral suppression. Robertson
et al. (2017) performed a comparative analysis of clients who received or did not receive
care coordination. Interestingly, in 24 months, the two groups did not show any
significant difference in viral suppression. The noted difference was not a result of access
to medication as everyone had access, but possibly it was due to adherence instead.
Early diagnosis and engagement in HIV care are associated with not only better
health outcomes, but also lower medical costs. According to one study, entry into care
within 72 of HIV positive test results led to rapid HIV treatment, faster viral suppression,
improved health outcomes, and reduced HIV transmission (Halperin, Butler et al., 2017).
Gebo et al.’s (2010) analysis indicated that treating one person with HIV in 2006 in three
states in the U.S. was $19,912, with a higher cost for people with low CD4 counts. In
2015, the CDC estimated that it took about $23,000 per year to treat an individual with
HIV—an increase of more than three thousand dollars (CDC, 2019i). A lifetime

63
treatment in 2010 was estimated to be $379,668 (CDC, 2019i), while the country sees
about 40,000 new infections every year. Economically speaking, a lifetime treatment of
HIV is definitely astronomical compared to prevention. Therefore, ensuring that
transmission does not happen should be the priority. Adhering to medication and
engagement in HIV treatment reduces the virus in the system, which reduces infectivity.
As treatment amounts to prevention, ensuring that HIV-positive individuals are
diagnosed early and put on treatments seems to be reasonable and logical.
HIV Continuum of Care
The continuum of care is currently used to assess and measure the efficacy of HIV
treatment from the early stage of diagnosis of the disease through a continuum of steps
until there are improved health outcomes characterized by viral suppression. According
to the Department of Health in the District of Columbia, the continuum of care begins
with the number of HIV cases diagnosed for residents in the district, followed by the time
linked to care, engaged in care, prescribed ARV, and virally suppressed. In 2017, 12,078
people with HIV diagnoses were living in Washington, DC. Of these, 98% were ever
linked to HIV care (11, 875), with 29% having sporadic care (only 1 medical visit) and
71% in continuous care (more than one medical visit); 7, 950 (66%) were virally
suppressed (DC/DOH/HAHSTA, 2019). Improvement in health outcome is obvious from
2016 to 2018 with a viral suppression rate of 63% to 66% respectively.
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Figure 3. 2018 DC HIV Continuum of care. From “Annual epidemiology report,” by
DC/DOH/HAHSTA (2019).

Figure 4. Care dynamic among HIV cases living in District of Columbia, 2016. From
“Annual Epidemiology and Surveillance Report 2017,” by DC/DOH/HAHSTA (2017).

The District of Columbia fares better than the nation as a whole when it comes to
viral suppression. According to CDC data, only 49% of the 1.1 million persons with HIV
in the U.S. achieved viral suppression in 2014 (CDC, 2017a), which increased to 51% in
2017(CDC, 2019a).
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Yet a look at the performance of specifically the Ryan White program in
Washington, DC, reveals the possibility of even better health outcomes. The Ryan White
HIV/AIDS Treatment Extension Act of 2009 was created in 1990 to provide a system of
services that helps persons living with HIV in the United States to achieve improved
health status (Health Resources and Services Administration, 2016). Grants are awarded
to sub-recipients to develop comprehensive services for individuals living with HIV and
help optimize health. The array of services ranges from outpatient ambulatory health
services, dental services, mental health, substance abuse, medical case management, food
bank, and home delivered meals to psychosocial services, respite care, childcare, and
others. The various funding parts A, A (MAI), B, B (MAI), C, D, and F of the Ryan
White Act integrate to ensure the provision of optimal health for various populations who
are eligible. The person must live within the region or geographic area and meet income
qualifications (Health Resources and Services Administration, 2016).
By December 2018, 4,229 persons with HIV living in the city were also Ryan
White clients, while 73% (3,090) of Ryan White clients were in continuous care (i.e., at
least 2 viral loads reported 90 days apart). Of that number, 95% (4,003) were prescribed
antiretroviral therapy (ART) and 80% were virally suppressed (DC/DOH/HAHSTA,
2019). The 2018 Ryan White data shows a substantially higher success rate compared to
the 66% viral suppression in Washington, DC, as a whole in the same year (see Figure 5).
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Figure 5. 2018 Care dynamics among Ryan White Clients, District of Columbia. From
“Annual Epidemiology and Surveillance Report,” By DC/DOH/HAHSTA (2019)
Viral Suppression and Health Outcomes
Viral suppression reflects the result of a viral load test in which the level of HIV
in a person’s body is very low (<200 copies/ml) or undetectable (Cohen et al., 2012;
Pollini et al., 2011). Suppressed viral load improves the health of the person living with
HIV, increases survival, and reduces the risk of transmitting HIV (AIDSinfo, 2019a).
Virally suppressed HIV-infected persons are less likely to transmit HIV (Skarbinski et al.,
2015). Thus, the goal of treatment is to achieve viral suppression, where the virus is
undetectable in the blood, there is an increased CD4 count, and there are improved health
outcomes (AIDSinfo, 2019a).
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Women who are HIV positive should learn the importance and meaning of viral
suppression for their own well-being and as a means to reduce transmission. To
understand HIV infection within the AA community, it is necessary to understand
African American women’s knowledge of viral suppression at diagnosis and during the
continuum of care. In 2016, viral suppression among women in Washington, DC, was
low at 64%. Figure 6 shows that at least 25% of HIV-positive women in the district do
not consistently engage in HIV treatment to achieve viral suppression.

Figure 6. Care dynamics among women diagnosed with HIV living in Washington, DC,
in 2016. From “Annual Epidemiology and Surveillance Report,” by DC/DOH/HAHSTA
(2017).
Although viral suppression is the gold standard for the goal of HIV treatment, it
does not necessarily remove the harmful effects of viral attacks on the immune system.
HIV infection is characterized by increased immune activation even in people with a
suppressed viral load (Malherbe et al., 2014). However, a long interruption in treatment
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often leads to increased immune activation and negatively affected health (Musinguzi,
2018). In addition to improved health outcomes, viral suppression is associated with a
decrease of new HIV cases (Montaner et al., 2010). Viral suppression is also a
component of reduced community viral load, which in turn reduces new infections (Das
et al., 2010). Yet as important as this is as an indicator of positive health outcomes, Black
people are less likely to be virally suppressed. African Americans are less likely to have
controlled viral load and medication adherence and more likely to have more
comorbidities than Whites (Vaughan-Sarrazin et al., 2018). This scenario results in nonretention, which is a hallmark of disengagement in care and increased inflammation.
Positive health outcomes, according to Parrish (2012), include being alive and
having a state of well-functioning mental, physical, and social being, while negative
outcomes are death, illness, and a lack of wellness. Viral suppression leads to positive
health outcomes for people who are HIV positive, including women. Various studies
have shown that, when the HIV virus is reduced to undetectable levels (viral suppression)
in an infected person, there is a non-transmission of the virus, even with condomless sex
(Cohen, McCarley, & Gamble, 2011; Rodger et al., 2016; World Health Organization
[WHO], 2018a). There is no evidence that individuals who have achieved and maintained
undetectable levels of the virus transmit HIV to their sexual partners. This knowledge is
fueling the campaign known as U (undetectable) = U (Un-transmittable) as a key strategy
to ending HIV infection.
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Stigma as a Barrier to Treatment
Stigma is defined as a mark of disgrace related to someone’s circumstances due to
incarceration, disease, mental health, or something else that a society looks down on.
Usually the negative belief is unfair and may affect the health of the individual. HIV
stigma negatively affects testing, engagement with, and staying in HIV care, which in
turn leads to more infections (Valdiserri, 2002; Nyota, 2017). Stigma is regarded as a
major barrier that affects HIV-positive persons from seeking care and receiving the
benefits of HIV treatment. Stigma leads to a negative self-image that can prevent
individuals from seeking treatment and can delay treatment. Studies have found an
association between stigma and reduced initiation of antiretroviral medication, low
retention in care, and non-adherence (Logie et al., 2018; Sangaramoorthy, Jamison, &
Dyer, 2017).
According to Buseh and Stevens (2008), African American women experience
stigma socially, internally, and externally. Stigma has deep roots in gender, race,
ethnicity, class, sexuality, and culture and will continue to be seen as a great impediment
to reducing HIV transmission (Valdiserri, 2002, Nyota, 2017). Reducing stigma should
be incorporated into many educational programs. Coleman, Tate, Gaddist, and White’s
(2016) study in a faith-based community found lower HIV-related stigma among females
who have higher education, know someone with HIV/AIDS, and/or know a gay person.
Black churches have embarked on numerous health-related outreach programs in the
Black community, but stigma in Black churches continues to affect the provision of HIVrelated health activities (Pryor, Gaddist, & Johnson-Arnold, 2015).
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AA women who experience such barriers as stigma, denials, and depression and
who lack a support network may be able to mitigate these issues by obtaining resources
from their healthcare provider (Petralia, 2016). According to Stewart, Hong, and Powell
(2018), multifaceted intervention approaches may provide relief and improve the HIV
continuum of care. AA churches can facilitate interventions to reduce stigma, get
involved in providing a social support network, provide HIV education, act as agents that
link HIV-positive women to care, and provide support groups. AA experience stigma in
both the community and healthcare settings. Therefore, there is a need to understand the
interactions of all these issues as they apply to AA women with HIV in Washington, DC.
Logie et al. (2018) observed that stigma has a negative influence on the initiation and use
of HIV medications among women living in Canada.
Any intervention that could eliminate or reduce stigma may increase adherence to
treatment and medication and thus improve health outcomes. I had planned this study
towards understanding AA women’s lived HIV experiences during such challenges. The
review of existing literature did not identify any research on AA women’s HIV timeline
and resilience.
HIV/AIDS and Health Disparities
The CDC (2014) defined health disparity as the greater occurrence of a disease in
a particular population. It might occur in association with gender, race, education, or even
geographical location (CDC, 2018d). Health disparity is also defined as a particular
health difference between groups, which could be socially, economically, or
environmentally engineered (CDC, 2018d; HealthyPeople.gov, 2018), and often affects
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people who have challenges accessing quality healthcare. The various areas in which AA
women experience health disparities include viral suppression for AA women infected
with HIV (Billioux et al., 2015; Castel et al., 2016; Crepaz, et al., 2016; Hall, Tang,
Westfall, & Mugavero, 2013; Nwangwu-Ike, Hermandez, An, Huang, & Hall, 2015;
Torian, Xia, & Wiewel, 2014).
Although HIV/AIDS-related deaths continue to decline with effective
antiretroviral therapy, the District of Columbia records show that its death rate is higher
than the nation’s, at 20.4 per 100,000 population versus 2.6 per 100,000
(DC/DOH/HAHSTA, 2017). One of the objectives of the national HIV strategy is to
design health programs to reduce disparities in highly affected communities, especially in
terms of viral suppression and AIDS death (HIV.gov, n.d.; NHAS, 2015; White House
Office of National AIDS Policy, 2016). Washington, DC, is uniquely positioned as a
large metropolitan city and the capital of the United States. As such it should be the
epitome of health for all its residents. However, in 2016, AA women accounted for 94%
of all new HIV cases in the city, an increase from 92.5% in 2015 (DC/DOH/HAHSTA,
2017). Therefore, the need to identify reasons for HIV disparities, especially among AA
women in the district, is critical to improve health outcomes in the city.
Geter et al. (2018) found that, although viral suppression increased among HIVpositive women, disparities were observed among racial and ethnic minority women. The
researchers underscored the need to study the disparities in HIV treatment, especially
among Black women and younger women. They also highlighted the need for genderbased and culturally sensitive interventions.
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Summary and Conclusions
HIV/AIDS affects millions of people, with approximately 36.9 million people
living with the disease as of 2017 (WHO, 2018b). Women who engage in heterosexual
sex are disproportionately affected and, in the United States, AA women are especially
affected (CDC, 2019b). The HIV infection rate remains a public health issue as AA
women continue to experience increases. Fortunately, HIV treatment has evolved from
having no medications to more than 30 active antiretroviral medications. When taken as
prescribed, ARV works to reduce the virus in the system, resulting in viral suppression. It
has been shown that the virally suppressed person is not infectious and does not transmit
HIV to negative partners during times of condomless sex (Skarbinski et al., 2015; WHO,
2018a).
Despite the numerous articles reviewed, no research article or intervention
discussed the importance of viral suppression at the time of diagnosis. To achieve viral
suppression, one has to be on ARV and adhere to the treatment. In a practical best case
scenario, an HIV-infected person who adheres to treatment could achieve viral
suppression within 48 weeks and maintain optimal health if other comorbidities do not
affect health (AIDSinfo, 2019a; Robertson et al., 2017). The importance of viral
suppression and all its positive health implications are known, yet there is a dearth of
information on education on viral suppression.
Furthermore, AA women experience stigma in their search for HIV treatment and
care. Social stigma of HIV-positive status remains prevalent in society, including in the
churches that have otherwise served as refugee for the AA community for hundreds of
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years. Stigma is a barrier to care and treatment. Stigma impedes the disclosure of HIV
status, preventing honesty in relationships and leading to further infections (Avert.org,
2018; Kontomanolis, Michalapoulos, Gkasdaris & Fasoulakis, 2017; Saki, Kermanshahi,
Mohammadi & Mohraz, 2015). The stigma and silence that surround HIV is a barrier for
the AA community’s health and well-being.
The literature has a great deal of information on health disparities experienced by
African Americans. AA women, in particular, are disproportionately infected with
HIV/AIDS. In Washington, DC, alone, AA women account for 94% of new HIV
infections (DC/DOH/HAHSTA, 2017). As the disparities continue, some HIV-positive
women are also considered to be living well with the disease. Often infected at an early
age, they have lived through time spans of no treatment to effective treatment.
The review of existing literature found that it does not ask or answer questions
regarding the characteristics of HIV-positive AA women who have survived decades of
infection. To date, no research had ventured to look at the lives of these AA women and
their lived experiences with HIV/AIDS, especially their knowledge of viral suppression.
Although often infected between 18 and 25 years of age, some AA women are still living
today. Their lessons learned should be incorporated into interventions for current younger
HIV-infected women. The lessons learned in this study should provide information to
help close the gap in the education and counseling on viral suppression at the time of
diagnosis and the resultant effect on engaging and remaining in HIV treatment and care.
Chapter 3 will delineate all the steps and methods used in designing this study.
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Chapter 3: Research Method
Introduction
Learning from the experiences of HIV positive AA women is indeed vital,
especially as their experiences relate to achieving viral suppression. Ensuring there is
viral suppression when taking antiretroviral medication is an important precursor to
ending HIV/AIDS (United Nations AIDS, 2014). Therefore, one of the key purposes of
the study was to understand in greater detail how HIV positive AA women gained
knowledge of viral suppression at their diagnosis and achieving viral suppression. The
insights obtained provided valuable guidance when crafting prevention messages.
Another purpose of this study was to increase the understanding of HIV infection and
viral suppression from the perspectives of AA women who are living with HIV. The
study used a phenomenological approach to uncover the lived experiences of HIV
positive AA women and their viral suppression, including how HIV positive individuals
are discriminated against in the community and further still can experience strong stigma
from family and friends, as reported by Buseh and Stevens (2007). Another aspect of this
study was the use of feminist lens to better understand the unequal position of black
women in the context of HIV infection.
The study findings supported gender as the basic framework that conditions
women for an increased risk of HIV infection. In an analysis of the HIV/AIDS disease
burden among AA women, a gender responsive model also furnished useful initial steps
for new dialogue and a fresher examination of HIV/AIDS as a social issue (Brawner,
2014). Issues related to gender roles and socialization may also have to be explored to

75
understand the HIV vulnerability of African American women. HIV infection may also
reflect geo-behavioral characteristics. In addition, the study findings may contribute more
knowledge and understanding of how power relationships, social constructs, and social
positions actually impact acquisition of HIV infection.
In Chapter 3, I detail the research design and the rationale including the research
questions, phenomenon of study, and the research tradition that informed this study. Most
importantly, the rationale for choosing a qualitative phenomenological design is
discussed. The role of the researcher is an important part of this discussion. Working in
HIV/AIDS for more than 20 years may create a certain bias that I must interrogate to
ensure that the study was conducted in a professional manner and vigor applied. A
detailed discussion of how researcher bias was managed is also presented.
Another important part of Chapter 3 is my discussion of the selection of the study
participants, methods of recruitment, the logic for that selection, the purposeful sampling,
inclusion criteria, sample size, and saturation point. Plans for analysis and issues of
trustworthiness in a qualitative study are also discussed. Other sections in this chapter
include ethical issues and concerns, and how these are managed, including the actual
steps for obtaining institutional board review (IRB) approval to conduct the study.
Research Design and Rationale
The three main questions that drove this study are:
Research Question 1: What is the lived experience of African American women
with HIV/AIDS in DC?
Subquestion 1a: What are their daily routines of medication adherence?
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Subquestion 1b: What challenges constitute stigma and discrimination that they
face in daily living?
Research Question 2: How do HIV positive women describe/explain viral
suppression?
Research Question 3: How do HIV positive women explain/describe the high rate
of HIV infection among African Americans in the District?
The Study Phenomenon
African American females are disproportionately affected by HIV/AIDS in the
United States and the District of Columbia in particular. The infection rate continues to
increase within this group, even though new infections are decreasing overall across races
and ethnicities. One of the hallmarks and clinical benefits of HIV treatment today is
achieving viral suppression (AIDSinfo, 2019). Because viral suppression is important,
health educators and medical providers must educate newly infected individuals on
engaging in medical care, taking medication as prescribed, and achieving viral
suppression. Viral suppression means having an undetectable viral load, which according
to DHHS guidelines (2018) is when an individual has less than 200 copies of the HIV
virus (RNA <200 copies/mL). The knowledge of AA women at diagnosis regarding viral
suppression and during the continuum of care will be assessed. Understanding the lived
experiences of these women and understanding what they know about the goal of
treatment are both important. In addition, the study will look at the increase in HIV
infection experienced by this group through the lens of empowerment theory.

77
Research Tradition
The most appropriate design used in this research is a qualitative study wherein
the people experiencing the phenomenon under study were recruited and asked questions.
The phenomenology design chosen is appropriate because HIV infection in this instance
was studied among HIV positive women who experienced the phenomenon.
Phenomenological inquiry also has a philosophical basis (Giorgi, 2017). There are three
major phenomenological traditions, namely, transcendental, existential, and hermeneutic
(Moustakes, 1994; Kafle, 2011). Transcendental phenomenology is the original form
postulated by Husserl with the premise that experiences will have to transcend to reality
(Sheehan, 2014; Moustakes, 1994). For this philosophical concept/focus, the researcher
will suspend personal experiences and knowledge of the studied phenomenon so as to
understand the “lived” experiences of the participants. Personal opinion is suspended, and
the phenomenon is instead strictly and descriptively presented. However, challenges that
are inherent in this school of thought is the practicability of suspending personal opinion
using bracketing and epoche (Kafle, 2011). Transcendental phenomenology demands the
suspension of judgment about reality and includes an actual intentionality of
consciousness (Percy, Kostere & Kostere, 2015,). The existential phenomenology school
of thought argues that only an engaged individual will see the world and rejects the idea
that a researcher should suspend personal experience in order to be effective in carrying
out such research. (Kafle, 2011).
The third tradition is known as hermeneutic phenomenology. This school of
thought was presented by Heidegger and is described as a deviation from Husserl.

78
Heidegger simply posits that suspending personal opinion is difficult, and there should
rather be an interpretation of the descriptive. A hermeneutic phenomenological approach
is applied in this particular study and seen in two ways. The first stage was to make sense
of what a participant is experiencing and the second stage is to interpret those experiences
critically (Taylor, 2015). According to Mjorud, Engedal, Rosvik, and Kirkevoid (2017),
interpreting the transcriptions of interviews of participants emphasized the hermeneutic
aspect of the methodology. This school of thought considers the researcher to be a
signpost that points to understanding the phenomenon during the study so as to ensure
and enhance the knowledge of the essence and meaning that has been experienced by the
participants (Kafle, 2011).
In this study, the hermeneutic approach allowed the researcher to understand the
participant’s inner essence, their internal subjective experiences, and at the same time,
make sense of the phenomenon (Subramoney, 2015; Taylor, 2015). In this case, the
phenomenon is actually living with HIV/AIDS. Also, for this method of research,
participants’ own cognitive processing structures are also involved. It becomes a
conscious experience to understand the reason for the phenomenon (Percy, Kostere &
Kostere, 2015). This methodology hinges on the assumption that reality consists of
certain phenomena as understood by a person’s consciousness. The uniqueness of
individuals affects the way they process information, how different individuals will
attribute meaning to similar life experiences, and how the phenomenon is ultimately
understood by the person (Burkholder, Cox, & Crawford, (Eds.), 2016; Rudestam &
Newton, 2015; Kelly, n.d.). These processes are called interpretive phenomenology.
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A study guided by interpretive phenomenology identified the participants who
have the relevant lived experiences in order to utilize those experiences and their
meanings for further development of effective policies for practice. Information obtained
using this approach was subjective. However, it does provide in-depth understanding as
the individual experiences and meaning of the phenomenon are described in terms of
“what” the people experienced and “how” they experienced it. (Creswell, 2013; Crosby,
DiClemente, & Salazar, 2006).
Role of the Researcher
An interpretive (hermeneutics) phenomenology approach was applied to this
study. Interpretive phenomenology often involves four steps: Bracketing, intuiting,
analyzing, and describing. This process means that the researcher must remove all
preconceived ideas about HIV among AA women so as to investigate and collect an
unbiased dataset and separate what is known of the phenomenon from the pure
phenomenon (Van Manen, 1990). During the intuition/intuitive stage, the researcher
focuses directly on the phenomenon and the meaning ascribed to it by those who have
experienced it, while still continuing to analyze the data until its essence is obtained.
Researchers are immersed in the phenomenon and must analyze it using open, axial, and
selective coding, categorizing the data into themes until an identifiable essence is
obtained (Tavallaei & Talib, 2010). The end stage or end process involves producing a
description or definition of the phenomenon being studied. A phenomenological
approach studies conscious lived experiences without theories or objective reality, but
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rather according to how the people who are the participants in the study constructed their
meaning of the experience.
As the primary data collection instrument, I disclosed personal biases and
assumptions (Creswell, 2014). I have worked on HIV/AIDS issues for more than twenty
years. Therefore, as a researcher, I acknowledged my personal bias, beliefs, and values
and stated them upfront. This process was needed to understand the perceptions and
assumptions that I bring to the table (Janesick, 2011). The strategy of reflexivity was
utilized to enhance credibility (Draper & Swift, 2010). It was my role as the researcher to
ensure that the method of data collection was appropriate and can answer the central
question of the study. Researchers’ techniques and strategies for sampling was very
critical and important in all qualitative studies.
I do not provide clinical care to HIV positive women in the District of Columbia,
thereby reducing the concerns about a power relations conflict. As a project officer, the
majority of my duties related to project design, technical assistance, and organizational
compliance with Federal and State public health laws. Due to the demographics and
characteristics of the population of this particular study, I intend to provide incentives for
transportation and lunch. These facilitated participants’ travel to the interview location.
Smart-trip cards ($5.00) and a $25 for lunch was provided, with a total cost of $30 dollars
for each participant.
Methodology
Most times, identifying a relevant research method is a difficult task. The most
applicable tool must be geared towards obtaining the right information to answer the
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research question. In this qualitative study, the right participants who have experienced
the phenomenon must be identified and sampled.
Participant Selection Logic
HIV positive AA women residing in the District of Columbia are the population
that was studied. Participants have lived with HIV for more than 10 years. These are
generation X’ers who were born between 1960 and 1980. It is the generation that
witnessed the onset of the HIV epidemic, lived through the early days when there was no
treatment, but only comfort measures available when people died. The generation also
witnessed and lived through the era of thirty different types of effective antiretroviral
medication being developed with a consequent improved longevity.
Purposeful Sampling
Purposeful sampling targets a pre-existing group and usually depends on the
research question (Crosby, DiClemente & Salazar, 2006). The most practical and best
strategy for this particular phenomenological approach is to use group-characteristics
sampling, and specifically search for maximum variation (heterogeneity sampling). The
purposeful sampling technique selects a wide range of cases to gain good variation in the
dimension of interest with two purposes in mind. The intention was to document diversity
and also important common patterns across that diversity. Patton (2015), however, noted
a problem with this type of sampling, as it is often difficult to select a sample that is
representative enough of the population. This issue might lead to having a sample that is
homogeneous and not heterogeneous. At the same time, Patton suggested ways to
maximize the diversity, namely, by constructing criteria selected from different sites and
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locations. In order to have a representative sample of the women who have a specific
phenomenon, purposeful sampling was the most appropriate way to ensure that only
members of the targeted group were selected.
Inclusion Criteria
The following were eligibility criteria for all participants included in this study.
All participants were:
•

HIV positive,

•

African American women,

•

Between 35 and 60 years old,

•

Reside in the District of Columbia,

•

Lived with HIV for 10 years or more, and

•

Attending one of the Ryan White funded medical care clinics.

Participants came from already known clinics providing HIV care. Each
participant provided self-reported clinical information and demographic information used
to confirm that criteria were met. Another strategy applied in this study was triangulation
of data. Clinical outcomes for HIV positive AA women were extracted from DC
Health/HAHSTA Surveillance system. The data was used to triangulate information
obtained from the in-depth interviews during the primary data collection. The researcher
obtained approval from the DC Institutional Review Board for Public Health (IRBPH) for
permission to use the secondary data already in its system for effective data triangulation.
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Sample Size
According to Draper and Swift (2010), qualitative research looks for theoretical
generalization instead of empirical generalization and does not require a large sample size
to accomplish that goal. Small numbers from a rich source of information are ideal.
Sample size is an essential part of designing any study, and according to Buckholder
(n.d.), a researcher must ensure that the essential components are contained in the sample.
Choosing the sample size in qualitative research was a challenge and does not need
power calculations, which are usually linked to quantitative research design (Buckholder,
n.d.). The golden rule is to have a sample that is large enough to obtain answers to the
research question and not so large as to hinder successful in-depth analysis (Draper &
Swift, 2010). A sample size should emerge within a framework of clearly stated aims,
approach, and goals, and also be dependent on the resources available (Luborsky &
Rubinstein, 1995). According to Patton (2015), 6-10 participants are an ideal number for
a proper phenomenological qualitative interview size.
In this study, a sample of 10 HIV positive AA women were drawn from the
District of Columbia. Ryan White programs already serving these women were
approached. Many of the organizations provide outpatient ambulatory health services and
medical case management to residents. The main organizations that serve the majority of
the AA minority population in DC were approached and agreed to participate in the
study.
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Saturation Point
The strategy for this study meant that I started interviewing as soon as IRB
approval was obtained. Each interview was analyzed, as more interviews were being
conducted. This snowball type of analysis continued until no new information was
obtained from new interviews. This was the saturation point when interviewing stopped
(Kumar, 2005). Saturation is accepted in qualitative research, but its operationalization
depends on the methodology. Saunders et al. (2018) identified four distinct ways of
operationalization to ensure that further data collection and analysis does not yield any
new information. They concluded that a saturation point should be consistent with the
research question. This study conducted 10 in-depth interviews. However, I monitored
for saturation point for data collection and analysis. I continued to interview and analyze
until no new information was identified and further data collection and analyses did not
contribute new information and are thus more interview was not necessary.
Instrumentation
This is the process of identifying research tool that could specifically be used to
gather data in this qualitative study. There are different types of tools available for use.
The most common tool applied here is the semi-structured interview protocol. Another
instrument applied include aggregated clinical data from DC Health used for
triangulation which is a way to corroborate that information received from participants
are accurate
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Interview protocol.
I developed the interview questions and protocol for the study. Constructs
selected from resilience theory and empowerment theory were utilized to design the
interview questions. Jacob and Furgerson (2012) suggested that interviewers ask
questions in a particular order with easy questions asked before more difficult ones. The
interview protocol was also flexible enough, so it can be revised on the spot when
something interesting but not part of the script emerged. I used a script to start and end
each interview. An expert panel and peers earlier validated the interview questions. The
questions were also distributed to three expert researchers for their input on the content.
This process was to ensure that the questions exactly result in gathering answers to the
noted research questions. Another validity strategy to determine ease of comprehension
was to administer the questions to peers also.
Recruitment, Participation, and Data Collection Procedures
Solicitation to participate was advertising on fliers and brochures. These were
made available at different organizations that receive money from Ryan White funds to
serve people who are HIV positive. Information about the researcher and her contact
phone number were included on the fliers. Another strategy for recruitment was through
medical providers who shared the study opportunity with their patients and contacted me
about any willing participant. On a personal level, I approached patients who have
publicly shared their HIV status that met my study criteria and ask for their participation.
DC HIV Planning Commission on HIV/AIDS was approached with the flier to distribute
to their contacts for interested participants to contact me.
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Data collection method.
Usually, a research interview is a logical sequence that is actively utilized in the
research process. A nine-step interview process, as itemized by Creswell (2013), includes
the use of open-ended questions that are focused on the central phenomenon being
studied. Interview is an art of conversing used to obtain information (Patton (2015) and
also an exchange of conversation between two or more people. Types of interviews
include responsive interviewing, creative interviewing, active interviewing, portraiture,
and reflective interviewing. Alshenqeeti (2014) defined the process as one that
encourages interviewees to answer questions correctly. All interviews in this study were
conducted one-on-one and audio recorded with appropriate equipment. The interview
protocol validated by experts guided the discussions.
Other strategies of good interview skills included identifying quiet location where
a participant felt comfortable and safe, then administering and obtaining consent from the
interviewee. The interviews were conducted in quiet safe rooms at clinics where
participants receive clinical care. Only one interview was conducted in a private office
space. The researcher actively listened during the interview process, was courteous and
respectful, and ensured that the participant’s time was respected (Jacob & Furgerson,
2012). Participants signed the consent to take part in the study. This consent form
included formal permission to record the interview and all needed information regarding
ethical issues.
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Primary data collected through interviews.
Data was collected from participants in the District of Columbia by using
interview questions that followed well scripted protocol. I interviewed participants
individually. The interview responses were audio recorded and later transcribed. This was
a one-time, 60- 90 minutes in-depth interview with each participant. The interviews were
completed within six weeks of the first interview. The first interview was conducted on
September 10 and last interview was October 22, 2019. This ensured that the data was
collected within the same timeframe so as to reduce any effects of adverse weather,
political developments, or other events that may influence any responses. Completing the
data collection within six weeks ensured that the data also remained relevant within the
same timeframe. Participants availability were accommodated as the interview sessions
were scheduled. Data was collected using open-ended interview questions that were
audio-recorded and then transcribed.
During the interview, participants were asked to recall medical information for the
timeline that relates to them. For example, if they were diagnosed in 1990, the participant
was asked to recall their CD4 count at diagnosis, current CD4 count, viral load at
diagnosis, current viral load, the first medication regimen they started, current
medication, when they became engaged in HIV care, and any other pertinent information
relevant to their lived experience. All these responses formed the bulk of the data that
was analyzed and validated through data gathered from DC Health during the
triangulation processes.
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Data for triangulation.
Another source of data for this study came from the District of Columbia Health
Department (DC Health). Clinical records, specifically viral loads, CD4 counts, of
African American women who meet the criteria for the study were extracted from the
Department’s surveillance database. The system is highly protected with physical locks
and electronic passwords. Anyone accessing the information was directed to a locked
room to extract the information, and no identifying information leaves the room. For this
study, there was no protected health information from the system and the surveillance
team pulled the aggregated data for triangulation for the researcher.
Clinical data on the participants was used to triangulate and validate the interview
responses. Patton (2015) noted that triangulation is a relevant method for confirming
consistency in the results. The time series data extracted were newly diagnosed AA
women diagnosed in 2000, and their clinical data in 2000, 2010, 2015 and 2018. This
process helped to identify for patterns of viral suppression and engagement in care for
participants, and supports the clinical picture used to validate the interviews. The
information from this objective data also support some of the self-reported responses.
Most of the information collected by the Department of Health came through State
Laboratories and the mandated infectious diseases reporting system. The instrument used
by medical laboratories and medical facilities to report infectious diseases were already
validated and used nationally. Therefore, there was no need to validate any secondary
data from the department.
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Follow-up plan if few participants were recruited.
In the event that I was not able to recruit 8- 10 participants, I was to solicit the
help of the Ryan White Consumer Advisory Council of DC Health, which met
periodically. Another alternative strategy was to attend some of the support group
meetings hosted by various organizations, so I could explain to their attendees the need
for the study, the benefits for AA women, and the inclusion of incentives that covered
transportation and lunch. A last resort measure to ensure that I recruited the number of
women needed would have been to increase the age gap being studied to include older
AA women. All these contingency measures were not implemented because I recruited
the exact number of participants that I needed and stopped.
Debriefing, exit process, and follow-up interviews.
After each interview, each participant was debriefed on the next processes of the
study and thanked for their participation. The researcher reiterated the benefits of the
study and the commitment that the participant will receive a copy of the study when
completed. In addition, an incentive package was provided to each participant. Each
participant will also be notified on how she had contributed to social change through their
act of participation. Part of the debriefing process included providing the researcher’s
contact information to the participants. Participants willingness to come back during data
analysis if further clarification was needed for any interview responses was solicited and
confirmed.
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Data Analysis Plan
Data was analyzed and grouped into specific research questions and how each
question was answered. As the interview questions were designed with various research
questions in mind, the collection of information was grouped in the same format. There
were groups of responses on lived experiences related to self-efficacy, resiliency,
empowerment, stigma, HIV as a gender issue, medication, and treatment adherence.
Another group included the women’s experiences and knowledge of viral suppression at
diagnosis and along their continuum of care. Clinical data for the women was arranged in
tables to reflect clinical outcomes in a time series that runs from diagnosis to 2018. There
were tables of descriptive statistics on the demographics of the participants.
In this phenomenological research, data was managed by hand coding. Coding is
a process of combining and analyzing data into categories or themes, to increase the ease
of information retrieval at a later stage for comparison (Taylor & Gibbs, 2010, Adu,
2013). While a code can represent a phrase or word that pulls the meaning of each bit of
data. It is important, therefore, that the process is done as thoroughly as possible.
Although interviews generated lot of data, thorough reading of the transcripts several
times helped to reduce codes into a manageable number without missing important
information. Creswell (2013) advised a good approach is to start lean and broaden later.
Gibbs (2010) discussed many ways to approach coding, namely, line by line, sentence by
sentence, several paragraphs together, paragraph by paragraph, and whole document
coding. This process helped the researcher to be thorough in coding and all subsequent
analysis. After all the information was collated, the most significant comments were
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grouped into relevant recurring statements and themes. Then, I wrote a textual description
of the participants’ experiences, along with a structural description or the context of each
experience. The two write-ups were then be merged for a composite description of the
participants’ experiences of HIV disease. The analysis included examining the diversity
of the sample. Each case was unique, as the researcher looked for common patterns or
traits that unify even in diversity except that all of the cases were HIV positive. There
was no discrepant case encountered.
Issues of Trustworthiness
Clinical data on the AA women in this study were used to triangulate the
qualitative data collected. Patton (2015) and Creswell (2014) proposed that qualitative
researchers used the concept of reflexivity, which advises researchers to be conscious of
their biases, values, and experiences in order to write and communicate more objectively.
The credibility of data and the findings in any research is key. This focus propels
researchers to put solid strategies in place to ensure that all data is credible, validated, and
trustworthy. Creswell (2014) discussed various methods used for ensuring credibility,
such as ensuring that codes are cross checked, checking transcripts for errors, and
performing useful triangulations.
Triangulation of data enhances the building and integrating of many sources to
validate the information collected during interviews. Four types of data triangulation will
help ensure the validity and credibility of data, namely, triangulation of qualitative
sources, mixed triangulation, analytical triangulation, and the theory/perspective
triangulation (Patton, 2015. In this study, analytical triangulation was conducted. Data

92
from DC Health was crosschecked with medical information obtained during the
interviews. Triangulation helped the researcher make sense of any inconsistent or
conflicting data. Another method for ensuring trustworthiness was peer review. This
aspect involved passing the information through peers who acted as fact checkers and
through peer debriefings (Creswell, 2014). In addition, this study methodology is
reproducible, as all the steps for data collection were clearly elucidated. I kept a journal
of the daily and weekly activities being carried out during data collection, interviews, and
communications to ensure accurate information was obtained. Peer support was also
utilized to discuss the credibility of the information obtained.
Another action taken to ensure trustworthiness of the collected data was checking
the transcripts of the recorded interviews and identifying alternative words for the ones
provided. I also engage in member checking, which Hadi and Closs (2016) described as a
form of ongoing validation. This was informally with the participants and during the
interpretation of the collected information. No participants were contacted further to
verify the information that they provided during their personal interviews.
In addition, I used reflexive writing, which basically means putting my feelings in
control to enable a full objective analysis void of any bias to be produced. This focus was
needed especially during the interpretation of the findings. Hadi and Closs (2016) advised
that researcher apply the same critical analysis to the researcher’s own knowledge of the
field of study or the phenomenon being studied.
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Ethical Procedures
This study required the use and collection of very sensitive information where
confidentiality is important. Participants meet the inclusion criteria, consented to
participation, and signed a confidentiality form. The protocols followed in this study was
clearly documented to enable future researchers clearly follow the steps used in this
research and potentially use them.
Research on HIV/AIDS always has unique ethical and legal aspects to consider.
Due to the nature of the disease and the stigmatization of the community associated with
the infection, many HIV positive persons do not disclose their status. It is also illegal and
against HIPAA rules to conduct research and disclose someone’s medical status without
consent. All participants signed consent forms. The contents of the study/analysis was
explained in detail to participants before signatures were obtained. Moreover, in this
qualitative research, ahead of the data collection, all legal and ethical issues were
discussed with each participant along with the strategies to mitigate any issue discussed.
Two Institutional Review Board (IRB) agreements were obtained for undertaking
this study. IRB approval number from Walden University is 08-29-19-0450160 while DC
Health IRB approval number is IRBPH # 2019-18. Approval by each institutional review
board was obtained as required for research with human subjects. A brief description of
the study proposal was also submitted to the DC Health Institutional Review Board (IRB)
as the data for triangulation was collected from the DC Health surveillance system. The
methodology was itemized to ensure that it posed no harm to any of the participants.
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After gaining IRB approval from both institutions, the study started and there was no
change in the proposed methodology that needed correction or amendment.
In addition to the ethical issues mentioned above, bias was another key problem
that was seriously considered. Bias is the tendency to bring prejudice and subjectivity
into the research process that may affect the findings and/or make answering the research
questions questionable or impossible (Pannucci & Wilkins, 2010). This issue can be
introduced at any point in the data collection. In such a case, the researcher must be able
to set aside personal assumptions about AA women and HIV infection, set aside societal
moral codes, and be fully open to new ideas.
I ensured that any information provided by participants was treated as confidential
unless required by law for disclosure. I also respected all privacy laws and followed the
code of ethics of the health education profession (Fertman & Allensworth, 2017). To
ensure cultural appropriateness and acceptability, all effort was made to respect each
participant’s religious beliefs, socioeconomic status, family style, and values. (Fertman &
Allensworth, 2017).
All participants were given clear information on the voluntary nature of
participation and their ability to withdraw at any time from the study. There was no
coercion to participate. All the data collected were stored in a locked cabinet and
electronic information password protected. The use of a $30 incentive for transportation
and lunch was explained to all participants. This modest fund was to help and assist the
participants’ ability to take a metro train or bus to the location of the interview and by no
means a payment for their participation. And participants were also informed that
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receiving these incentives did not bind them, as any withdrawal from the study can still
be exercised even after an interview had been completed.
Summary
An interpretive (hermeneutics) phenomenology approach was applied to study the
lived experiences of HIV positive AA women who reside in the District of Columbia.
Study of the members of this population, particularly due to their HIV status and the use
of their patient health information and records, necessitates the review and approval of
the Walden University IRB and the DC Health IRB. Collection of data was twofold
through an interview instrument that I developed and used secondary data from DC
Health. The interview questions were reviewed by experts in the field of HIV research,
who validated the questions to determine whether they had the capacity to elicit correct
information when posed to the participants. Peers reviewed the comprehensibility of the
interview questions to ensure they are at a 9th grade reading level. Secondary data on
health outcomes was collected from DC Health, primarily for triangulation purposes. The
methods of recruitment were carefully considered and outlined, and inclusion criteria
elucidated. Data was manually coded, and nodes created When all data had been
collected and collated, the related analyses were conducted to look for themes and
findings that were then presented in Chapter 4. These results answered the research
questions on the resiliency of women and offer further insight into the lived experiences
of the women in this study.
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Chapter 4: Results
Introduction
In Chapter 4, I describe the results of the interviews that were conducted
individually with 10 AA women in the District of Columbia who were HIV positive.
Using a phenomenological approach, the purpose of the study was to learn and
understand the lived experiences and clinical outcomes of HIV positive AA women with
an emphasis on their perspectives related to becoming informed about viral suppression
at or after the time of diagnosis. Another component of this study was an examination of
how gender contributed to women’s vulnerability to HIV infection. Theories of resilience
and empowerment were considered in analyzing the responses of the interviewed women
who have lived with the disease from reproductive age, often had children, and have dealt
with the disease at the same time for 10 years or more.
The open-ended research questions were designed to elicit information on the
lived experiences among the study participants. Three main questions drove the direction
of the study with additional subquestions.
Research Question 1: What is the lived experience of African American women
with HIV/AIDS in DC?
Subquestion 1a: What are their daily routines of medication adherence?
Subquestion 1b: What challenges constitute stigma and discrimination that they
face in daily living?
Research Question 2: How do HIV positive women describe/explain viral
suppression?
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Research Question 3: How do HIV positive women explain/describe the high rate
of HIV infection among African Americans in the District?
In this chapter, I discuss the setting of the interviews at the various organizations,
including information on who participated. I address the demographics and
characteristics of the participants. I also discuss the data collection methods, data
analysis, evidence of trustworthiness. Finally, I present the results of the interviews and
key findings.
Research Setting
All interviews were conducted in a private and quiet location. Nine interviews
took place at community clinics located in the heart of the District. One interview was
conducted in Ward 2 in a private office space. The interviews were conducted based on
participants’ support groups or clinic appointments to ensure it did not infringe on their
daily schedule. The participants chose dates and times to schedule the interviews as were
convenient for them. The interview dates spanned from September 10 to October 22,
2019. The interview rooms were medical case management offices or small conference
rooms which were private. The rooms were very comfortable and quiet, away from the
clinic activity. There were also medical case managers across from the hall if needed and
clinic was in session if any of the women needed any intervention due to stress during the
interview. None of the participants displayed signs of stress requiring intervention.
However, two participants became emotional as they recounted their experiences stating
that they had not been able to narrate their experiences in a long time and talking about it
brought some relief. One of the two participants who became emotional stated that this
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was her first time in more than 15 years discussing the experience in full and appreciated
the opportunity. The voice recorder on my HP computer was placed next to myself and
the interviewee to allow for eye contact and acknowledgement during the sessions.
Demographics
The 10 participants are all residents of the District of Columbia, the location for
the study. Seventy percent (70%) of the participants were either born in Ward 8, Ward 7,
raised in Ward 8 or just moved to Ward 8. Together, Wards 7 and 8 are areas of high
HIV/AIDS prevalence in the District of Columbia (District of Columbia Department of
Health, HIV/AIDS, Hepatitis, STD and Tuberculosis Administration, 2016). The study
was open to any DC resident who was female and matched the other study eligibility
criteria, but many of the women who volunteered to speak about their experiences and
were interviewed lived in Ward 8. Among the others, one was from Ward 7, one was
from Ward 1, and two were from Ward 5 respectively. The location of respondents is
important, as findings are relevant to targeting interventions at the heart of HIV infection
in the District.
Participant age ranged from the youngest at 39 years old to the oldest at 60 years
old. All the women had lived with the infection for 10 years or more. They were all
infected during reproductive ages of 22 years up to 45 years and 60% were diagnosed
during pregnancy. Among the 10 women, three were married and lived with their
spouses. Seven participants reported they were currently single, had never been married,
and were not in a committed relationship. Six single participants reported having and
raising four to a total of 21 children without a spouse. Half (five) of the participants were
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employed and had jobs in the healthcare sector counseling other women as peer support
and the other half (five) were unemployed. The participants’ level of education included
no education, 10th grade, high school attempted, high school diploma, some college, to
master’s degree.
Table 1
Demographics of Participants
Participants

Age

Education

1

53

2
3

43
44

4

48

5
6
7
8

40
55
39
55

9

43

10

60

Some
College
High School
Some
College
No
Education
High School
10th Grade
High school
Some
College
Associate
Degree
Master’s
Degree

Employment
Employed

Marital
Status
Single

Ward in
DC
8

Employed
Employed

Married
Single

5
5

Unemployed

Single

8

Unemployed
Unemployed
Unemployed
Unemployed

Single
Single
Single
Single

8
8
7
8

Employed

Married

8

Own
Business

Married

1

Data Collection
Walden University IRB approved an interview protocol of 42 questions. I
designed the questions to evince from the study participants answers to the major
research questions. Primary data were collected from participants during face-to -face
interviews with open-ended questions. The interview sessions lasted from 40 minutes to
60 minutes. The setting appeared to be comfortable for the participants as they
individually volunteered answers to every question asked. Each participant was only
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interviewed once. In addition, participants were asked if the interview could be recorded
for ease of transcription. A voice recorder in an HP computer was used to record all
interviews and later transcribed verbatim.
Secondary data was collected through the surveillance system of DC Health. DC
Health and Walden University IRB approved secondary data for triangulation. Data of
newly diagnosed AA women from the years 2000, 2010, 2015 and 2018 were extracted
(Table 2). The specific variables were the median viral load at diagnosis, median viral
load at the end of each of the years, median CD4 count at diagnosis, and median CD4 at
end of the each of the years.
Table 2
Data for triangulation from DC Health/HAHSTA
Variables
African American Women
diagnosed with HIV
Ages 25 - 34
Ages 35 - 44
Ages 45 - 54
Ages 55 - 60
Median CD4 Count at
diagnoses
Median Viral load at
diagnoses
Median Viral load at end of
year
Median CD4 at end of the
year

2000
201

2010
123

2015
108

2018
105

1205

20

20

20

126

586

646

582

73
77
46
5
154.5
1205
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In addition, a cohort of data from all newly diagnosed AA women in 2000, 2010
and 2018, were extracted. The specific variables of the same cohort were median CD4
Count and viral load at end of the years 2010 and 2018. The range in ages of newly
diagnosed in year 2000 were also extracted from the surveillance system. The form below
was used to extract data from the DC surveillance system for newly diagnosed AA
women. The collected information was used to discuss the self-reported narratives
collected from face to face interview of participants.
Table 3
Women newly diagnosed in 2000 (Ages 35 – 54) through 2018
Variable
CD4 count end of
year
Viral Load end of
year

2000
156

2010
586

2018
612

3687

47

46.5

I attempted to use NVivo software to transcribe the recorded interviews.
However, after two interview transcriptions, I found that the software output was
incomprehensible. The transcriptions were not coherent for both the questions I posed,
and the answers participants provided. Thus, I performed a manual transcription, listening
to the interviews multiple times and transcribe the recorded interviews verbatim.
Data Analysis
All interviews were recorded using ‘voice recorder’, software program in my HP
computer. I transcribed each interview into Microsoft Word. The first step of the data
analysis was a careful reading and re-reading of each interview transcript. The intent of
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this reading and re-reading was to gain an overall idea of the content of the women’s
responses before proceeding to code the responses.
Coding is a process of combining and analyzing data into categories or themes to
increase ease of information retrieval at a later stage for comparison (Taylor & Gibbs,
2010; Adu, 2013). A code represents a phrase or word that pulls the meaning of a data
point. It is important therefore that it is done as thoroughly as possible. The approach I
took was to read the responses line by line, sentence by sentence, paragraph by
paragraph, and then the whole document. Supported by Gibbs (2010), this approach is
known as an inductive approach. Thomas (2006) further described it as a process used to
“condense extensive and varied raw text data into a brief, summary format” (p. 241).
There were no discrepant cases used in the analysis. Specific codes and 18 themes
emerged from the data. Appendix A is a is a compilation of the themes and codes
including important quotations that emphasized responses from participants. In addition,
clinical data of women in DC, generated from DC Health Surveillance system, were
arranged in tables in a time series. Data of newly diagnosed AA women from the years
2000, 2010, 2015 and 2018 were extracted (Table 2). Clinical data of the women at time
of HIV diagnosis in year 2000 were compared to clinical outcomes in 2010, 2018 and
self-reported clinical data from participants. Specific clinical variables from the same
cohort were analyzed. Clinical data from surveillance system of newly diagnosed AA
women, ages 35-54years, were particularly analyzed because this is the age group mostly
affected by HIV in the District (Table 3).
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Evidence of Trustworthiness
Participants were interviewed individually, each seated in a comfortable private
room. Evidence of trustworthiness comprised of the credibility, transferability,
dependability and confirmability of the information collected. The interviews sessions
had an introductory section, which explained who I am, the purpose of the interview and
if the participants had any reservation in participation. The consent form was signed, and
interview conducted. At the end of the semi structured interview, the closing statement
contained an appreciation message and incentive given for participation.
Credibility
The credibility of the data was implemented as stated in Chapter 3. Clinical data
of HIV positive AA women from DC health were used for triangulation of the qualitative
data collected. Triangulation enhances integrating other sources to confirm data collected
through interviews. The DC Health surveillance system that houses HIV data for the
District of Columbia was used to confirm the self- reported clinical outcomes collected
from the participants. I applied the strategy of reflexive writing in this analysis. This
meant that my personal feelings were put in control and that enabled objective analysis
void of bias. In addition, I confirmed the credibility of the data through cross checking
personal notes obtained during the interviews with the audio recorded interview which I
transcribed. To avoid ambiguity of information, during the interview, there was reflective
affirmation to ensure participant’s information was understood. At the end of the
interviews, a summary of responses was read back to participants to ensure they were
adequately represented and no misrepresentation.
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Transferability
A detailed description of the research method was provided to allow for
replicability by other researchers. There was a rich description of the participants’
demographics to enable comparison to other population living in the District of
Columbia. The data collected was from DC residents. However, the 42 open-ended
questions in this study can be used in any setting of HIV infection. The ten women’s
information on lived experience were collected in very private interview rooms in a clinic
and one in office setting. Each face to face meeting lasted more than 40 minutes. This
data is specific to AA women in DC but can be generalized to all HIV positive AA
women receiving treatment in DC. The information and experience can only be limited to
DC residents due to the generosity of the city making HIV treatment accessible to DC
residents. The application of the hermeneutic circle in this analysis and triangulation of
clinical outcome data from the DC surveillance system makes the findings of this study
generalizable to other HIV positive women from other races living in the District.
Dependability
Interviews were transcribed verbatim using Microsoft word. I kept daily and
weekly activities during the data collection interviews to ensure correct information was
obtained. Each participant was asked the same questions, time given to ensure
information obtained was accurate. Participants were also allowed to ask questions before
and after the interviews. Clarity was also provided in case where the participant may not
understand the words used. Audio recorder provided data used verbatim to avoid recall
bias. In addition, each interview was transcribed independently to ensure no information
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was mixed or credited to the wrong participant. Triangulation of data was conducted.
Triangulation also helped to make sense of any inconsistent or conflicting data.
Confirmability
The strategy to ensure confirmability included description of the participants. I
searched within the interview transcripts for negative instances that may contradict prior
data and these were none. All participants provided information to all 42 questions asked.
Each audio-recorded interview was transcribed within 48 hours and corroborated with the
interview notes. Triangulation of data was conducted by use of the DC surveillance
system and for newly diagnosed AA women in, 2000, 2010, and 2018 (Table 2). The
clinical data was consistent with self-reported data from the participants. Another strategy
employed here was use of writing memos. This strategy ensure confirmability in
qualitative study. All transcripts were read many times, line-by-line, sentence by sentence
to ensure that all ideas are from participants.
Study Results
The three main research questions were thoroughly answered through data
collected from the 10 participants. The results are presented according to the questions.
There was other subquestions that also proffered answers to the research questions.
Hermeneutic approach was used for the analysis of the data in understanding the lived
HIV experiences. Results of this study was collated from all the responses from the 10
participants who answered 42 open-ended-questions. Eighteen different themes were
identified from many codes.

106
Research Question 1
The first research question was: What are the lived experiences of African
American women with HIV/AIDS in DC? Four themes emerged related to this question.
These themes are: (a) Theme 1: Diagnosed at reproductive age; (b) Theme 2: Adaptive
ability to lived experience; (c) Theme 3: Intense expectations for cure; and (d) Theme 4:
Positive strengths that contributes to resilience. The following section addresses each
them in turn.
Table 4
Specific codebook and themes from question 1
Question
Question 1

Theme
1.Diagnosed at
reproductive age
2.Adaptative ability to
lived experience
3.Era of denials and not
involved in care
4.Positive strengths that
contributes to resilience

Description
Infection at age of planning families and
future
Growing up in a family culture
Denials of diagnosis
Spirituality as strength to survive
Self -efficacy
Empowerment
Involvement in Support groups
Relationships
Receiving the diagnosis and when
effects of such diagnosis at the time of
diagnosis and subsequently

Theme 1: Diagnosed at reproductive age. The participants were diagnosed
during various years, the longest lived experience with a diagnosis made in 1992, and the
shortest lived experience with a diagnosis made in 2007. Nine of the women were
diagnosed with HIV at ages between 22 to 36 years old and only one was diagnosed at
age 45 years. Sixty percent of the participants were diagnosed while pregnant (See Table
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5 for age at diagnoses) and 40% diagnosed at sickness. They had gone for prenatal care
and got tested for HIV. Participant 5 said that, she was diagnosed at age 23 when
pregnant with her 4th child. She went ahead to have 3 more babies and one of her children
is HIV positive. The positive baby was born 18 months before the next pregnancy when
the diagnosis was made. Participant 4 (diagnosed age -36years) went to a clinic for a
pregnancy test and they asked her “do you know you are HIV and pregnant right? Until
that moment, she did not know, saying during the interview, “it was really hard, life
changing’. Eighty percent (80%) of the participants have children.
Table 5
Participants’ Age, Viral Load and CD4 Count at time of diagnosis
Age
Viral
Current (years)
CD4
load at
Participants
Age
at
Count at
Diagnos
(years)
Diagnos Diagnosis
is
is
Cases\\PARTICIPANT
1
53
33
150
500000
Cases\\PARTICIPANT
2
43
22
150
1000000
Cases\\PARTICIPANT
3
44
30
132
950000
Cases\\PARTICIPANT
4
48
36
150
500000
Cases\\PARTICIPANT
5
40
23
69
1000000
Cases\\PARTICIPANT
6
55
45
3
1000000
Cases\\PARTICIPANT
7
39
23
5
1000000
Cases\\PARTICIPANT
8
55
28
150
1000000
Cases\\PARTICIPANT
9
43
25
2
1000000
Cases\\PARTICIPANT
10
60
34
215
1000000
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Participant 7 (diagnosed at 23years) stated she was losing so much weight and
could not hold any food and experienced constant blackouts. She decided to go a clinic
where she was diagnosed with HIV. According to her, “my health deteriorates very bad,
my mother took me to the hospital… the hospital did not disclose to my mother, I
explained everything to her’. The age of diagnoses for all the participants were at a
reproductive age ranging from 22 to 45 years. Many of them were at the period of life
when they are planning their future when their diagnoses were received. However, 100%
of the participants discussed the effects of the diagnoses, initial denials, empowerment,
resilience, and the point of turnaround to embrace the diagnosis and learn to live with the
disease.
Theme 2: Adaptive ability to lived experience. Many of the participants were
not raised in a two- parents households, 50% were raised only by their mothers, who
they said were very strong and stood by them through the experience, 20% were
homeless and going from one foster home to another while growing up, 10% (1) was
raised by a grandmother and an older sister. The other 20% had relationships with both
mother and father in the same household.
For the 80% that had a mother, grandmother and parents in the home, they
described the positive influence of their backgrounds on surviving HIV. Participant 1
stated “my mom kept telling me that I have a purpose to live”. According to Participant 2,
“I was slow to learn… special aid, born drug addicted baby, and was not going to make
it…I did not know that I was on special aid in school. My grandmother said you are not
slow or stupid, it is that you learn different than others”. Upbringing and family culture
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where the participant grew up had some influence on how they have dealt with the
experiences living with the disease. Some participants had negative influences while
growing up in the home, such as drug addicted parents, drug addicted single mothers,
lived in abusive foster homes, but developed adaptive ability which helped to turn around
all the negative influences somewhere in the HIV journey.
For some participants, the point of behavior change, turnaround and decision to
survive HIV was dramatic while others achieved it slowly. However, at the initial time of
HIV diagnoses, denial was more at the forefront for 80% of the women.
Theme 3: Era of denials and not involved in care. Many of the women
described a period of denial after the diagnosis. Out of fear, anger and bewilderment,
60% of the participants denied the diagnosis and went on with their lives as if nothing
happened. The ones diagnosed during sickness, once they felt better, or those diagnosed
during pregnancy, once babies were born, disengaged from receiving treatment.
Participant 6 said, “I immediately went into denial, did not believe it, I had no feeling”.
Participant 7 also said, “I was in denial at time of diagnosis and wanted to kill
everybody… I never had issue accessing care, just not interested, in denial”. It took some
of the participants sometimes, up to years and Participant 2 specifically stated that it took
her about 10 to 15 years after diagnosis to get involved in treatment. According to
Participant 10, “there was nothing to live for, no history, gonna die anyway…did drugs
heavily for 4 years”. At this denial era, the participants were not involved in HIV
treatment, which meant, there was increased HIV virus in their community, which may
lead to more infections among their sexual partners.
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Theme 4: Positive strengths that contributes to resilience. Theme 4 tapped into
strengths that related to resilience. I grouped these strengths into subthemes. The
subthemes are decision to survive and thrive, drawing on spirituality for strength,
involvement in support groups, and identifying other supportive relationships.
Subtheme 4a: Decision to survive and thrive. There was resilience embedded in
all the responses from the participants. After the initial stage of denial, 100% of the
participants although still struggling with some individual difficulties, decided to thrive
and live with HIV. Participant 8 stated “different things were going on in my mind, how
am I going to raise them, take care of me, provide, all by myself… the father is not there
on regular basis to help with day to day, so I went through different changes’… I found
peace in my chaos”. Some of the survival and resilience statements among the women
included, a decision to live for the children’s sake. For example, Participant 2 shared
“have two kids to live for, that stayed in my mind, keep my mindset”. Others stated, “my
kids, its mine kids, I don’t want to just die for anybody to raise them…sick, tired, I’ve got
to get off my butts, they depend on me to do everything… it is not for me, it is for them
(Participant 5) and ‘the children are the motivation to stay alive (Participant 7). For some,
the sheer decision to stay alive and not allow HIV to define who they are motivated their
interest to engage in HIV treatment.
Subtheme 4b: Spirituality as strength for survival on the lived HIV journey.
Spirituality plays a vital role in the lived experienced of AA HIV positive women. One of
the survival hallmarks is having a relationship with a higher being, often called God. The
women discussed improving their ability to manage their HIV status through praying to
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God and having the will to take control and live. Participant 9 was very adamant about
how God told her that she was going to leave her profession to tell others about the
disease. She started speaking publicly about the disease in seminars and among young
girls. Living with HIV was also described as an emotional and spiritual journey. “God
has kept me going... he is my healer, keep positive attitude, keep my eyes on the prize, I
will be fine, that what I hold onto” (Participant 4).
“When I got pregnant with my 3rd child, I went back to church where I started
from… when I got myself together in the church that helped me to really digest and
grasp” (Participant 8). There was deep rooted relationship with spiritual leader, who
functioned as role father model that influenced one of the women. One participant
decided to stop using drugs that God had things better for her. To the extent that
Participant 4, will have to pray for the medicine to work before taking her daily
antiretroviral medication. She stated, “Everyday say a prayer, God let this medicine work,
God is good”. In all, there is a belief among the participants, that on a daily living,
involving God will make the HIV experience better.
Subtheme 4c: Involvement in support group. Among the keys to living well with
HIV was engagement in support groups. All the participants mentioned support groups
as a life saver. Forty percent of the participants are also engaged as peer educators in
various support groups. According to Participant 1, her support group “is a safe place to
vent, cry, disseminate information, give each other encouragement”. Having a place and
people one can relate with without fear of being judged was seen as a critical need for the
women. Some women do not have families, so instead being in a support group becomes
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a key factor to surviving. Participant 10 stated “I got involved in many support groups
and is better”. ‘This is a disease that cripples you, not just physically but mentally, if you
are not built for it and don’t have a support system, this is another key factor you have to
have a support system in place in case anything in life happens, what type of support
system do you have? That’s the lot of life” (Participant 8). Some called for mental health
support groups, self-esteem groups, more psychiatrists, including setting up HIV hotlines
to assist newly infected people navigate the health system to get help.
Subtheme 4d: Positive relationships. A gender issue raised was the role of men in
the lives of women after the infection. Some of the participants were able to find love
again. Among those that found love, whether the men were HIV positive or negative,
they have been a source of strength in the lived HIV experience. They are not judged by
their new partners and some because of the role of the men in their lives, have been
shielded from stigma. In one participant, the spouse was instrumental in her stopping a
life of prostitution and drugs, According to her, “Plus the dude told me, I come for you a
lot but I am not coming back no more because you act like you don’t want nothing better
and I said Oh Oh, I slapped myself up… I said, girl snap out of it, I decided am gonna
live right, gonna do my part… I met a guy who seemed to care more about me than I
cared for myself, but I met him in my addiction and prostitution…that my husband, so he
takes good care of me. We have been married 22 years” (Participant 10). Participant 4
met her spouse, who is HIV negative and states, “God is good, I found a man that loves
me, he encourages me to take my medication, he encourages me to keep positive attitude,
there is life after HIV, really is”. And for participant 9, her HIV negative husband has
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been the strength she needed to survive the disease. He also publicly acknowledges his
HIV positive wife further reducing her stigma and shame. “My husband had a T-shirt
which reads ‘my mate is beautifully made regardless of the HIV’… my husband is God’s
gift, celebrated 18years of marriage” (Participant 9). Participant 2 acknowledges never
experienced stigma because her husband in also positive and they work things together at
home ensuring that their children stays HIV negative. Forty percent (40%) of the
participants have positive relationships with their spouses and boyfriend, who provide
emotional strength and support.
Subquestion 1a
Subquestion 1a asked, what are their daily routines in relation to medication
adherence? Four themes emerged related to this question. These themes are: (a) Theme 5:
Importance of daily medication adherence; (b) Theme 6: Unfettered access to good HIV
treatment; (c) Theme 7: Intense expectations for cure; and (d) Theme 8: Conscientizationpersonal transformation to engage in HIV care. The following section addresses each
them in turn.
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Table 6
Specific codebook and themes from subquestion 1a
Question
Theme
Subquestion 5. Importance of daily
1a
medication adherence
6.Unfettered access to
good HIV care treatment
7.Intense expectation for
cure of HIV

Description
Individualized uniqueness in taking
medication
The need for a cure
Good access to HIV care in District of
Columbia
The need to survive and not die
Daily routines of medication adherence
Access to treatment
Satisfaction with care

8.Conscientizationpersonal transformation to
engage in HIV care

Theme 5: Importance of daily medication adherence. The women understood
the importance of taking antiretroviral medications on a daily basis. They built individual
skills to ensure adherence. Eighty percent are virally suppressed for many years while
twenty percent have achieved viral suppression sometime in the journey but currently not
suppressed. Among the ten women interviewed, each had a unique way of describing the
daily routine of taking antiretroviral medications. Not taking medication was likened to
abandoning children in the subway. According to Participant 5, “It is like leaving your
children in the subway and get off, anyone of them dies, you die”, I take it every day just
to live for them. I may miss sometimes but I get back to it”. Taking medication daily has
become part of life, either taking it in the morning or before bed. Some of the women
who take medication once a day profess how easy and convenient it is to be consistent
and take just one pill a day. The simplification of HIV medication was a vital factor to
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living well with the disease especially for women who were infected when there was little
to no medication. According to Participant 3 “Biktarvy once a day, that’s all”. “One time
a day with food, I take it in the afternoon, I don’t miss it. Because I take other heart
medicines” (Participant 2), “I take the medicine every night at 9pm, all the time, if the
medicine don’t work, it’s out of my control, I don’t have control of anything. The only
thing I have control is taking it” (Participant 4). “They are in bubble pack, Triumeq once
a day with food… prefers to take it in the morning as can forget in evening’ (Participant
10). According to Participant 8, a perfect reminder is to put the medication by the pillow
in the bedroom “It is by my pillow where I can see it before I sleep”. I see it, grab it and
take it. If not in my face, I will forget, it is not intentional, if you have a busy life like
mine”.
However, taking medication is still a challenge for all the women. This is not
necessarily because the participants do not understand the importance, rather because of
other life challenges. Participant 10 has a swallowing problem and Participant 7 can’t
take pills, shots including cough medicine and she was wondering, “if they make a patch,
all medicine in one into a patch. They have patches for cigarette, why can’t they make a
patch for HIV”.
Despite all challenges in medication adherence, medical providers and other
health workers who care for the participants play vital role in encouraging adherence.
Participant 2 stated “the way the medical provider treated me, she gave me the push, no
excuses, your numbers are good, but you have other health issues”. According to her, the
provider made her own her care by recommending to “call it your name”. Then
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Participant 2 stated that “mine is cocktail”. Using such names made her feel comfortable
taking the medications and she no longer refers to them as medication but as a cocktail.
Participant 6 was encouraged by her medical provider to join research study where she
was treated with utmost respect, became part of the research family, which played vital
positive role in her being adherent to treatment and medication.
Theme 6: Unfettered access to good HIV treatment. All of the 10 women
interviewed are satisfied with access to care and the care they receive in District of
Columbia. It was unanimous that some places that do not specialize in HIV treatment did
not do a good job, but wherever they were next referred after being diagnosed provided
great HIV care. One of the participants made the statement that “DC is a good place for
HIV treatment…no matter what you have you will never be turned away in DC”
(Participant 1). Their experiences with HIV treatment in the District of Columbia has
been very positive. According to participant 6, “I did not have problem accessing care, I
am engaged in the hospital that diagnosed me, I have been here all these years”. Other
statements confirming good HIV treatment and access to care in DC include, “I have
always had good care” (Participant 5), “I never had issue accessing care, just not
interested, in denial” (Participant 7) and Participant 9 stated “I am 103% satisfied, Father,
Son and Holy Ghost.”
However, Participant 8 discussed things that might be missing or lacking in DC HIV
care. According to her “DC don’t have services that really meet anything for people like
us and when they do, they have different types of rules and guidelines that you have to
cross all the “t” and dots all the “I”, I got my own wagon but you have to jump all these
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hoops just to get some help”. She said this with particular reference to financial help.
“Right now, its financial challenges, when I tried to get disability, it’s like pulling teeth,
that is the struggle right there. They want you to be close to death before they give you
anything. I can close up and lie and say I am mental and get it” Participant 8). Participant
9 put it succinctly: “From what I understand, some people play the mental health card just
to get a check”. However, Participant 10 summarized the discussion and put it in a
different perspective: “We are well and now we are looking for something to complain
about… because people are mad that they are not paying for their house anymore.
Because you live longer than they expected you to, where do you think the money go
come from?”. The participants agreed that the District of Columbia provide adequate
access to HIV treatment, but HIV positive women have other pressing issues that equally
need to be addressed in addition to HIV
Theme 7. Intense expectations for cure. One of the findings in this study is
during the interviews; some of the participants conveyed a desire for a cure to be
developed for HIV. Some of the women expressed a desire to be cured and look forward
to when they could stop taking antiretroviral medications. The women made statements
such as: “One day, there will be a cure…even though it did not have a cure, I could still
live a long healthy life with medications and things of that nature” (Participant 6).
Participant 7 wanted to know if there was a medication to cure HIV, “do you think they
already have a cure, they need a cure”. Another participant expressed satisfaction with
the care she received but still need to be cured, “I am satisfied with care but I wanna be
cured, can they cure us”? (Participant 10). Researches in HIV have continued but there
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are no news of HIV cure yet and that is a concern for some of the women that believe that
HIV cure should be discovered sooner than later.
Theme 8: Conscientization-personal transformation to engage in HIV care.
All the participants discussed times of denial and powerlessness as well as reaching an
empowered status. They attributed their empowered status to taking active role in
learning about the disease, getting involved in support groups, and linking up with other
women, churches, and other avenues to get information. Participant 9 stated, “I learned
about HIV, viral load, CD4”. Participant 9 speaks publicly about the disease in seminars
and recall an incident at a Walmart store with her supportive HIV negative status
husband. She stated that she wore a T-shirt written “I am HIV challenged, make sure you
are not”, while at same time, her husband wore had a T-shirt that read, “My mate is
beautifully made regardless of the HIV”. Many of the customers and staff at Walmart
stare at them. Another participant stated “I found these things by myself, I pitched
around to find anything that would educate me” (Participant 4). She reflected that,
“through HIV, I became empowered’ and Participant 3 stated that, “I advocate for
myself, asks for medicine ahead of time just in case they are needed”. Participant 6 said,
“this thing wont beat me, I will beat it, I did my part and still doing my part, I am a
survivor, being here is a testimony that I have survived the disease…I have come a long
way, as long as am taking my medicine, my virus is suppressed, I can’t stop”. One
common denominator among the women was coming to a point, when the reality of
living with the disease was conscientized and the personal transformation to be involved
in care occurred.
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Subquestion 1b
Subquestion 1b asked: What constitutes stigma and discrimination faced on daily
living? Three themes emerged related to this question. These themes are: (a) Theme 9:
Negative effects of HIV stigma on HIV Disclosures; (b) Theme 10: Stigma, self stigma/blame and engagement in care; and (c) Theme 11: Challenges in the ‘lived’ HIV
journey. The following section addresses each them in turn.
Table 7
Specific codebook and themes from subquestion 1b
Question
Theme
Question 1b 9.Negative effects of HIV
stigma on disclosures
10.Stigma, Selfstigma/Blame and
engagement in care
11.Challenges in the
‘lived’ HIV journey

Description
Ignorance, fear of the unknown,
uneducated, gossiping, false rumor and
hearsay
Complications of the disease
Financial challenges
Taking medications daily
Swallowing difficulties
Challenges that constitute stigma and
discrimination

Theme 9: Negative effects of HIV stigma on HIV Disclosures. According to
participants, stigma and discrimination include ignorance, fear of the unknown, lack of
education, gossip, the spreading of false rumors and hearsay. One hundred percent
(100%) of the women acknowledge the presence of stigma in the community. Half of
them reported having never experienced stigma personally but that they have heard other
women discuss stigma and personal journeys in their support groups. The participants
think ignorance and being uneducated about the disease is a major factor propelling the
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stigma and discrimination. To the extent that a mother would not accept food from her
HIV positive daughter because she was HIV positive but when a second daughter
(Participant 3) became positive, the mother had learned a lot about the disease and treated
the second daughter better than the first. Meanwhile, the second daughter was fearful
about disclosing because of the mistreatment she witnessed against her sister. But all the
participants have a very defiant attitude towards people propagating stigma. According to
participant 5, “it is on them…it is their rumor and ignorance and has nothing to do with
me”. Other experiences with stigma and discrimination are summarized in the statements
below:
•

When you tell anyone that you have HIV, the first question they ask is how did
you contract it, nobody asks how you contract diabetes or other diseases
(Participant 1)

•

I don’t face stigma on a daily basis, there is too much stigma around, stigma has
to be broken, know your status is not enough, you must do more than that, that’s
why I am in the field am working with young women, when I come across them, I
share my story to give hope’ (Participant 3)

•

There is so much stigma with HIV than any other disease…if they come to me, I
will ask them what they got, who are you to judge me, what you got? (Participant
6)

•

Now, I don’t care, work in the hospital, has never affected my job… it took a
minute to get there ...now judge me all you want, if I get it, you can get it too.
(Participant 7)
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Stigma is a barrier to some of the participants acknowledging the disease within their
families or in a public space. Stigma affects disclosures for some of the women while
others speak publicly about their diagnosis and will not be bordered about who is aware
of the status or not. The participants during individual interviews acknowledged that
stigma must stop for HIV infection to decrease.
Theme 10: Stigma, Self -Stigma/Blame and engagement in care. Among the
lived experiences, that the women shared was stigma, self-stigma/blame and overcoming
them to engage in HIV care. Self-stigma/blame was expressed as in part being aware and
having heard about HIV but not thinking that she herself would ever become infected.
Anger against self and self-blame became a barrier initially to engage in treatment.
According to Participant 1, “it took me a longtime to forgive myself, the shame of it…it
is bad enough that outside world to shame you, it is worst, personal shame”.
However, some of the participants devise measures to deal with stigma. Amongst
them is keep a circle of other AA women especially in peer support groups. Some
participants are prepared to defend themselves if disrespected or ignore the attacker.
Participant 5 stated “I don’t argue with them, whatever you think, run with yourself, it
does not matter, and they might be messed up themselves’. Participant 6 affirmed that
there was a lot of stigma in society in general, though not among healthcare providers.
She added, “if they come to me, I will ask them what they got, who are you to judge me,
what you got?”. The Participants became empowered to challenge anything that may be
an expression of stigma in their daily living. Participant 9 shared an experience she had
while providing education to young women about HIV disease. She stated
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Recently, I was invited to give a talk in one of my mentor’s shop in a live
program. I am speaking to a lot of girls. I told them that I was HIV challenged, I
call it HIV challenged, told them to be careful as young girls. One of the ladies
stood up. ‘I am taking my daughter out of here, coming here and boasting as if
HIV is a beautiful thing’. I was in shock; I was messed up and held my hand.
Before I could put it down, two other ladies stood up, I am not a part of this, you
people are dangerous to us who are normal.
According to Participant 9, in the live meeting, she asked the group if anyone wanted to
leave because she must complete her task. And she said,
Before I continue, does anyone wants to leave because these ones want to stay in
their mindset, I am here to let you know we have medications, they start out with
one pill and now we have more than twenty.
According to this participant, in her eighteen years of living with the disease she had
experienced stigma only about three times. All participants in this study expressed full
engagement in HIV care despite the stigma in the community.
Theme 11: Challenges in the ‘lived’ HIV journey. For many of the participants,
there are difficulties faced on a daily basis. Although all participants expressed positive
attitudes towards dealing and living with the disease, they unanimously agreed that there
are difficulties in the journey that is unique to HIV. Participant 4 stated, “living with HIV
is really hard, life changing…this is disease that cripples you not just physically but
mentally… the mental aspect of HIV is bigger than the physical, the mental and the
physical needs to go together”. For Participant 8, it “triggers feelings of depression” and
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Participant 6 expressed having, “mental health problems, depression…had bouts of
depressing modes”.
Another challenge is taking medication. The newest antiretroviral medications
have less intense side effects and are easier to take, especially the one-a-day pills. No
matter how simplified the regimen might be, some participants continues to have
problems physically swallowing the medication. “Not great at taking medicine, because
the pills are huge, they stuck in my throat” (Participant 10). Participant 7 would prefer the
medication to be patch. “They have patches for cigarette why can’t they make a patch for
HIV?”. Participant 5 has been struggling with medication adherence and expressed
frustration stating, “the only issue was to adjust to taking medications daily, taking the
medicine is the greatest challenge, I forget to take them many times, not taking them”.
Despite having a positive attitude towards dealing with the effects of the disease
on daily living, the women reflected on the devastation that the HIV diagnosis has had on
their lives. “You don’t die with HIV but all the complications that comes with it, now I
understand, that’s the scary part”, (Participant 4). It is a life-altering event, often
resulting in starting life afresh with new friends as old ones disappears. There are basic
housing and financial challenges that are on top of dealing with an HIV diagnosis,
especially in DC with its rising housing costs and overall high cost of living. Many of the
interviewed participants are single (70%), with children (80%). Half of the interviewed
women are unemployed. According to Participant 8, “housing is a challenge especially
raising 4 kids, you have to drag them from place to place, then they put you out, you
move to another”. Participant 10 offered a possible reason for the housing challenge,
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“Cause people are mad that they are not paying for their house anymore, because you live
longer than they expected you to, where do you think the money go come from?”. Other
issues going on in someone’s life may affect engagement in HIV care sometimes, but all
interviewed participants are engaged in HIV treatment.
Research Question 2
The second research question was: How do HIV positive African American
female describe/explain viral suppression? Two themes emerged related to this question.
These themes are: (a) Theme 12: Importance of viral suppression; and (b) Theme 13:
Improved clinical outcomes. The following section addresses each them in turn.
Table 8
Specific codebook and themes from question 2
Question
Question 2

Theme
12.Importance of
education of viral
suppression
13.Improved Clinical
Outcomes

Description
Knowledge of viral suppression at
diagnosis
Current understanding of viral suppression
Improved CD4 count
Improved immune system
Achieving viral suppression and improved
CD4 count among newly diagnosed ages 35
-54 years from year 2000 to 2018
Clinical outcome evidenced by self-reports
and medical records
Clinical outcomes evidenced by
triangulation data from DC Health

Theme 12: Importance of viral suppression. All the 10 participants
acknowledge the importance of virally suppressed. Each person had achieved viral
suppression at least one time during the course of her HIV journey. Eight (8) of the
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participant’s self- reported as currently virally suppressed. The 2 participants not virally
suppressed are at 540 and 119000 HIV copies, respectively. One (1) has been off
medication for the summer and the other off medication for 3 months. The goal of HIV
treatment is to achieve viral suppression. Achieving this status reduces inflammation and
is associated with various positive clinical outcomes.
Subtheme 12a: Knowledge of viral suppression at diagnosis. In this study, what
the women reported through the interviews as being taught at diagnosis especially with
reference to the importance of viral suppression, was assessed. Some of the participants
indicated that they did not receive any education on importance of viral suppression at
time of diagnosis. The experiences of the women with particular reference education of
viral suppression at diagnosis was unanimously negative. Seventy percent (70%) of the
women stated they were never taught at diagnosis the importance of engaging, remaining
and achieving viral suppression. Interviewed participants made clear statement below of
not receiving vital information at time of diagnosis:
•

“I did not learn about viral suppression and that HIV affects aging” (Participant 1)

•

“No education on viral suppression at diagnosis. The place that first diagnosed did
not discuss viral suppression… first diagnosed virus was in millions, dying”
(Participant 2)

•

“They did not teach me anything but refer me to teaching hospital clinic”
(Participant 3)

•

“At diagnosis, they did not say anything that stuck” (Participant 4)
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•

“No one communicated diagnosis in small clinic, here you go, HIV pamphlet and
here you go with lots of people in the waiting room looking at your HIV
pamphlet” (Participant 5)

•

“The thing that messed me up was that I did not have a social worker, I did not
have help, I did not know nothing” (Participant 9),

•

“At that time, they were just trying to save our lives” (Participant 10)
However, 20% of the women acknowledged receiving some general information

on HIV but they either were not in the right frame of mind to receive any education
and/or were much more focused on making sure that their babies were not born with
HIV. According to Participant 3, she was told “If you take this medicine, you will live
longer, and baby won’t have it”. And Participant 7 stated, “Education at the time of
diagnosis, not in a right frame of mind to understand teaching”. Only one Participant (6)
acknowledged receipt of education about viral suppression at time of diagnosis by her
medical provider, who also referred her to get involved in a research study. Overall, 70%
of the participants were not provided information on the best goal of HIV treatment,
taking medication to achieve viral suppression and reduce viral inflammation
Subtheme 12b: Current knowledge of viral suppression. After living with HIV
for ten years or more, 100% of the participants exhibited knowledge of the meaning of
viral suppression. They take joy in being virally suppressed. With reference to Table 9,
80% of the women are virally suppressed. Nonetheless, all the women have experienced
viral suppression during some point in their journey.
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For the two participants who indicated that they were not currently virally
suppressed, when considering a jump in viral load, expressed confidence in their
knowledge about what to do to get the viral count back in order. Participant 1’s viral load
is 540 copies. She stated, “I was taking medication, but in summertime, the sun makes
me to itch, affects my stomach… I had to do what is best for…stop taking medicine
during summertime and resume after 3 months break”. Participant 5 has been off
medication, non-adherent due to housing issues and moving, and she states, “was
undetectable, I will get it right back”. All interview participants expressed knowledge of
importance of achieving viral suppression and take pride in discussing the
accomplishments. The increased knowledge was attributed to years of engagement in
HIV care and attending support groups
Theme 13: Improved clinical outcomes.
The clinical outcomes for the participants were collected through self-reports.
Some of the self-reports were actual laboratory documents from the laboratories and
medical records. Some of the participants have access to patient portal in their clinics to
look up CD4 count and Viral load values and read medical providers notes. Part of the
improved health outcomes were also assessed through surveillance aggregated data
obtained from DC Health
Subtheme 13a: Evidenced by self-reports and medical records. Table 9 shows
the clinical outcomes of the interviewed participants. At diagnosis, viral load was at
millions while 80% are currently virally suppressed. The immune system also shows a
rebound immune reconstitution. At diagnosis, 100% 0f the women were diagnosed as
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AIDS status with CD4 counts below 200, while current CD4 counts are above 350 cells
per cubic millimeter for 80% of the participants. Participant 7 acknowledged, “been a
roller coaster, having missed so many medications, been on salvage, this is my last
option… built many resistances due to non-adherence”.
Table 9
Clinical Outcomes of Participants

Participants
Cases\\PARTICIPANT
1
Cases\\PARTICIPANT
2
Cases\\PARTICIPANT
3
Cases\\PARTICIPANT
4
Cases\\PARTICIPANT
5
Cases\\PARTICIPANT
6
Cases\\PARTICIPANT
7
Cases\\PARTICIPANT
8
Cases\\PARTICIPANT
9
Cases\\PARTICIPANT
10

Current
Age
(years)
53

Age
(years) at
Diagnosis
33
22

43

CD4
Count at
Diagnosis

CD4
Count
Nov.
2019

Viral
Viral
Load
load at
Nov.
Diagnosis
2019

150

610

500000

540

150

584

1000000

20

44

30

132

1300

950000

20

48

36

150

763

500000

20

40

23

69

160

1000000

119000

55

45

3

485

1000000

20

39

23

5

219

1000000

160

55

28

150

375

1000000

20

43

25

2

824

1000000

20

60

34

215

1400

1000000

40

Subtheme 13b: Evidenced by triangulation data. Data for triangulation obtained
from DC Health confirmed the clinical outcomes obtained from the participants. Table 3
shows the number of AA women diagnosed with HIV in Washington DC. The median
viral load at diagnosis was 1205 in 2000. Of the women diagnosed in 2000, 73 were
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between the ages of 25 and 34, 77 of them ages 35 to 44 years, 46 women between 45
and 54, and 5 were ages between 55 to 60 years. At the same time, CD4 counts at
diagnosis was at AIDS defined status (156 viral copies) when CD4 count is below 200.
Table 3 also shows an analysis of the AA women between ages 35 and 54 years and
diagnosed in year 2000. The clinical outcomes of the same cohort in year 2010 and 2018
are also displayed in Table 3. The clinical outcomes show a reduction in viral load from a
median load of 3,687 in the year 2000, 47 in 2010 and 46.5 in 2018. Also relevant is the
median CD4 count in year 2000 which steadily increased to 586 in 2010 and 612 in 2018.
This data supports the positive clinical outcomes the participants self-reported during the
individual interviews in Table 9.
Research Question 3
The third research question was: How do HIV positive AA women
explain/describe the high rate of HIV infection among African Americans women in the
District of Columbia? Five themes emerged related to this question. These themes are: (a)
Theme 14: Unprotected Sex and nonuse of condoms; (b) Theme 15: Gender Roles/Issues
in HIV infection; (c) Theme 16: Nondisclosure of HIV Status; (d) Theme 17: The
importance of high community viral load; and (e) Theme 18: Importance of community
education and knowledge of HIV transmission. The following section addresses each
them in turn.
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Table 10
Specific codebook and themes from question 3
Question
Question 3

Theme
14.Unprotected sex and
multiple sex partners in
closed area
15.Gender role/Issues in
HIV infection
16. Non-Disclosure of
HIV status

Description
Presence of multiple partners in closed area
Search for love, acceptance and loneliness
Denials of HIV at diagnosis
Among the population
Incarceration and nonuse of condom
Unable to disclosure HIV status to sex
partner
Reducing HIV infection among AA women

17.The importance of high
community viral load
18. Importance of
community education and
knowledge of HIV
transmission

Theme 14: Unprotected Sex and nonuse of condoms. According to the 10
participants, unprotected sex was mentioned as the main culprit of the high rate of HIV
among AA women in the District. As described, at the end of the day, no matter what one
is seeking, if condoms are used, transmission would definitely decrease. One hundred
percent (100%) of the participants discussed having multiple sex partners in the same
neighborhood. The following quotations describe the role of unprotected sex in the high
rates of HIV:
•

“You don’t think of anything until it is over and you wind up with STD. you are
to blame, you did not put it (condom) on” (Participant 2)
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•

“Women are having unprotected sex” (Participant 6)

•

“Women not knowing to protect themselves” (Participant 7)

•

“Women are not protecting ourselves; we think men will protect us” (Participant
8)

•

“The nonchalant protection of themselves, you don’t just go sleep with any guy...
We are not using protection, protection is there, there are female condoms that
give protection for 8 hours, whole 8 hours to keep condom inside, why are you
not using condom”? (Participant 9)

Other reasons adduced by the women are what participants called “ignorance”,
“loneliness” and “looking for love in the wrong places”. All participants also called for
people to learn their HIV status as a means to reducing the infection rate. “People not
knowing their status and who they are dealing with” (Participant 3). In addition,
Participant 6 stated, “knowing status is not enough but honesty in communication” and
Participant 5 reinforced the same line of thought stating, “No one is communicating, lack
of honesty… before you lay your legs open, know your status”. The need among women
to belong and have a sense of belonging was also raised. “People are just lonely, and
people use sex as water, black woman thinks having a man means love, sex is not
love…ignorant among black people and they keep themselves ignorant, there are too
much stuff out there to cling to ignorance (Participant 4). Interviewed participants echoed
in many ways the need to have sex with condom, get tested to learn one’s status in order
to prevent from acquiring HIV.
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Theme 15: Gender Roles/Issues in HIV infection. The primary gender issue
identified by participants was regarding men returning from incarceration and multiple
sex partners in same neighborhood. All of the 10 participants discussed men as the
central force for HIV transmission in their communities. Specifically reported that men
returning from incarceration. “Men going to prison, coming back and infect women, I
think because in South East… might go with cousin and cousin with another person,
multiple partners in the close area… have multiple partners in same area” (Participant 1).
According to Participant 3, ‘Man coming from incarceration and not telling truthful, …
knowing you have something like that, coming home, just spreading, it’s crazy … but
while having sex, having sex dealing with different sex partners”. The participants
believe that men returning from prison have a secret life while in prison. Participant 5
stated, “It is not women, it’s the men, 99% of the time, it came from the men that has
been with another men, came home and spread it… come back to love women, whole
time had a boyfriend”. Participants in their individual interviews lay blame on men for
the high rate of HIV infection among the heterosexual women in the black community.
Theme 16: Non-Disclosure of HIV Status. The 10 participants discussed nondisclosure issues as another factor contributing to the high rate of infection in the District
of Columbia. The reason for non-disclosures sometimes hinges on previous experiences
of breach of confidentiality from friends and family members. Once the trust was broken,
the women shut down and swore to never disclose to others, including sexual partners for
fear of how they may react and mistreat them. One participant was so afraid of her
partner that she hid her medications for months. “Someone I knew who I told about
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status, co-worker told others, others did not want to work with me- the co-worker I told,
told other coworkers” (Participant 3). Participant 5 stated, “confided in a sister then she
became the enemy, one day, something did not go her way and now she is talking bad
and disclosed to others”. Although some participants would not allow their bad
experience to prevent them from disclosing to close family members and significant
others believing that it is the right thing to do. Disclosure brings peace of mind according
to Participant 6 and Participant 8 would only disclose if God led her to do so. When HIV
status is not disclosed, the sexual partner does not take precaution to prevent from getting
infected leading to more HIV infections among the multiple sex partners.
Theme 17: The importance of high community viral load. The participants
acknowledged having HIV virus in the blood in millions counts when diagnosed. With all
the ten participants having virus in millions shows that the community viral load was
very high and anyone having sex in such community have a higher chance of being
infected with HIV. After diagnosis, 8 of the participants denied the diagnosis of HIV and
went about living a ‘normal lifestyle’ in pretense while spreading the virus. All the10
participants described the treachery among many people who live in the community.
They denounced the culture of secrecy and denials of HIV in the black community. Eight
of the interviewed women mentioned a time when they were in denial about the diagnosis
and went about acting as if everything was normal. And in that timeframe, they were
having sex as usual without protection. Participant number 10 did drugs heavily for 4
years and had sex with everyone as she was selling sex in the street. It took another
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participant 10 to 15 years to acknowledge the diagnosis and get in care (Participant 2). At
the time of denials, life was going on as usual with unprotected sex.
Theme 18: Importance of community education and knowledge of HIV
transmission. The 10 participants complained about great ignorance in the black
community of health education and lack of knowledge about HIV transmission. The
average black person on the street of the District of Columbia lack information of what
happens in their body. The lack of knowledge of how HIV is contracted, and its mode of
transmission. According to Participant 4, “ignorance among black people and they keep
themselves ignorant, there are too much information out there to cling to ignorance.”
Participant 8 stated, “People said, don’t touch, phobia, like you touch it, it is
contaminated, fool, where is your literature, where is research at, they don’t know
nothing about it, they put you on an Island”. The reference was made to young people
who have indiscriminate sex encounters. According to participant 6, “Start at 8 years old,
teaching more ladies to care about their bodies…Start educating and teaching in the
homes and schools, you cannot get it any other way, eating behind someone, unprotected
sex is the key factor…educating young people.. Kids having sex, not knowing what sex
means, 8 to 9 years old having babies”. In addition, ignorance of transmission is also seen
among older women who believe they will not get pregnant but forget that there are other
infections including HIV. The women advocated for different messages for young people
whether positive or negative. In their community, the disease is still regarded as gay
disease and heterosexual males are not interested in anything gay (Participant 1). The
participants expressed concern at heterosexual males, whom they described as lacking
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health education, does not like to go to the doctor, as the major vehicle that propagates
the spread of the HIV disease among black females. Participants in this study discussed
the need to educate the black community and get the community to get engaged in health
knowledge. In addition, participants discussed organizing community days, where people
get tested and if they are negative, be engaged in the pre exposure prophylaxis (PrEP),
take a pill once a day and if positive to get engaged in HIV treatment at once.
Summary
This chapter presented the results of the research. Ten AA women who took part
in the research provided answers to the research questions. Data collections involved oneto-one interviews with the participants answering open-ended questions. In this chapter
also is the results of the data collected from the participants. The three research questions
and sub-questions were interrelated to gain a more thorough understanding of the lived
HIV experiences of the women interviewed. The questions explored how the women
describe their lived experience, how they have lived and are still living with the disease
for 10 years or more.
The results to question 1 indicate the interrelationships between many factors and
the meaning of the lived experience. The women shared among other things, the age of
infection (reproductive age/pregnancy), family culture, era of denials of infection and
noninvolvement in HIV care, positive strengths that contributes to resilience, spirituality,
support groups and relationships.
The aim of subquestion 1a was to glean in more details what antiretroviral
medication and treatment adherence looked like for the interviewed women. Results for
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subquestion 1a showed that all the women are experienced with antiretroviral medication
and are in various stages of medication adherence. Some expressed difficulty with the
medication such as swallowing issues and side effects but these difficulties did not stop
them from diligently taking the medication to remain alive. In addition, the results
indicate that the women did not experience challenges in getting access to care in the
District of Columbia and became empowered in living with the disease.
Subquestion 1b was asked to learn more about the women’s experience with
stigma and some of the effects of living with the disease. In response, the women
described stigma and discrimination as ignorance, fear of the unknown, lack of education,
gossip and hearsay. Many of them have never experienced stigma directly but have
knowledge of colleagues that have and decry its practice. Answers to this question also
revealed struggles with self -stigma and other challenges that the women had to deal with
daily.
The aim of research question 2 was to acquire specific information about what the
women knew at the time of HIV infection on one of the goals of treatment and to learn
more about the education they received at that crucial time of diagnosis. Answers to
research question 2 revealed the unavailability of education to increase or acquire skills
on what to do to achieve viral suppression. Many were diagnosed with a very low CD4
count and high viral load. In contrast, women demonstrated that they have since then
gained much more extensive knowledge regarding viral suppression. They have positive
clinical outcomes, low viral loads and high CD4 counts, substantiated with surveillance
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data from DC Health. Their clinical outcome data showed their rebound from AIDS
status to being HIV positive per CDC staging of the disease.
The last question was intended to solicit the women’s perspectives on what
factors are contributing to the high infection rate of AA women in the District of
Columbia. The participants’ answers to research question 3 identified unprotected sex as
the major cause of infection among these women in the District. Other factors mentioned
were denials of HIV diagnosis, gender roles and issues related to high incarceration rates
among men. The participants also discussed the impact of nonuse of condoms among
men and women and non-disclosure of status to sexual partners.
In Chapter 5, I provided an interpretation of the findings, an exploration of
implications, a discussion on limitations of the study, recommendations for policy, future
research and conclusion. The potential impact of social change was also described. As
part of Chapter 5, strong recommendations for practice were provided and discussed
within the boundaries of the scope of the study.
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Chapter 5: Discussion, Conclusions, and Recommendations
Introduction
This qualitative study was conducted to increase the understanding of HIV infection
and viral suppression from the perspectives of AA women living with HIV. The study
used a phenomenological approach to uncover the lived experiences of HIV positive AA
women and viral suppression, including how HIV positive AA women describe and
explain both the actual stigma of the disease and the discrimination coming from family,
friends and the community.
Another aspect of this research was the use of a feminist lens to understand black
women’s unequal position regarding HIV infection. Pursuant to understanding their lived
experience, it is important to understand the increases in HIV infection among this
particular group. There are findings that support gender as the basic framework that
conditions women to an increased risk of HIV infection. This point of view means that
issues of gender roles and socialization have to be explored further to understand HIV
vulnerability among AA women. This study equally confirmed that geo-behavior is a link
to vulnerability to HIV infection. Examining the lives of this group of women provided a
new and better opportunity to learn how they experience this disease, what prevention
methods might be most effective, and how their experiences link to achieving successful
viral suppression which is a prelude to ending HIV infection.
Key Findings
HIV AA women who are living in DC have exhibited resiliency and
empowerment in their lived experiences with HIV infection. HIV positive AA women are
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dependent on many factors unique to them and their community when surviving and
living with this disease. All of the women were infected at reproductive age of 22 to 45
years. Participants in my study discussed their resilience and empowerment toward being
infected in their prime of planning families, getting education, and raising children. They
relied on self-efficacy, spirituality, support groups, and relationships as major strengths to
address and handle their unique challenges. At the initial time of diagnosis, many were in
denial, but this issue was conquered. Positive relationships with spouses or significant
others played a critical role in supporting their survival. Most importantly, the
participants expressed an increased understanding of viral suppression after many years
of lack of education on its importance, especially at the time of diagnosis. Viral
suppression as a goal of HIV treatment was well understood, as these women adhered to
antiretroviral medication to achieve suppression of the virus. Access to HIV treatment
and antiretroviral medication in DC was expressed as unfettered providing these AA
women the platform to survive the adversity of their infection.
My respondents explained the high rate of HIV infection among AA women as
mainly attributed to unprotected sex. According to them, heterosexual men and nonuse of
condoms propagated increased instances of HIV infection among AA women in the
District. In addition, AA women are more vulnerable to HIV because of where they live,
and their potential pool for sex and relationships in their neighborhood. This study added
to the knowledge that HIV stigma negatively affects the patient’s engagement in HIV
care. Although, the AA women in my study have devised positive means and better ways
to actively connect to care and not allow stigma to affect engagement in HIV treatment.
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However, stigma, they said, affects their disclosures and leads to people engaging in
sexual practices without disclosing HIV status to their partners and not wearing condoms.
The more condomless (unprotected) sex there is in a community that has a high viral load
becomes a recipe for disaster via the incidence of increased HIV infection.
Interpretation of the Findings
The findings were interpreted in three major ways. New information obtained
geared towards advancing new knowledge in HIV care, treatment and/or prevention. The
second part of the interpretation discussed the confirmations of other literature from peer
review articles. In the third aspect, findings were also interpreted from the theoretical
framework of resilience and empowerment theories applied in the study.
Advancing New Knowledge
This study offers new knowledge and information relevant to answering all three
of the research questions. The most important knowledge gained is this research is that
my study participants were not provided education on viral suppression as a goal of HIV
treatment and its subsequent benefits of reducing HIV inflammation at the time of
diagnosis. However, these HIV positive AA women became very knowledgeable after
living with the disease for 10 years or more and engaging in HIV treatment. The
knowledge was acquired because of the women’s tenacity to learn and know all they
could about the disease. However, they had to go search out this knowledge from both
HIV clinics and churches. Viral suppression is a clinical outcome that is positively
associated with an improved health outcome. Women in this study achieved viral
suppression at least once in their course of the disease with an improved CD4 count from
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the time when their diagnosis of infection was confirmed. Providing information on the
benefits of viral suppression may thus be beneficial to women to help them engage in
HIV treatment as a precursor to achieving and maintaining viral suppression.
Another critical key finding of my study that advances the HIV/AIDS knowledge
is that HIV positive AA women interviewed have unfettered access to HIV treatment in
the District of Columbia. The women laid emphasis that Health Care Services operating
in the District of Columbia who receive Ryan White Funds for HIV treatment do not
discriminate against women who are HIV positive. Antiretroviral medications are
available to all AA women who are un-insured or underinsured and have no other means
of paying for their HIV treatment. All the AA women interviewed were referred to clinics
that specialize in HIV care. After diagnosis. The women also have access to all Food and
Drugs Administration (FDA) approved HIV medications to treat their infection.
One of the positive strengths that contributed to the women’s resiliency in this
study group is involvement in a good relationship with a HIV positive or negative
significant other or spouse. Positive relationships with spouses or significant others play a
critical role in supporting survival. According to the women in this study, good
relationship with men is a positive strength that can shield from experiencing stigma in
the community.
Although 8 of the participants achieved viral suppression, defined as viral load
below 200 by CDC (2018) and Cohen et al. (2016), they also described difficulties
adhering to the prescribed medications. The quest for a cure for HIV is paramount in the
minds of these longtime survivors. Many respondents described praying and hoping for a
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cure, while others were looking for another way of taking their HIV medications. Some
new HIV medications under development may offer solutions to some of these needs,
especially with long-acting, monthly or bimonthly injectable (Simoni et al. 2019).
Women who have trouble taking daily medications or experiencing swallowing
difficulties may benefit from these new drugs coming into the pipeline once they are
approved.
Support for Findings of Other Studies
The resilience of these women after HIV infection was well elucidated in this
study. The respondents in this research attributed their survival of the disease to
numerous things, including developing positive strengths in the face of adversity. The
decision to deal with HIV infection and engage in treatment was personal. It was
attributed to various things depending on the person who was infected. There was a
decision to survive and thrive, regardless of the circumstances. The interviewed AA
women have great attachment to their children and for many of them, their children are
the thread to which life is attached, confirming a study by Islam, Minichiello and Scott,
(2018).
The women in my study stated spirituality was another pillar of resilience which
helped them to build self-efficacy. There was lots of praying including praying over
medication to work effectively in the body among the participants. When someone is a
believer in a higher power and God, self-efficacy is built to conquer adversity. According
to Nokes, et al. (2012), enhancing one’s self-efficacy was found to be a predictor of
medication adherence. Multifaceted interventions approach that are used to reduce
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stigma, provide social support network, HIV education, provide support groups, as
studied by Stewart, Hong and Powell (2018) may also provide relief and improve the
continuum of care. The AA women in the study developed a connection to God
(spirituality), engaged in support groups, and have a strong determination to live for their
children’s sake, thus supporting the study by Dalmida, et al., (2017) that found that
religious attendance and social support are significant predictors of adherence to
antiretroviral medications. The participants attachment to their support groups provided
them with a safe place where they met and discuss challenges and proffer solutions.
Another key finding is the importance of medication adherence for HIV positive
AA women in the District. They devised different means to ensure that they remain
adherent to their medication. The 10 participants understood that continued adherence to
medication results in viral suppression. My study showed that 8 of the respondents were
adherent and virally suppression. These respondents also understood the importance of
medication adherence and the role of consistent medication for healthy outcomes. When
an HIV positive individual is on medication and adherent, viral suppression is achieved.
Adherence to medication at least 95%of the time is clearly associated with improved
health outcomes (CDC, 2013). Care providers are encouraged to assess periodically for
medication adherence to identify the people at risk for non-adherence. Analysis of
Medicaid data showed that 57% failed to restart ART after 18 months of stopping
(Zhang, Shireman, Youn, Lee & Wilson, 2018) and adults are more adherent to medical
visits and experience greater viral suppression than younger females (Waldrop-Valverde,
Guo, Ownby, Rodriguez & Jones, 2013). The mean age (48 years) for this study,
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supported the findings that adults experience greater viral suppression than younger
females. My qualitative sample supported findings in the literature of larger quantitative
study (Castel et al. 2016) and gave a contextual understanding of how AA HIV positive
women talk and understand these issues. The findings of this study support Castel et al.
who stated that 83% of people who had ARV adherence in the past seven days were
engaged in care compared to 69% of people who were out of care. Although in my study,
100% of the women were engaged and retained in care, two of them still had personal
reasons not to adhere to their medications, which resulted in not being virally suppressed.
According to Musinguzi (2018), interruption of HIV treatment often leads to increased
immune activation, which then negatively affects health outcome.
This study added qualitative support to the fact that AA women in DC are at high
risk of HIV infection because of where they live and who they are with. According to
Brawner (2014), despite efforts to reduce risk, people who are located in areas where
there are higher concentrations of HIV infected people still face a higher vulnerability of
infection, which is referred to as geo-behavioral vulnerability to HIV.
Although everyone in this study had unfettered access to antiretroviral
medications (ARV), 8 out of the ten participants were virally suppressed. This study
finding supports the study by Robertson et al (2017) and their comparative analysis of
two groups who received care coordination and followed for 24 months. There was no
difference noted in their access to medication, but a difference was attributed to
adherence. The two non-virally suppressed women in this study reported non-adherence
to ARV and taking medication holidays. However, this small qualitative sample of 10
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women provides a snapshot of high viral suppression rate. The national average of viral
suppression is 49% (CDC, 2017).
The HIV Care Continuum
The care continuum in this study supports the Ryan White care continuum for
women living in the District with 80% viral suppression in 2018. However, there is still a
gap in viral suppression to meet the goal in the Mayor’s ending the HIV epidemic plan
(Bowser, 2017). A description of HIV care continuum in this small qualitative sample of
10 AA women when laid beside large quantitative studies of HIV care continuum is
noteworthy. There is a support for DC Ryan White HIV Care Continuum in 2018, the DC
HIV general population and the national HIV Care Continuum, as portrayed in the table
below:
Table 11
Comparison of HIV Continuum of Care
Indicators

The Current Study
(Olejemeh, 2020
unpublished)

DC Ryan
White Data
(2018)

USA (2014)

100%

DC,
General
Population
(2018)
100%

% Diagnosed

100%

% Receiving Care

100%

73%

98%

62%

% Retained in care

100%

95%

79%

48%

% Virally

80%

80%

66%

49%

Suppressed

85%
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The viral suppression snapshot of this qualitative study supports the viral
suppression of the Ryan White Program in DC at 80%. However, there is still a gap of
10% that needs to be targeted to achieve 90% viral suppression goal by year 2020 as
articulated by the DC 90-90-90-50 goal plan to ending the HIV epidemic in the District
(Bowser, 2017).
High Community Viral Load
Study respondents reported being diagnosed during pregnancy (8), and 2 were
very sick when diagnosed. The viral load at diagnosis ranged from 500,000 to millions.
Depicting that the viral load for my respondents at diagnoses were very high. One of the
hallmarks of high infectivity of HIV is a high community viral load (Castel et al, 2012;
Das et al. 2010; Das, 2012). According to Brawner (2014), community viral load is a
population marker for the infectivity of people living in a specific geosocial area, and
Castel (2012) was able to demonstrate that a reduced community viral load is associated
with the reduced incidence of HIV. This current study supports such knowledge.
Increases in HIV Infection Among AA Women
My respondents reported HIV acquisition primarily through having heterosexual
unprotected sex with men supporting the study by Drayton & Grant, 2017 and CDC
(2018) report. The lack of knowledge of HIV transmission among African American did
not translate into making less risky choices, as discussed by Klein, Sterk and Elifson
(2016). The same way, knowledge of HIV transmission did not translate into reduction in
the acquisition of the disease, as my study supported Perkins, Stennis, Spriggs, KwegyirAfful and Prather (2014). Many of the participants reported unprotected sex with men
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who did not know their own HIV status or refused to disclose their status. In a study by
Lindong, Edwards, Dennis and Fajobi (2017), AA youths did not perceive themselves as
having highly risky behavior and knowledge of HIV did not deter these young girls from
high risk behavior even in detention facilities (Baillargeon et al, 2017; Raidford, Seth,
Fasula, & DiClemente, 2017). Increased effort to create more awareness and deliver HIV
education in these communities are necessary and indeed critical to reducing HIV
infection. The study participants reported that lack of knowledge for how HIV is
transmitted among the AA population is attributed to ignorance, seeking love and
acceptance. Any program that targets AA women living in DC may be able to make
progress in reducing the rate of infection by including these topics.
Gender Is Associated with Increased HIV Infection Risk
Of the 10 women interviewed for this study, 4 live with their husband or
significant other. Some respondents have children and the father of the children are not
part of their daily living or care. Brawner (2014) proposed a gender responsive model as
an initial step to more dialogue and examination of HIV/AIDS as a social issue. Issues of
gender roles and socialization may also have to be explored to understand the nature of
HIV vulnerability among African American women. Nine (9) of the women interviewed
were infected by heterosexual contact with men whom they were in relationship with, and
one was raped. All of the participants reported men as the central force for HIV
transmission in the AA community especially men returning from incarceration. This
finding supports Bradley, Geter, Lima, Sutton, and Hubbard McCree (2018) that there is
disparity in AA HIV infection due to high rate of incarceration among black men. The
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study by Rice, et al. (2018) was also supported as they mentioned that gender was one of
the multiple interrelated social determinants that continues to perpetuate HIV stigma. In
this study, gender was indeed associated with an increased risk of HIV infection.
Findings in the Context of the Theoretical and/or Conceptual Framework
For this study, I applied truly relevant theories of resiliency and empowerment.
These theories supplied the framework that guided the development of the semistructured interview questions that were used. The focus was on strength, either innate or
built from family interactions, overcoming adversity, staying on medication, and
achieving positive health outcomes. Based on these findings, resiliency and
empowerment played critical roles in women’s ability to survive the disease. Resiliency
is appropriate, as it is built alongside the continuum of care from diagnosis, engagement
in care, and taking medication to viral suppression and especially the resilience constructs
of self –efficacy, motivation, and protective factors. According to Dr Catherine Panter—
Bricks, resiliency is not a one-time achievement, but must be sustained over time along
with the continuum of care (Southwick, et al, 2014). Using the empowerment theory,
women turned inwards and identified the source of their disenfranchisement and took
charge to ensure better life outcomes (Turner & Maschi, 2015). Some became involved in
support groups, focused on raising children, got more education, and ultimately made the
decision to live. These decisions helped them overcome the trauma and adversity of HIV
infection, leading to their surviving HIV for 10 years or more and achieving positive
health outcomes. The construct of nurture and nature in this study showed how home
discipline and family culture may positively affect one’s adaptive ability. This resilience
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guided study also allowed the researcher to emphasize successful adaptation for
overcoming negative challenges. These two theories were indeed a best fit for this study.
Methodology: A Phenomenological Approach
A phenomenological approach was applied in the data analysis using the
hermeneutic loop. Each participant’s understanding and meaning of their experience
brought meaning to the whole. Participants also showed uniqueness in their experiences.
They discussed the meaning of their infection, as each tried to look for meaning and
action. A cyclical loop, at the first stage, indicated that some were in denial and without
any treatment spanning 2 years all the way up to 15 years. After which, their engagement
in HIV treatment became a part of life. As they continued to gather information and
knowledge of the disease, they had to deal with challenges, such as taking daily
medication, attending medical visits, and having laboratory visits. More reflection on
what the disease meant triggered more challenges, a personal reflection to survive, and
greater understanding of the need to remain in care and be virally suppressed. Eighty
percent (80%) of the participants are virally suppressed while one hundred percent
(100%) currently retained in HIV treatment.
Each participant expressed an understanding of their whole experience, and many
used spiritual and religious arguments to cement their positive experiences. This
methodology was very effective in the current study, allowing for personal uniqueness of
a lived experienced to be described by these women. Each person’s uniqueness and
understanding of their adversity was exclusive for them and not related to others’
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experiences. Using this method made all the women, experts in their experiences, and
able to discuss those experiences profusely and profoundly.
Limitations of the Study
One notable limitation was the use self-reported information. The participants
may have tried to impress the interviewer by stating details that may not have necessarily
been accurate. It is also possible that someone may have said certain things just to
impress or create an atmosphere of strength when they were actually struggling. There is
no way to really verify such distinctions. However, the two variables, viral load and CD4
count for health outcomes were verified through data triangulation and produced similar
results as reported by the participants.
Another limitation may be what Creswell (2014) called the power relationship
between researcher and participants. Although the researcher did not work with, know, or
relate to the participants, purposeful and snowball recruitment may have influenced the
participants. Some may have discussed the HIV knowledge of the researcher with their
peers which then could have influenced their responses to questions. Two participants
came from the same organization, seven from another, while one came from a still
different organization. These participants also attend various support groups and may
have discussed the study and the researcher in them. Interested participants were still
calling to be part of the study after the study was completed because they heard about the
study from others and exchanged information about the study among the group.
Being a qualitative study, these findings may not be generalizable outside of the
study sample and the District of Columbia. The sample was not conducted using a
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random sampling design, thus creating a limitation wherein the sample may not have
been the best possible representation of HIV positive AA women. In addition, many of
the participants reside in Wards, 1, 5, 7 and 8 and thus may not geographically represent
all the nine (9) wards in the District of Columbia.
Recommendations
The importance of viral suppression to the treatment of HIV and its health
outcome is synonymous to surviving the disease. Even when infected women are not
ready to receive education about the importance of viral suppression, providers should
not abandon the idea and its goal and need rather to continue to provide the information
at every encounter with their patients. Spirituality, involvement with support groups, selfefficacy, relationships with significant others should also be assessed by healthcare
providers and incorporated into each patient’s treatment plan. According to Dalmida, et
al. (2017), the factors that affect treatment adherence should be considered in the
treatment plan by the care team that includes mental health providers, social workers and
pastoral counselors. These inclusions should reinforce the factors that will help AA
women the most to remain in and continue their HIV care.
The lived experiences of HIV positive AA women researched through this
qualitative study provides information that is very critical to the ongoing reduction of
HIV infection among the black population. Policy makers and DC Health should
incorporate all the factors identified by these women as strengths that led to their
surviving this adversity and develop these factors into a comprehensive assessment tool
to use to develop better interventions for HIV positive women. Further still, develop key
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social marketing strategies for community education and engagement that addresses
unprotected sex, stigmas, disclosure of HIV status to sexual partners and multiple sex
partners. Social marketing techniques could be used to create greater awareness of these
issues in the community while at the same time equipping clinics with more clinical
providers to serve more patients/clients who will hopefully return to engage in HIV care.
Most importantly, this study supports that gender is a factor that affects the
increased rate of infection among AA women. Both community education and
engagement targeting especially AA men reentering society after incarceration,
organizing town hall meetings on the issue of HIV awareness, testing and linkages to
HIV treatment can indeed be beneficial in reducing HIV infection in AA community and
in DC.
Future Research
In the past 10 years or more, AA women entered HIV care late in the progression
of their disease with a very low CD4 count and high viral loads. Thus, future research
may want to investigate whether this trend has changed, especially by looking at AA
women who have been diagnosed in the last one or two years. Another future research
topic might be to conduct the same type of research among White females and Hispanic
females in order to compare the three populations and more adequately discuss health
disparities among the general HIV positive female population in the District of Columbia.
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Implications for Positive Social Change
The findings of this study have the potential for positive social change for black
AA women living in the district. Most important is the social change in the advancement
of HIV treatment and prevention in the era of the Mayor Bowser 90 -90 – 90 - 50
initiative plan in the District (Bowser, 2017). This study calls for a more concerted effort
to target AA women for achieving 90% viral suppression by 2020. At the moment, this
study finding shows the level of viral suppression at 80% and thus 10% away from
reaching the DC goal. The end of HIV/AIDS is indeed contingent upon diagnosing all
infected persons and providing full access to ARV to ensure successful viral suppression
for all persons with HIV disease.
This study contributes new knowledge on the lack of education for viral
suppression among HIV positive AA women at diagnosis. HIV positive AA women do
not receive education on one of the hallmark outcomes of HIV treatment, namely, viral
suppression. Interventions can be developed with well-crafted education on viral
suppression that is provided to all AA women who test positive for HIV. The knowledge
gained will be critical to engaging in treatment to achieve greater viral suppression.
Developing and implementing such education in all Ryan White clinics in the District
will also contribute needed information on the importance of medication adherence to
achieve viral suppression as well as the importance of viral suppression. According to the
research, when viral suppression is achieved, inflammation is drastically reduced thereby
leading to better health outcomes sooner and for longer periods (Eshleman et al. 2017;
Cohen, McCarley & Gamble, 2011; Crepaz et al, 2016).
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In addition, the findings of this study will impact how to address health
disparities. This study identified spirituality, support groups, and positive relationship
with men as some of the strengths that helped these AA women to engage and continue to
remain in care after many years of living with the disease. This knowledge could lead to
policy changes to include all these factors and combine them into a more comprehensive
assessment tool in every clinic that is serving AA women in the District.
The knowledge gained in this study will be beneficial for addressing the high rate
of infection among AA women. DC Health/HAHSTA can thus develop community
education that will address unprotected sex, stigma, disclosure of HIV status to sexual
partners and multiple sex partners. Social marketing techniques could be used to create
awareness of these issues in the community while also equipping clinics with more
clinical providers to serve more people who will choose to return to engage in the
important HIV treatment.
Conclusions
In summary, the strongest predictor for surviving HIV among AA women in the
District of Columbia is having unfettered access to HIV treatment, a level of spirituality,
the availability of antiretroviral medication, engagement in support groups, and viral
suppression. To achieve viral suppression, one must adhere to antiretroviral medication.
Discussion on the importance of viral suppression at the time of diagnosis and during the
course of treatment is very important. This study provided increased knowledge to target
prevention of HIV transmission and highlight the importance of heterosexual
transmission for HIV in DC. Viral suppression predicts positive health outcomes and
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improved immune system. Therefore, any experience of achieving viral suppression will
hopefully translate into decreasing HIV transmission and the community’s viral load.
This study also adds to the wealth of knowledge of stigma on disclosures of HIV status to
sexual partners and the non-use of condoms during sexual intercourse. Targeted HIV
education for DC’s black community should continue to include information on
transmission, biology, treatment and care to provide greater support for all women who
live with HIV.
A compelling argument can be made to support that AA women’s lived
experiences from this qualitative study in the District of Columbia can be generalized to
other women in the District. These study findings illustrated somewhat themes related to
living with HIV including resiliency, self-efficacy, support, spirituality, adherence, viral
suppression, stigma and community education. The accessibility of treatment,
medication, and support groups around the city offers a positive platform that can support
engagement in care. Developing interventions using this new knowledge might be critical
to reducing HIV infection overall.
As the District of Columbia plans to end the HIV epidemic (Bowser, 2017),
taking greater care to develop District wide interventions to address the difficulties
identified in this study is critical. As the nation and the world plans to end the HIV
epidemics (HIV.gov, 2019b; United Nations on AIDS, 2014), the lived experiences of
HIV positive AA women should be incorporated. Prevention interventions can be
informed by the findings of this study and thus help prevent new infections among this
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group and enhance their level of engagement in ongoing focused and effective HIV
treatment.
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Appendix A: Specific Codes and Themes that Emerged from Data and Quotations from
Participants

Themes
1.Diagnosis at
reproductive age
2.Adaptative
ability to lived
experience
3.Era of denials
and not involved
in care

Codes
Reproductive age

•

Family culture

•

Denials at
diagnosis

•

Resilience
Spirituality

•

4.Positive strength Support groups
that contributes to
Pregnancy
resilience
Self-Efficacy

•
•

Relationship

•
•
•
•
•
•
•
•
•

Some Quotations from participants
Everyday say a prayer, God let this
medicine work, God is good
God kept me going, he is my healer,
keep positive attitude, keep my eyes
on the prize, I will be fine
By the grace of God, the meds are
working in your favor because the
meds do not always work in people
favor
When I got pregnant with my 3rd
child, I went back to church where I
started from… when I got myself
together in the church that helped me
to really digest and grasp
The Lord has seen me all of that
Diagnosed when pregnant with first
child
Went to doctor for pregnancy care in
2007
Diagnosed when pregnant at 23 years
with 4th child
A safe place to vent, cry, disseminate
information, give each other
encouragement
HIV is past in my mind, that is why I
do support group
Did drugs heavily for 4 years
There was nothing to live for, no
history, gonna die anyway
If the medicine don’t work, it is out
of my control. The only thing I have
control is taking it
I was undetectable, I will get it right
back
(table continues)
Not powerless, got knowledge and
information
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•
•
•
•
•

•
•

•
•
•
•
•

I immediately went into denial, did
not believe it, I had no feeling
I was in denial at time of diagnosis
and wanted to kill everybody
It took me 10-15 years to get into
care
I have the knowledge that using
medication, will survive and that kept
me going
But there were times, I was tired
about going to the doctors, the only
thing that made me afraid is that I
might catch cold and die
I don’t want to get sick and die
God is good, I found a man that loves
me, he encourages me to take my
medication, he encourages me to
keep positive attitude, there is life
after HIV, really is’
Support group save my life
Housing and support group for
women
Self-esteem groups
Participate in groups
I got involved with many support
groups and is better
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Appendix B: Responses to Question 1a

Responses to question 1a
Themes
Codes
5.Unfettered access Access to good
to good HIV care
care
treatment
Empowerment
6.Importance of
Uniqueness in
daily medication
medication
adherence
adherence
7. Intense
Medication
expectation for
adherence lifeline
cure for HIV
8.Conscientizationpersonal
transformation to
engage in HIV care

Need for cure
Need to survive

•
•
•
•
•
•
•
•
•
•

•
•

•

•
•

Some Quotations from participants
DC is a good place for HIV
treatment
No matter what you have, you will
never be turned away in DC
I did not have problems finding
clinic
Biktarvy once a day, that’s all
I found peace in the midst of my
chaos
I advocate for myself, asks for
medicine ahead of time just in case
they are needed
You have to take medicine, keep all
your doctor’s appointments, if not
you deteriorate really fast
I take it in the afternoon, I don’t
miss it because I take other heart
medicines
It’s about taking medicine
Forgetting to take the medicine is
like leaving your children at the
subway station and leave them, if
any of them die, you will die
One day, there will be a cure
Even though it did not have a cure, I
could still live a long healthy life
with medications and things of that
nature
I think they can make a pill for
that… and I am going to be part of
it... I am a superstar, very special
superstar
Do you think they already have a
cure, they need a cure?
I am satisfied with care but I wanna
to be cured, can they cure us?
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Appendix C: Responses to Question 1b
Responses to Question 1b
Themes
Codes
9.Negative effects Stigma
of HIV stigma on
disclosures
Self-stigma/blame
10. Selfstigma/Blame as
part of barrier to
engagement in
care

Difficult life
journey

•

•

Disclosure silence
•

11.Challenges in
the ‘lived’ HIV
journey

•
•
•

•
•
•
•

Some Quotations from participants
It took me a longtime to forgive
myself, the shame of it…It is bad
enough that outside world to shame
you, it is worst -personal shame
When you tell anyone that you have
HIV, the first question they ask is
how did you contract it? nobody asks
how you contract diabetes or other
diseases
I only self- disclose since my friend
used it against me
I live on daily basis with stigma, I
am very careful in disclosing
Taking a chance, meeting someone
and when do you tell?
Confided in a sister then she became
the enemy, one day, something did
not go her way and now she is
talking bad and disclosed to
others...It did not affect me, it does
not stop a man from trying to take
my draws
It has been a life altering thing that I
face day to day
This is disease that cripples you not
just physically but mentally
It was really hard, life changing
I tried to kill myself, I did, thank
God it did not work, thank God, it
did not work
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Appendix D: Responses to Question 2

Themes
12.Importance of
education of viral
suppression
13.Improved
Clinical Outcomes

Codes
Knowledge at
diagnosis

•
•

Education of viral
suppression
Knowledge of
Viral load
Knowledge of
CD4 count

•
•
•
•

Self-reports and
medical records
•

•
•

•

Some Quotations from participants
I did not learn about viral
suppression
The first that first diagnosed did not
discuss viral suppression
They did not teach me anything but
refer me to teaching hospital clinic
At diagnosis, they did not say
anything that stuck
They did not teach me nothing
No one communicated diagnosis in
small clinic, here you go, HIV
pamphlet and here you go with lots
of people in the waiting room
looking at your HIV pamphlet
She really helped me to come to grip
to understand that what I have, even
though it did not have a cure, I could
still live a long healthy life with
medication and things of that nature
Education at the time of diagnosis,
not in a right frame of mind to
understand teaching
They started me on medication and
the medicine started working
gradually from 2 cells up to 5…CD4
829, undetectable
I achieved viral suppression long
time ago
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Appendix E: Responses to Question 3
Responses to question 3
Themes
Codes
14.Unprotected
Unprotected sex
sex and multiple
sex partners in the Multiple sex
same
partners
neighborhood
Men coming
15.Gender
home
role/Issues in HIV
infection
Nonuse of
condoms
16. NonDisclosures of
Education
HIV status
Engagement
17.The importance
of high
community viral
load
18. Importance of
community
education and
knowledge of HIV
transmission

•
•
•
•
•
•
•
•
•
•

•
•
•
•
•
•

•

Some Quotations from Participants
Multiple partners in close areas
Lots of females do not like condom
They don’t care about their body
You don’t think of anything until it is
over and you wind up with STD
People not knowing their status and
who they are dealing with
Having sex, having sex dealing with
different sex partners
Black woman thinks having a man
means love, sex is not love
Men return from prison
Man coming from incarceration and
not telling the truth
It is not women, it’s the men, 99% of
the time, it came from the men that
has been with another men, came
home and spread it
Education is a key
They should have different messages
for young people positive and
negative
Black men in their manhood cannot
put themselves in anything gay
Health education for everyone, health
education should tell you everything
It is the biggest thing if we have
health education included in groups
Start at 8 years old, teaching more
ladies to care about their
bodies…Start educating and teaching
in the homes and schools, you cannot
get it any other way, eating behind
someone, unprotected sex is the key
factor…Educating young people..
kids having sex, not knowing what
sex means, 8-9 years old having
babies
Education, education got to matter
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•
•
•

They need hotlines for HIV for
people to talk and get help
On community days, get tested and
you don’t have it, take this pill
We need to reach young people walk
to community and talk to people,
some of the other places young
people go to, in the schools, like they
have televisions running different
things
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Appendix F: Permission to Alter Survey Question
From: Machtinger, Edward <
Sent: Monday, August 12, 2019 5:19 PM
To: Christie Olejemeh
Subject: Re: Permission to modify one of your questions from research study
I’m delighted that you found this question helpful and you have my permission to use it.
I’d love to heR more about your work!
Warmly,
Edward Machtinger, MD
Professor of Medicine
UCSF
Sent from my iPhone
On 12 Aug 2019, at 1:47 PM, Christie Olejemeh <christie.olejemeh@waldenu.edu>
wrote:
Good day Professor Edward
My name is Christie Olejemeh, a doctoral student of Public Health at Walden
University. I am making a request to include one of the question in your research in my
study. The referenced journal articles is titled 'An expressive therapy group disclosure
intervention for women living with HIV improves social support, self-efficacy, and the
safety and quality of relationship: A qualitative analysis. Journal of the association of
nurses in AIDS care. 20(2): 187 – 198.http://dx.doi.org/10.1016/j.jana.2014.05.001

The question I want to modify and use states "What was your experience disclosing your
status publicly on stage? and What if any, impact did this experience have on you, your
interaction with others, family and relationships?
I hope to get your permission to use this question. Please let me know. Thank you

Sincerely
Christie Olejemeh

